[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f1kGdu9VeZ2K8WF_CajltbSUH3UUAjTA7g8uwstPGumA":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":36,"phaseBuckets":85,"rows":92},"The Cleveland Clinic",[4],808,false,152,31,415053,51,583,[14,17,20,23,26,28,30,33],{"name":15,"count":16},"Obesity",24,{"name":18,"count":19},"Atrial Fibrillation",19,{"name":21,"count":22},"Surgery",12,{"name":24,"count":25},"Multiple Sclerosis",11,{"name":27,"count":25},"Cardiovascular Diseases",{"name":29,"count":25},"Pain",{"name":31,"count":32},"Parkinson Disease",10,{"name":34,"count":35},"Heart Failure",9,[37,42,47,51,56,61,65,70,75,80],{"nctId":38,"briefTitle":39,"date":40,"intervention":41},"NCT04191681","Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study","2022-03","Sacubitril-Valsartan",{"nctId":43,"briefTitle":44,"date":45,"intervention":46},"NCT04513808","Total Intravenous Anesthesia and Recurrence Free Survival","2025-12","Propofol-based total intravenous anesthesia",{"nctId":48,"briefTitle":49,"date":45,"intervention":50},"NCT04084548","Perioperative Lidocaine and Ketamine in Abdominal Surgery","Lidocaine and ketamine",{"nctId":52,"briefTitle":53,"date":54,"intervention":55},"NCT06212661","Migraine Medication Effects on Urinary Symptoms","2026-05","Ubrogepant",{"nctId":57,"briefTitle":58,"date":59,"intervention":60},"NCT06709573","Early Versus Late Adjunctive Vasopressin in Septic Shock","2026-05-01","vasopressin - early initiation",{"nctId":62,"briefTitle":63,"date":59,"intervention":64},"NCT04371445","Dextenza in the Post-op Management of Vitreoretinal Surgeries","Dexamethasone Ophthalmic Insert",{"nctId":66,"briefTitle":67,"date":68,"intervention":69},"NCT07138560","BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's Disease","2026-05-15","CREXONT ER",{"nctId":71,"briefTitle":72,"date":73,"intervention":74},"NCT06373978","NonNarcotic Pain Control in Percutaneous Needle Tenotomy of Elbow","2026-06-30","Diclofenac",{"nctId":76,"briefTitle":77,"date":78,"intervention":79},"NCT07127354","The Impact of GLP Medication on Colonoscopy Bowel Preparation Quality","2026-08","Continue GLP\u002FGIP",{"nctId":81,"briefTitle":82,"date":83,"intervention":84},"NCT04641351","Corticosteroid Meniscectomy Randomized Trial","2026-08-01","Zilretta Injectable Product or Placebo",[86,87,88,89,90,91],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[93,139,174,195,218,241,259,282,300,322,347,365,398,416,445,472,490,508,526,552,570,624,664,702,728,746,764,782,805,823,846,910,957,980,1003,1037,1063,1089,1107,1125,1151,1177,1195,1221,1239,1257,1275,1293,1311,1329,1347,1365,1402,1435,1472,1496,1514,1540,1558,1584,1602,1628,1646,1673,1691,1717,1735,1760,1783,1808,1826,1850,1875,1899,1924,1950,1968,1986,2013,2039,2063,2081,2099,2117,2140,2164,2188,2214,2232,2257,2283,2301,2327,2345,2363,2387,2410,2435,2453,2471,2489,2516,2541,2567,2585,2611,2635,2658,2682,2710,2728,2754,2772,2796,2822,2840,2858,2876,2900,2950,2977,2995,3020,3047,3069,3087,3112,3138,3162,3180,3198,3224,3249,3267,3293,3316,3342,3365,3383,3409,3427,3484,3521,3547,3598,3632,3662,3692,3729,3757,3790,3818,3843,3879,3909,3933,3958,3981,3999,4017,4035,4053,4071,4094,4112,4130,4148,4173,4199,4223,4247,4273,4291,4313,4339,4357,4375,4397,4415,4441,4459,4483,4501,4525,4543,4561,4584,4608,4626,4650,4673,4698,4739,4761,4783,4807,4828,4846,4864,4891,4909,4935,4960,4978,5003,5021,5039,5057,5082,5100,5118,5142,5166,5188,5211,5235,5261,5279,5347,5409,5446,5502,5537,5576,5615,5654,5680,5713,5738,5773,5795,5822,5844,5872,5894,5926,5957,5975,6000,6025,6048,6072,6090,6111,6136,6161,6179,6203,6226,6251,6275,6302,6328,6346,6368,6390,6415,6442,6460,6478,6496,6514,6536,6554,6576,6594,6617,6639,6661,6687,6705,6723,6741,6764,6786,6810,6828,6852,6870,6894,6912,6933,6951,6969,6995,7013,7038,7056,7080,7103,7126,7144,7162,7185,7209],{"intervention":94,"totalTrials":95,"cells":96},"Orlistat",2,{"EARLY_PHASE1":97,"PHASE1":100,"PHASE2":102,"PHASE3":104,"PHASE4":106,"NA":137},{"trials":98,"activeCount":99},[],0,{"trials":101,"activeCount":99},[],{"trials":103,"activeCount":99},[],{"trials":105,"activeCount":99},[],{"trials":107,"activeCount":136,"soonestReadout":128},[108,123],{"nctId":109,"briefTitle":110,"status":111,"phases":112,"primaryCompletion":113,"completion":114,"start":115,"enrollment":116,"conditions":117,"interventions":119},"NCT04531176","EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial","TERMINATED",[90],"2022-08-15","2023-08-04","2020-09-01",74,[118,15],"Type 2 Diabetes",[120,121,122,94],"Phentermine \u002F Topiramate Extended Release Oral","naltrexone\u002Fbupropion extended-release","liraglutide 3.0 mg",{"nctId":124,"briefTitle":125,"status":126,"phases":127,"primaryCompletion":128,"completion":129,"start":130,"enrollment":131,"conditions":132,"interventions":133},"NCT06854614","Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)","ACTIVE_NOT_RECRUITING",[90],"2027-04-28","2028-04-28","2025-03-01",150,[15],[134,135,94],"Phentermine-Topiramate","Naltrexone-Bupropion Combination",1,{"trials":138,"activeCount":99},[],{"intervention":41,"totalTrials":95,"cells":140},{"EARLY_PHASE1":141,"PHASE1":143,"PHASE2":145,"PHASE3":147,"PHASE4":149,"NA":172},{"trials":142,"activeCount":99},[],{"trials":144,"activeCount":99},[],{"trials":146,"activeCount":99},[],{"trials":148,"activeCount":99},[],{"trials":150,"activeCount":136,"soonestReadout":40},[151,162],{"nctId":152,"briefTitle":153,"status":154,"phases":155,"primaryCompletion":156,"completion":156,"start":157,"enrollment":99,"conditions":158,"interventions":160},"NCT04206865","Comparison of ARNI to Alternate Oral Vasodilator Therapies in Patients With Low Cardiac Output","WITHDRAWN",[90],"2020-09-10","2019-11-25",[159],"Cardiogenic Shock",[41,161],"Standard Oral Vasodilators",{"nctId":38,"briefTitle":39,"status":163,"phases":164,"primaryCompletion":40,"completion":165,"start":166,"enrollment":167,"conditions":168,"interventions":170},"RECRUITING",[90],"2022-12","2019-11-08",50,[169],"Stage D Heart Failure",[41,171],"Usual care (standard-of-care) arm",{"trials":173,"activeCount":99},[],{"intervention":69,"totalTrials":136,"cells":175},{"EARLY_PHASE1":176,"PHASE1":178,"PHASE2":180,"PHASE3":182,"PHASE4":184,"NA":193},{"trials":177,"activeCount":99},[],{"trials":179,"activeCount":99},[],{"trials":181,"activeCount":99},[],{"trials":183,"activeCount":99},[],{"trials":185,"activeCount":136,"soonestReadout":68},[186],{"nctId":66,"briefTitle":67,"status":163,"phases":187,"primaryCompletion":68,"completion":188,"start":189,"enrollment":190,"conditions":191,"interventions":192},[90],"2027-05-15","2025-07-24",22,[31],[69],{"trials":194,"activeCount":99},[],{"intervention":84,"totalTrials":136,"cells":196},{"EARLY_PHASE1":197,"PHASE1":199,"PHASE2":201,"PHASE3":203,"PHASE4":205,"NA":216},{"trials":198,"activeCount":99},[],{"trials":200,"activeCount":99},[],{"trials":202,"activeCount":99},[],{"trials":204,"activeCount":99},[],{"trials":206,"activeCount":136,"soonestReadout":83},[207],{"nctId":81,"briefTitle":82,"status":126,"phases":208,"primaryCompletion":83,"completion":83,"start":209,"enrollment":131,"conditions":210,"interventions":215},[90],"2021-05-27",[211,212,213,214],"Osteoarthritis, Knee","Meniscus Tear","Meniscus; Degeneration","Synovitis",[84],{"trials":217,"activeCount":99},[],{"intervention":74,"totalTrials":136,"cells":219},{"EARLY_PHASE1":220,"PHASE1":222,"PHASE2":224,"PHASE3":226,"PHASE4":228,"NA":239},{"trials":221,"activeCount":99},[],{"trials":223,"activeCount":99},[],{"trials":225,"activeCount":99},[],{"trials":227,"activeCount":99},[],{"trials":229,"activeCount":136,"soonestReadout":73},[230],{"nctId":71,"briefTitle":72,"status":163,"phases":231,"primaryCompletion":73,"completion":73,"start":232,"enrollment":233,"conditions":234,"interventions":237},[90],"2024-08-12",92,[235,236],"Elbow Pain","Chronic Pain",[74,238],"Tramadol",{"trials":240,"activeCount":99},[],{"intervention":238,"totalTrials":136,"cells":242},{"EARLY_PHASE1":243,"PHASE1":245,"PHASE2":247,"PHASE3":249,"PHASE4":251,"NA":257},{"trials":244,"activeCount":99},[],{"trials":246,"activeCount":99},[],{"trials":248,"activeCount":99},[],{"trials":250,"activeCount":99},[],{"trials":252,"activeCount":136,"soonestReadout":73},[253],{"nctId":71,"briefTitle":72,"status":163,"phases":254,"primaryCompletion":73,"completion":73,"start":232,"enrollment":233,"conditions":255,"interventions":256},[90],[235,236],[74,238],{"trials":258,"activeCount":99},[],{"intervention":60,"totalTrials":136,"cells":260},{"EARLY_PHASE1":261,"PHASE1":263,"PHASE2":265,"PHASE3":267,"PHASE4":269,"NA":280},{"trials":262,"activeCount":99},[],{"trials":264,"activeCount":99},[],{"trials":266,"activeCount":99},[],{"trials":268,"activeCount":99},[],{"trials":270,"activeCount":136,"soonestReadout":59},[271],{"nctId":57,"briefTitle":58,"status":163,"phases":272,"primaryCompletion":59,"completion":59,"start":273,"enrollment":274,"conditions":275,"interventions":278},[90],"2025-04-29",300,[276,277],"Sepsis","Septic Shock",[60,279],"vasopressin - standard initiation",{"trials":281,"activeCount":99},[],{"intervention":279,"totalTrials":136,"cells":283},{"EARLY_PHASE1":284,"PHASE1":286,"PHASE2":288,"PHASE3":290,"PHASE4":292,"NA":298},{"trials":285,"activeCount":99},[],{"trials":287,"activeCount":99},[],{"trials":289,"activeCount":99},[],{"trials":291,"activeCount":99},[],{"trials":293,"activeCount":136,"soonestReadout":59},[294],{"nctId":57,"briefTitle":58,"status":163,"phases":295,"primaryCompletion":59,"completion":59,"start":273,"enrollment":274,"conditions":296,"interventions":297},[90],[276,277],[60,279],{"trials":299,"activeCount":99},[],{"intervention":79,"totalTrials":136,"cells":301},{"EARLY_PHASE1":302,"PHASE1":304,"PHASE2":306,"PHASE3":308,"PHASE4":310,"NA":320},{"trials":303,"activeCount":99},[],{"trials":305,"activeCount":99},[],{"trials":307,"activeCount":99},[],{"trials":309,"activeCount":99},[],{"trials":311,"activeCount":136,"soonestReadout":78},[312],{"nctId":76,"briefTitle":77,"status":163,"phases":313,"primaryCompletion":78,"completion":78,"start":314,"enrollment":315,"conditions":316,"interventions":319},[90],"2025-08-01",132,[317,318],"GLP - 1","Bowel Preparation for Colonoscopy",[79],{"trials":321,"activeCount":99},[],{"intervention":64,"totalTrials":136,"cells":323},{"EARLY_PHASE1":324,"PHASE1":326,"PHASE2":328,"PHASE3":330,"PHASE4":332,"NA":345},{"trials":325,"activeCount":99},[],{"trials":327,"activeCount":99},[],{"trials":329,"activeCount":99},[],{"trials":331,"activeCount":99},[],{"trials":333,"activeCount":136,"soonestReadout":59},[334],{"nctId":62,"briefTitle":63,"status":163,"phases":335,"primaryCompletion":59,"completion":59,"start":336,"enrollment":337,"conditions":338,"interventions":343},[90],"2020-06-01",30,[339,340,341,342],"Vitreoretinal Surgery","Ocular Inflammation","Post-operative Pain","Post-Operative Inflammation",[64,344],"Prednisolone Acetate 1% Oph Susp",{"trials":346,"activeCount":99},[],{"intervention":344,"totalTrials":136,"cells":348},{"EARLY_PHASE1":349,"PHASE1":351,"PHASE2":353,"PHASE3":355,"PHASE4":357,"NA":363},{"trials":350,"activeCount":99},[],{"trials":352,"activeCount":99},[],{"trials":354,"activeCount":99},[],{"trials":356,"activeCount":99},[],{"trials":358,"activeCount":136,"soonestReadout":59},[359],{"nctId":62,"briefTitle":63,"status":163,"phases":360,"primaryCompletion":59,"completion":59,"start":336,"enrollment":337,"conditions":361,"interventions":362},[90],[339,340,341,342],[64,344],{"trials":364,"activeCount":99},[],{"intervention":366,"totalTrials":136,"cells":367},"OnabotulinumtoxinA",{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":396},{"trials":369,"activeCount":99},[],{"trials":371,"activeCount":99},[],{"trials":373,"activeCount":99},[],{"trials":375,"activeCount":99},[],{"trials":377,"activeCount":136,"soonestReadout":382},[378],{"nctId":379,"briefTitle":380,"status":163,"phases":381,"primaryCompletion":382,"completion":383,"start":384,"enrollment":385,"conditions":386,"interventions":394},"NCT07220382","Preoperative BOTOX® Injection for Large Ventral Hernia Repair",[90],"2027-12-15","2029-12-15","2025-11-03",188,[387,388,389,390,391,392,393],"Hernia Abdominal Wall","Botox Injection","Hernia Incisional Ventral","Hernia Repair With Compartment Syndrome","Hernia Surgery","Hernia","Hernia Incisional",[366,395],"0.9 % Normal Saline",{"trials":397,"activeCount":99},[],{"intervention":395,"totalTrials":136,"cells":399},{"EARLY_PHASE1":400,"PHASE1":402,"PHASE2":404,"PHASE3":406,"PHASE4":408,"NA":414},{"trials":401,"activeCount":99},[],{"trials":403,"activeCount":99},[],{"trials":405,"activeCount":99},[],{"trials":407,"activeCount":99},[],{"trials":409,"activeCount":136,"soonestReadout":382},[410],{"nctId":379,"briefTitle":380,"status":163,"phases":411,"primaryCompletion":382,"completion":383,"start":384,"enrollment":385,"conditions":412,"interventions":413},[90],[387,388,389,390,391,392,393],[366,395],{"trials":415,"activeCount":99},[],{"intervention":417,"totalTrials":136,"cells":418},"Anti-Obesity Pharmacotherapy",{"EARLY_PHASE1":419,"PHASE1":421,"PHASE2":423,"PHASE3":425,"PHASE4":427,"NA":443},{"trials":420,"activeCount":99},[],{"trials":422,"activeCount":99},[],{"trials":424,"activeCount":99},[],{"trials":426,"activeCount":99},[],{"trials":428,"activeCount":136,"soonestReadout":433},[429],{"nctId":430,"briefTitle":431,"status":163,"phases":432,"primaryCompletion":433,"completion":434,"start":435,"enrollment":436,"conditions":437,"interventions":442},"NCT07058155","Optimizing Portal Hypertension With TIPS and Interval Metabolic Surgery for Advanced Liver Disease",[90],"2029-02-01","2034-02-01","2025-12-17",70,[438,439,440,441],"Liver Cirrhoses","Portal Hypertension Related to Cirrhosis","Severe Obesity","TIPS",[417],{"trials":444,"activeCount":99},[],{"intervention":446,"totalTrials":136,"cells":447},"Methadone",{"EARLY_PHASE1":448,"PHASE1":450,"PHASE2":452,"PHASE3":454,"PHASE4":456,"NA":470},{"trials":449,"activeCount":99},[],{"trials":451,"activeCount":99},[],{"trials":453,"activeCount":99},[],{"trials":455,"activeCount":99},[],{"trials":457,"activeCount":136,"soonestReadout":462},[458],{"nctId":459,"briefTitle":460,"status":163,"phases":461,"primaryCompletion":462,"completion":463,"start":464,"enrollment":465,"conditions":466,"interventions":469},"NCT07222072","Methadone to Reduce Chronic Opioid Use After Major Spine Surgery: The MEND Pilot Feasibility Study",[90],"2027-10","2028-10","2025-11-15",120,[467,468],"Post Operative Pain","Spinal Surgery",[446],{"trials":471,"activeCount":99},[],{"intervention":171,"totalTrials":136,"cells":473},{"EARLY_PHASE1":474,"PHASE1":476,"PHASE2":478,"PHASE3":480,"PHASE4":482,"NA":488},{"trials":475,"activeCount":99},[],{"trials":477,"activeCount":99},[],{"trials":479,"activeCount":99},[],{"trials":481,"activeCount":99},[],{"trials":483,"activeCount":136,"soonestReadout":40},[484],{"nctId":38,"briefTitle":39,"status":163,"phases":485,"primaryCompletion":40,"completion":165,"start":166,"enrollment":167,"conditions":486,"interventions":487},[90],[169],[41,171],{"trials":489,"activeCount":99},[],{"intervention":134,"totalTrials":136,"cells":491},{"EARLY_PHASE1":492,"PHASE1":494,"PHASE2":496,"PHASE3":498,"PHASE4":500,"NA":506},{"trials":493,"activeCount":99},[],{"trials":495,"activeCount":99},[],{"trials":497,"activeCount":99},[],{"trials":499,"activeCount":99},[],{"trials":501,"activeCount":136,"soonestReadout":128},[502],{"nctId":124,"briefTitle":125,"status":126,"phases":503,"primaryCompletion":128,"completion":129,"start":130,"enrollment":131,"conditions":504,"interventions":505},[90],[15],[134,135,94],{"trials":507,"activeCount":99},[],{"intervention":135,"totalTrials":136,"cells":509},{"EARLY_PHASE1":510,"PHASE1":512,"PHASE2":514,"PHASE3":516,"PHASE4":518,"NA":524},{"trials":511,"activeCount":99},[],{"trials":513,"activeCount":99},[],{"trials":515,"activeCount":99},[],{"trials":517,"activeCount":99},[],{"trials":519,"activeCount":136,"soonestReadout":128},[520],{"nctId":124,"briefTitle":125,"status":126,"phases":521,"primaryCompletion":128,"completion":129,"start":130,"enrollment":131,"conditions":522,"interventions":523},[90],[15],[134,135,94],{"trials":525,"activeCount":99},[],{"intervention":527,"totalTrials":136,"cells":528},"Early Highly Effective Therapies Group",{"EARLY_PHASE1":529,"PHASE1":531,"PHASE2":533,"PHASE3":535,"PHASE4":537,"NA":550},{"trials":530,"activeCount":99},[],{"trials":532,"activeCount":99},[],{"trials":534,"activeCount":99},[],{"trials":536,"activeCount":99},[],{"trials":538,"activeCount":136,"soonestReadout":543},[539],{"nctId":540,"briefTitle":541,"status":126,"phases":542,"primaryCompletion":543,"completion":543,"start":544,"enrollment":545,"conditions":546,"interventions":548},"NCT03535298","Determining the Effectiveness of earLy Intensive Versus Escalation Approaches for RRMS",[90],"2027-07-30","2019-01-03",800,[547],"Multiple Sclerosis, Relapsing-Remitting",[527,549],"Escalation Therapies Group",{"trials":551,"activeCount":99},[],{"intervention":549,"totalTrials":136,"cells":553},{"EARLY_PHASE1":554,"PHASE1":556,"PHASE2":558,"PHASE3":560,"PHASE4":562,"NA":568},{"trials":555,"activeCount":99},[],{"trials":557,"activeCount":99},[],{"trials":559,"activeCount":99},[],{"trials":561,"activeCount":99},[],{"trials":563,"activeCount":136,"soonestReadout":543},[564],{"nctId":540,"briefTitle":541,"status":126,"phases":565,"primaryCompletion":543,"completion":543,"start":544,"enrollment":545,"conditions":566,"interventions":567},[90],[547],[527,549],{"trials":569,"activeCount":99},[],{"intervention":571,"totalTrials":95,"cells":572},"Botulinum Toxin A",{"EARLY_PHASE1":573,"PHASE1":575,"PHASE2":577,"PHASE3":579,"PHASE4":598,"NA":600},{"trials":574,"activeCount":99},[],{"trials":576,"activeCount":99},[],{"trials":578,"activeCount":99},[],{"trials":580,"activeCount":136,"soonestReadout":585},[581],{"nctId":582,"briefTitle":583,"status":163,"phases":584,"primaryCompletion":585,"completion":586,"start":587,"enrollment":588,"conditions":589,"interventions":597},"NCT06721520","Effectiveness of Methods for Pyloric Drainage in esophagecTomY: Botox vs. Pyloromyotomy",[88,89],"2027-12-31","2028-05-31","2024-12-03",170,[590,591,592,593,594,595,596],"Esophageal Cancer Surgery","Esophagectomy","Delayed Gastric Emptying Following Procedure","Esophageal Diseases","Esophageal Achalasia","Pylorus Dysfunction","Esophageal Dysmotility",[571],{"trials":599,"activeCount":99},[],{"trials":601,"activeCount":136,"soonestReadout":54},[602],{"nctId":52,"briefTitle":53,"status":603,"phases":604,"primaryCompletion":54,"completion":605,"start":606,"enrollment":607,"conditions":608,"interventions":616},"ENROLLING_BY_INVITATION",[],"2026-12","2024-04-05",200,[609,610,611,612,613,614,615],"Overactive Bladder","Bladder Pain Syndrome","Migraine Disorders","Overactive Bladder Syndrome","Overactive Detrusor","Migraine","Interstitial Cystitis",[55,617,618,619,620,621,622,623],"Rimegepant","Atogepant","Eptinezumab","Fremanezumab","Galcanezumab","Erenumab","Botulinum toxin A",{"intervention":625,"totalTrials":95,"cells":626},"Ketorolac",{"EARLY_PHASE1":627,"PHASE1":629,"PHASE2":631,"PHASE3":633,"PHASE4":647,"NA":662},{"trials":628,"activeCount":99},[],{"trials":630,"activeCount":99},[],{"trials":632,"activeCount":99},[],{"trials":634,"activeCount":136,"soonestReadout":639},[635],{"nctId":636,"briefTitle":637,"status":163,"phases":638,"primaryCompletion":639,"completion":640,"start":641,"enrollment":337,"conditions":642,"interventions":645},"NCT06973785","Non-Narcotic Pain Control After ACL Reconstruction",[89],"2026-09-30","2026-12-31","2025-07-15",[643,644],"ACL - Anterior Cruciate Ligament Rupture","ACL Injuries",[646,625],"dispense of study drug",{"trials":648,"activeCount":99},[649],{"nctId":650,"briefTitle":651,"status":652,"phases":653,"primaryCompletion":654,"completion":654,"start":655,"enrollment":656,"conditions":657,"interventions":660},"NCT03888144","Study of Ketorolac Versus Opioid for Pain After Endoscopy","COMPLETED",[90],"2021-08-01","2017-10-13",81,[658,659],"Kidney Calculi","Ureteral Calculi",[661,625],"Oxycodone",{"trials":663,"activeCount":99},[],{"intervention":665,"totalTrials":95,"cells":666},"Triamcinolone",{"EARLY_PHASE1":667,"PHASE1":669,"PHASE2":671,"PHASE3":673,"PHASE4":698,"NA":700},{"trials":668,"activeCount":99},[],{"trials":670,"activeCount":99},[],{"trials":672,"activeCount":99},[],{"trials":674,"activeCount":136,"soonestReadout":680},[675,687],{"nctId":676,"briefTitle":677,"status":678,"phases":679,"primaryCompletion":680,"completion":681,"start":68,"enrollment":682,"conditions":683,"interventions":685},"NCT04990128","Bone Marrow Aspirate Concentrate Versus Triamcinolone Injection For Hip Osteoarthritis","NOT_YET_RECRUITING",[89],"2027-07","2027-11",100,[684],"Hip Osteoarthritis",[686,665],"Aspire Needle + Emcyte PureBMC",{"nctId":688,"briefTitle":689,"status":652,"phases":690,"primaryCompletion":691,"completion":691,"start":692,"enrollment":693,"conditions":694,"interventions":696},"NCT00658736","Efficacy of EUS-guided Celiac Plexus Blockade in Chronic Pancreatitis",[89],"2011-01","2008-03",40,[695],"Chronic Pancreatitis",[665,697],"Bupivicaine alone",{"trials":699,"activeCount":99},[],{"trials":701,"activeCount":99},[],{"intervention":703,"totalTrials":136,"cells":704},"2 mg\u002Fkg sugammadex",{"EARLY_PHASE1":705,"PHASE1":707,"PHASE2":709,"PHASE3":711,"PHASE4":724,"NA":726},{"trials":706,"activeCount":99},[],{"trials":708,"activeCount":99},[],{"trials":710,"activeCount":99},[],{"trials":712,"activeCount":136,"soonestReadout":717},[713],{"nctId":714,"briefTitle":715,"status":163,"phases":716,"primaryCompletion":717,"completion":640,"start":718,"enrollment":719,"conditions":720,"interventions":722},"NCT06136585","Sugammadex Vs Neostigmine in Reversing Neuromuscular Blocks in Outpatient ERCP. A Randomized, Double-Blinded Trial",[89],"2026-10-31","2024-06-01",80,[721],"Neuromuscular Blocks",[703,723],"0.07 mg\u002Fkg neostigmine",{"trials":725,"activeCount":99},[],{"trials":727,"activeCount":99},[],{"intervention":723,"totalTrials":136,"cells":729},{"EARLY_PHASE1":730,"PHASE1":732,"PHASE2":734,"PHASE3":736,"PHASE4":742,"NA":744},{"trials":731,"activeCount":99},[],{"trials":733,"activeCount":99},[],{"trials":735,"activeCount":99},[],{"trials":737,"activeCount":136,"soonestReadout":717},[738],{"nctId":714,"briefTitle":715,"status":163,"phases":739,"primaryCompletion":717,"completion":640,"start":718,"enrollment":719,"conditions":740,"interventions":741},[89],[721],[703,723],{"trials":743,"activeCount":99},[],{"trials":745,"activeCount":99},[],{"intervention":646,"totalTrials":136,"cells":747},{"EARLY_PHASE1":748,"PHASE1":750,"PHASE2":752,"PHASE3":754,"PHASE4":760,"NA":762},{"trials":749,"activeCount":99},[],{"trials":751,"activeCount":99},[],{"trials":753,"activeCount":99},[],{"trials":755,"activeCount":136,"soonestReadout":639},[756],{"nctId":636,"briefTitle":637,"status":163,"phases":757,"primaryCompletion":639,"completion":640,"start":641,"enrollment":337,"conditions":758,"interventions":759},[89],[643,644],[646,625],{"trials":761,"activeCount":99},[],{"trials":763,"activeCount":99},[],{"intervention":686,"totalTrials":136,"cells":765},{"EARLY_PHASE1":766,"PHASE1":768,"PHASE2":770,"PHASE3":772,"PHASE4":778,"NA":780},{"trials":767,"activeCount":99},[],{"trials":769,"activeCount":99},[],{"trials":771,"activeCount":99},[],{"trials":773,"activeCount":136,"soonestReadout":680},[774],{"nctId":676,"briefTitle":677,"status":678,"phases":775,"primaryCompletion":680,"completion":681,"start":68,"enrollment":682,"conditions":776,"interventions":777},[89],[684],[686,665],{"trials":779,"activeCount":99},[],{"trials":781,"activeCount":99},[],{"intervention":46,"totalTrials":136,"cells":783},{"EARLY_PHASE1":784,"PHASE1":786,"PHASE2":788,"PHASE3":790,"PHASE4":801,"NA":803},{"trials":785,"activeCount":99},[],{"trials":787,"activeCount":99},[],{"trials":789,"activeCount":99},[],{"trials":791,"activeCount":136,"soonestReadout":45},[792],{"nctId":43,"briefTitle":44,"status":163,"phases":793,"primaryCompletion":45,"completion":794,"start":795,"enrollment":796,"conditions":797,"interventions":799},[89],"2027-12","2020-08-15",1614,[798],"Esophageal Cancer",[46,800],"Sevoflurane intravenous anesthesia",{"trials":802,"activeCount":99},[],{"trials":804,"activeCount":99},[],{"intervention":800,"totalTrials":136,"cells":806},{"EARLY_PHASE1":807,"PHASE1":809,"PHASE2":811,"PHASE3":813,"PHASE4":819,"NA":821},{"trials":808,"activeCount":99},[],{"trials":810,"activeCount":99},[],{"trials":812,"activeCount":99},[],{"trials":814,"activeCount":136,"soonestReadout":45},[815],{"nctId":43,"briefTitle":44,"status":163,"phases":816,"primaryCompletion":45,"completion":794,"start":795,"enrollment":796,"conditions":817,"interventions":818},[89],[798],[46,800],{"trials":820,"activeCount":99},[],{"trials":822,"activeCount":99},[],{"intervention":50,"totalTrials":136,"cells":824},{"EARLY_PHASE1":825,"PHASE1":827,"PHASE2":829,"PHASE3":831,"PHASE4":842,"NA":844},{"trials":826,"activeCount":99},[],{"trials":828,"activeCount":99},[],{"trials":830,"activeCount":99},[],{"trials":832,"activeCount":136,"soonestReadout":45},[833],{"nctId":48,"briefTitle":49,"status":126,"phases":834,"primaryCompletion":45,"completion":45,"start":835,"enrollment":836,"conditions":837,"interventions":839},[89],"2019-10-15",420,[838],"Postoperative Pain",[50,840,841],"Lidocaine","Ketamine",{"trials":843,"activeCount":99},[],{"trials":845,"activeCount":99},[],{"intervention":840,"totalTrials":847,"cells":848},5,{"EARLY_PHASE1":849,"PHASE1":851,"PHASE2":853,"PHASE3":855,"PHASE4":861,"NA":876},{"trials":850,"activeCount":99},[],{"trials":852,"activeCount":99},[],{"trials":854,"activeCount":99},[],{"trials":856,"activeCount":136,"soonestReadout":45},[857],{"nctId":48,"briefTitle":49,"status":126,"phases":858,"primaryCompletion":45,"completion":45,"start":835,"enrollment":836,"conditions":859,"interventions":860},[89],[838],[50,840,841],{"trials":862,"activeCount":99},[863],{"nctId":864,"briefTitle":865,"status":652,"phases":866,"completion":867,"start":868,"enrollment":869,"conditions":870,"interventions":874},"NCT00330941","Intravenous Lidocaine and Acute Rehabilitation",[90],"2004-12","2003-01",45,[871,872,873],"Pain, Postoperative","Opioid Consumption, Postoperative","Postoperative Fatigue",[875],"lidocaine",{"trials":877,"activeCount":99},[878,890,899],{"nctId":879,"briefTitle":880,"status":111,"phases":881,"primaryCompletion":882,"completion":883,"start":884,"enrollment":885,"conditions":886,"interventions":888},"NCT00721110","Lidocaine and Ketamine in Abdominal Surgery",[91],"2010-10","2012-07","2008-07",64,[887],"Abdominal Hysterectomy (& Wertheim)",[840,841,889],"Ketamine + Lidocaine",{"nctId":891,"briefTitle":892,"status":111,"phases":893,"primaryCompletion":894,"completion":894,"start":895,"enrollment":896,"conditions":897,"interventions":898},"NCT00840918","Intravenous Lidocaine and Postoperative Outcomes After Cardiac Surgery",[91],"2014-12-15","2009-02",123,[18],[840],{"nctId":900,"briefTitle":901,"status":652,"phases":902,"primaryCompletion":903,"completion":904,"start":905,"enrollment":906,"conditions":907,"interventions":909},"NCT00840996","Perioperative Intravenous Lidocaine or Epidural Anesthesia on Outcomes in Complex Spine Surgery",[91],"2011-12","2012-02","2008-05",116,[908],"Spine Surgery",[840],{"intervention":841,"totalTrials":911,"cells":912},4,{"EARLY_PHASE1":913,"PHASE1":915,"PHASE2":917,"PHASE3":919,"PHASE4":936,"NA":938},{"trials":914,"activeCount":99},[],{"trials":916,"activeCount":99},[],{"trials":918,"activeCount":99},[],{"trials":920,"activeCount":136,"soonestReadout":45},[921,932],{"nctId":922,"briefTitle":923,"status":652,"phases":924,"primaryCompletion":925,"completion":925,"start":926,"enrollment":927,"conditions":928,"interventions":930},"NCT03831854","Lamotrigine in Reducing Psychologic Side-Effect of Perioperative Ketamine",[89],"2020-12-31","2019-01-24",46,[929],"Reducing Psychological Side Effects of Ketamine",[931,841],"Lamotrigine 300 MG",{"nctId":48,"briefTitle":49,"status":126,"phases":933,"primaryCompletion":45,"completion":45,"start":835,"enrollment":836,"conditions":934,"interventions":935},[89],[838],[50,840,841],{"trials":937,"activeCount":99},[],{"trials":939,"activeCount":99},[940,944],{"nctId":879,"briefTitle":880,"status":111,"phases":941,"primaryCompletion":882,"completion":883,"start":884,"enrollment":885,"conditions":942,"interventions":943},[91],[887],[840,841,889],{"nctId":945,"briefTitle":946,"status":652,"phases":947,"primaryCompletion":948,"completion":948,"start":949,"enrollment":950,"conditions":951,"interventions":955},"NCT02522377","Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression",[91],"2018-03-01","2015-08",15,[952,953,954],"Treatment Resistant Depression","Major Depressive Disorder","Severe Depression",[841,956],"Midazolam",{"intervention":958,"totalTrials":136,"cells":959},"Tirzepatide",{"EARLY_PHASE1":960,"PHASE1":962,"PHASE2":964,"PHASE3":974,"PHASE4":976,"NA":978},{"trials":961,"activeCount":99},[],{"trials":963,"activeCount":99},[],{"trials":965,"activeCount":136,"soonestReadout":640},[966],{"nctId":967,"briefTitle":968,"status":163,"phases":969,"primaryCompletion":640,"completion":970,"start":971,"enrollment":682,"conditions":972,"interventions":973},"NCT06802081","TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation",[88],"2027-06-01","2025-04-08",[18,15],[958],{"trials":975,"activeCount":99},[],{"trials":977,"activeCount":99},[],{"trials":979,"activeCount":99},[],{"intervention":981,"totalTrials":136,"cells":982},"Ruxolitinib Topical Cream",{"EARLY_PHASE1":983,"PHASE1":985,"PHASE2":987,"PHASE3":997,"PHASE4":999,"NA":1001},{"trials":984,"activeCount":99},[],{"trials":986,"activeCount":99},[],{"trials":988,"activeCount":136,"soonestReadout":605},[989],{"nctId":990,"briefTitle":991,"status":163,"phases":992,"primaryCompletion":605,"completion":794,"start":993,"enrollment":950,"conditions":994,"interventions":996},"NCT06857240","Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis",[88],"2025-06-01",[995],"Dermatomyositis",[981],{"trials":998,"activeCount":99},[],{"trials":1000,"activeCount":99},[],{"trials":1002,"activeCount":99},[],{"intervention":1004,"totalTrials":95,"cells":1005},"Sodium Hyaluronate",{"EARLY_PHASE1":1006,"PHASE1":1027,"PHASE2":1029,"PHASE3":1031,"PHASE4":1033,"NA":1035},{"trials":1007,"activeCount":95,"soonestReadout":1012},[1008,1018],{"nctId":1009,"briefTitle":1010,"status":163,"phases":1011,"primaryCompletion":1012,"completion":1013,"start":1014,"enrollment":16,"conditions":1015,"interventions":1017},"NCT05025865","HA35 Acute Alcohol Study",[86],"2026-10-01","2027-10-01","2022-02-01",[1016],"Healthy Controls",[1004],{"nctId":1019,"briefTitle":1020,"status":163,"phases":1021,"primaryCompletion":1012,"completion":1013,"start":1022,"enrollment":1023,"conditions":1024,"interventions":1026},"NCT05018481","HA35 Moderate Alcoholic Hepatitis (AH) Study",[86],"2022-09-01",54,[1025],"Alcoholic Hepatitis",[1004],{"trials":1028,"activeCount":99},[],{"trials":1030,"activeCount":99},[],{"trials":1032,"activeCount":99},[],{"trials":1034,"activeCount":99},[],{"trials":1036,"activeCount":99},[],{"intervention":1038,"totalTrials":136,"cells":1039},"Giapreza",{"EARLY_PHASE1":1040,"PHASE1":1053,"PHASE2":1055,"PHASE3":1057,"PHASE4":1059,"NA":1061},{"trials":1041,"activeCount":136,"soonestReadout":1046},[1042],{"nctId":1043,"briefTitle":1044,"status":126,"phases":1045,"primaryCompletion":1046,"completion":1046,"start":1047,"enrollment":337,"conditions":1048,"interventions":1052},"NCT07568275","Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance",[86],"2028-01","2024-11-15",[277,1049,1050,1051],"Cirrhosis","Vasodilatory Shock","Acute Kidney Injury",[1038],{"trials":1054,"activeCount":99},[],{"trials":1056,"activeCount":99},[],{"trials":1058,"activeCount":99},[],{"trials":1060,"activeCount":99},[],{"trials":1062,"activeCount":99},[],{"intervention":1064,"totalTrials":136,"cells":1065},"Antibiotics",{"EARLY_PHASE1":1066,"PHASE1":1079,"PHASE2":1081,"PHASE3":1083,"PHASE4":1085,"NA":1087},{"trials":1067,"activeCount":136,"soonestReadout":794},[1068],{"nctId":1069,"briefTitle":1070,"status":126,"phases":1071,"primaryCompletion":794,"completion":1072,"start":1073,"enrollment":682,"conditions":1074,"interventions":1076},"NCT01731236","CARNIVAL Study: Gut Flora Dependent Metabolism of Dietary CARNItine and Phosphatidylcholine and cardioVAscuLar Disease",[86],"2029-12","2011-02-11",[1075],"Dietary Modification",[1064,1077,1078],"Choline and Aspirin","Carnitine and Aspirin",{"trials":1080,"activeCount":99},[],{"trials":1082,"activeCount":99},[],{"trials":1084,"activeCount":99},[],{"trials":1086,"activeCount":99},[],{"trials":1088,"activeCount":99},[],{"intervention":1077,"totalTrials":136,"cells":1090},{"EARLY_PHASE1":1091,"PHASE1":1097,"PHASE2":1099,"PHASE3":1101,"PHASE4":1103,"NA":1105},{"trials":1092,"activeCount":136,"soonestReadout":794},[1093],{"nctId":1069,"briefTitle":1070,"status":126,"phases":1094,"primaryCompletion":794,"completion":1072,"start":1073,"enrollment":682,"conditions":1095,"interventions":1096},[86],[1075],[1064,1077,1078],{"trials":1098,"activeCount":99},[],{"trials":1100,"activeCount":99},[],{"trials":1102,"activeCount":99},[],{"trials":1104,"activeCount":99},[],{"trials":1106,"activeCount":99},[],{"intervention":1078,"totalTrials":136,"cells":1108},{"EARLY_PHASE1":1109,"PHASE1":1115,"PHASE2":1117,"PHASE3":1119,"PHASE4":1121,"NA":1123},{"trials":1110,"activeCount":136,"soonestReadout":794},[1111],{"nctId":1069,"briefTitle":1070,"status":126,"phases":1112,"primaryCompletion":794,"completion":1072,"start":1073,"enrollment":682,"conditions":1113,"interventions":1114},[86],[1075],[1064,1077,1078],{"trials":1116,"activeCount":99},[],{"trials":1118,"activeCount":99},[],{"trials":1120,"activeCount":99},[],{"trials":1122,"activeCount":99},[],{"trials":1124,"activeCount":99},[],{"intervention":1126,"totalTrials":136,"cells":1127},"whole lung allergen challenge",{"EARLY_PHASE1":1128,"PHASE1":1141,"PHASE2":1143,"PHASE3":1145,"PHASE4":1147,"NA":1149},{"trials":1129,"activeCount":136,"soonestReadout":1134},[1130],{"nctId":1131,"briefTitle":1132,"status":603,"phases":1133,"primaryCompletion":1134,"completion":1134,"start":691,"enrollment":1135,"conditions":1136,"interventions":1140},"NCT01536522","Asthma Inflammation Research",[86],"2027-06",60,[1137,1138,1139],"Asthma","Allergic Asthma","Non-allergic Asthma",[1126],{"trials":1142,"activeCount":99},[],{"trials":1144,"activeCount":99},[],{"trials":1146,"activeCount":99},[],{"trials":1148,"activeCount":99},[],{"trials":1150,"activeCount":99},[],{"intervention":1152,"totalTrials":136,"cells":1153},"Nifedipine and Enalapril",{"EARLY_PHASE1":1154,"PHASE1":1156,"PHASE2":1158,"PHASE3":1160,"PHASE4":1162,"NA":1164},{"trials":1155,"activeCount":99},[],{"trials":1157,"activeCount":99},[],{"trials":1159,"activeCount":99},[],{"trials":1161,"activeCount":99},[],{"trials":1163,"activeCount":99},[],{"trials":1165,"activeCount":136,"soonestReadout":1170},[1166],{"nctId":1167,"briefTitle":1168,"status":678,"phases":1169,"primaryCompletion":1170,"completion":1170,"start":1171,"enrollment":607,"conditions":1172,"interventions":1175},"NCT07363343","Nifedipine and Enalapril vs Nifedipine and Labetalol for the Treatment of Postpartum Hypertension Study",[91],"2029-12-31","2026-02-01",[1173,1174],"Hypertension","Postpartum Preeclampsia",[1152,1176],"Nifedipine and Labetalol",{"intervention":1176,"totalTrials":136,"cells":1178},{"EARLY_PHASE1":1179,"PHASE1":1181,"PHASE2":1183,"PHASE3":1185,"PHASE4":1187,"NA":1189},{"trials":1180,"activeCount":99},[],{"trials":1182,"activeCount":99},[],{"trials":1184,"activeCount":99},[],{"trials":1186,"activeCount":99},[],{"trials":1188,"activeCount":99},[],{"trials":1190,"activeCount":136,"soonestReadout":1170},[1191],{"nctId":1167,"briefTitle":1168,"status":678,"phases":1192,"primaryCompletion":1170,"completion":1170,"start":1171,"enrollment":607,"conditions":1193,"interventions":1194},[91],[1173,1174],[1152,1176],{"intervention":1196,"totalTrials":136,"cells":1197},"Alcohol",{"EARLY_PHASE1":1198,"PHASE1":1200,"PHASE2":1202,"PHASE3":1204,"PHASE4":1206,"NA":1208},{"trials":1199,"activeCount":99},[],{"trials":1201,"activeCount":99},[],{"trials":1203,"activeCount":99},[],{"trials":1205,"activeCount":99},[],{"trials":1207,"activeCount":99},[],{"trials":1209,"activeCount":136,"soonestReadout":1214},[1210],{"nctId":1211,"briefTitle":1212,"status":163,"phases":1213,"primaryCompletion":1214,"completion":1214,"start":1215,"enrollment":1216,"conditions":1217,"interventions":1219},"NCT06293638","Functional Brain Network Changes in Patients Undergoing Deep Brain Stimulation for Essential Tremor",[],"2028-12-31","2024-03-25",55,[1218],"Essential Tremor",[1196,1220],"Alprazolam",{"intervention":1220,"totalTrials":136,"cells":1222},{"EARLY_PHASE1":1223,"PHASE1":1225,"PHASE2":1227,"PHASE3":1229,"PHASE4":1231,"NA":1233},{"trials":1224,"activeCount":99},[],{"trials":1226,"activeCount":99},[],{"trials":1228,"activeCount":99},[],{"trials":1230,"activeCount":99},[],{"trials":1232,"activeCount":99},[],{"trials":1234,"activeCount":136,"soonestReadout":1214},[1235],{"nctId":1211,"briefTitle":1212,"status":163,"phases":1236,"primaryCompletion":1214,"completion":1214,"start":1215,"enrollment":1216,"conditions":1237,"interventions":1238},[],[1218],[1196,1220],{"intervention":55,"totalTrials":136,"cells":1240},{"EARLY_PHASE1":1241,"PHASE1":1243,"PHASE2":1245,"PHASE3":1247,"PHASE4":1249,"NA":1251},{"trials":1242,"activeCount":99},[],{"trials":1244,"activeCount":99},[],{"trials":1246,"activeCount":99},[],{"trials":1248,"activeCount":99},[],{"trials":1250,"activeCount":99},[],{"trials":1252,"activeCount":136,"soonestReadout":54},[1253],{"nctId":52,"briefTitle":53,"status":603,"phases":1254,"primaryCompletion":54,"completion":605,"start":606,"enrollment":607,"conditions":1255,"interventions":1256},[],[609,610,611,612,613,614,615],[55,617,618,619,620,621,622,623],{"intervention":617,"totalTrials":136,"cells":1258},{"EARLY_PHASE1":1259,"PHASE1":1261,"PHASE2":1263,"PHASE3":1265,"PHASE4":1267,"NA":1269},{"trials":1260,"activeCount":99},[],{"trials":1262,"activeCount":99},[],{"trials":1264,"activeCount":99},[],{"trials":1266,"activeCount":99},[],{"trials":1268,"activeCount":99},[],{"trials":1270,"activeCount":136,"soonestReadout":54},[1271],{"nctId":52,"briefTitle":53,"status":603,"phases":1272,"primaryCompletion":54,"completion":605,"start":606,"enrollment":607,"conditions":1273,"interventions":1274},[],[609,610,611,612,613,614,615],[55,617,618,619,620,621,622,623],{"intervention":618,"totalTrials":136,"cells":1276},{"EARLY_PHASE1":1277,"PHASE1":1279,"PHASE2":1281,"PHASE3":1283,"PHASE4":1285,"NA":1287},{"trials":1278,"activeCount":99},[],{"trials":1280,"activeCount":99},[],{"trials":1282,"activeCount":99},[],{"trials":1284,"activeCount":99},[],{"trials":1286,"activeCount":99},[],{"trials":1288,"activeCount":136,"soonestReadout":54},[1289],{"nctId":52,"briefTitle":53,"status":603,"phases":1290,"primaryCompletion":54,"completion":605,"start":606,"enrollment":607,"conditions":1291,"interventions":1292},[],[609,610,611,612,613,614,615],[55,617,618,619,620,621,622,623],{"intervention":619,"totalTrials":136,"cells":1294},{"EARLY_PHASE1":1295,"PHASE1":1297,"PHASE2":1299,"PHASE3":1301,"PHASE4":1303,"NA":1305},{"trials":1296,"activeCount":99},[],{"trials":1298,"activeCount":99},[],{"trials":1300,"activeCount":99},[],{"trials":1302,"activeCount":99},[],{"trials":1304,"activeCount":99},[],{"trials":1306,"activeCount":136,"soonestReadout":54},[1307],{"nctId":52,"briefTitle":53,"status":603,"phases":1308,"primaryCompletion":54,"completion":605,"start":606,"enrollment":607,"conditions":1309,"interventions":1310},[],[609,610,611,612,613,614,615],[55,617,618,619,620,621,622,623],{"intervention":620,"totalTrials":136,"cells":1312},{"EARLY_PHASE1":1313,"PHASE1":1315,"PHASE2":1317,"PHASE3":1319,"PHASE4":1321,"NA":1323},{"trials":1314,"activeCount":99},[],{"trials":1316,"activeCount":99},[],{"trials":1318,"activeCount":99},[],{"trials":1320,"activeCount":99},[],{"trials":1322,"activeCount":99},[],{"trials":1324,"activeCount":136,"soonestReadout":54},[1325],{"nctId":52,"briefTitle":53,"status":603,"phases":1326,"primaryCompletion":54,"completion":605,"start":606,"enrollment":607,"conditions":1327,"interventions":1328},[],[609,610,611,612,613,614,615],[55,617,618,619,620,621,622,623],{"intervention":621,"totalTrials":136,"cells":1330},{"EARLY_PHASE1":1331,"PHASE1":1333,"PHASE2":1335,"PHASE3":1337,"PHASE4":1339,"NA":1341},{"trials":1332,"activeCount":99},[],{"trials":1334,"activeCount":99},[],{"trials":1336,"activeCount":99},[],{"trials":1338,"activeCount":99},[],{"trials":1340,"activeCount":99},[],{"trials":1342,"activeCount":136,"soonestReadout":54},[1343],{"nctId":52,"briefTitle":53,"status":603,"phases":1344,"primaryCompletion":54,"completion":605,"start":606,"enrollment":607,"conditions":1345,"interventions":1346},[],[609,610,611,612,613,614,615],[55,617,618,619,620,621,622,623],{"intervention":622,"totalTrials":136,"cells":1348},{"EARLY_PHASE1":1349,"PHASE1":1351,"PHASE2":1353,"PHASE3":1355,"PHASE4":1357,"NA":1359},{"trials":1350,"activeCount":99},[],{"trials":1352,"activeCount":99},[],{"trials":1354,"activeCount":99},[],{"trials":1356,"activeCount":99},[],{"trials":1358,"activeCount":99},[],{"trials":1360,"activeCount":136,"soonestReadout":54},[1361],{"nctId":52,"briefTitle":53,"status":603,"phases":1362,"primaryCompletion":54,"completion":605,"start":606,"enrollment":607,"conditions":1363,"interventions":1364},[],[609,610,611,612,613,614,615],[55,617,618,619,620,621,622,623],{"intervention":1366,"totalTrials":95,"cells":1367},"Sugammadex",{"EARLY_PHASE1":1368,"PHASE1":1370,"PHASE2":1372,"PHASE3":1374,"PHASE4":1376,"NA":1400},{"trials":1369,"activeCount":99},[],{"trials":1371,"activeCount":99},[],{"trials":1373,"activeCount":99},[],{"trials":1375,"activeCount":99},[],{"trials":1377,"activeCount":99},[1378,1388],{"nctId":1379,"briefTitle":1380,"status":652,"phases":1381,"primaryCompletion":1382,"completion":1382,"start":1383,"enrollment":167,"conditions":1384,"interventions":1386},"NCT05545280","Postoperative Urinary Retention in Patients After Noncardiac Surgery and Reversal of Neuromuscular Block",[90],"2024-08-07","2023-12-01",[1385],"Neuromuscular Blockade",[1387,1366],"Neostigmine with glycopyrrolate",{"nctId":1389,"briefTitle":1390,"status":652,"phases":1391,"primaryCompletion":925,"completion":1392,"start":1393,"enrollment":1394,"conditions":1395,"interventions":1397},"NCT03322657","Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular",[90],"2021-02-01","2017-11-14",69,[1385,1396],"Anesthesia",[1398,1399,1366],"Neostigmine","Glycopyrrolate",{"trials":1401,"activeCount":99},[],{"intervention":1403,"totalTrials":95,"cells":1404},"enoxaparin",{"EARLY_PHASE1":1405,"PHASE1":1407,"PHASE2":1409,"PHASE3":1411,"PHASE4":1413,"NA":1433},{"trials":1406,"activeCount":99},[],{"trials":1408,"activeCount":99},[],{"trials":1410,"activeCount":99},[],{"trials":1412,"activeCount":99},[],{"trials":1414,"activeCount":99},[1415,1424],{"nctId":1416,"briefTitle":1417,"status":652,"phases":1418,"completion":1419,"enrollment":682,"conditions":1420,"interventions":1423},"NCT00298285","ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement",[90],"2006-10",[1421,1422],"Mechanical Valve Replacement","Warfarin Therapy",[1403],{"nctId":1425,"briefTitle":1426,"status":652,"phases":1427,"completion":1428,"start":1429,"enrollment":607,"conditions":1430,"interventions":1431},"NCT00289042","Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)",[90],"2004-11","1999-12",[18],[1432],"Enoxaparin",{"trials":1434,"activeCount":99},[],{"intervention":1436,"totalTrials":95,"cells":1437},"Ticagrelor",{"EARLY_PHASE1":1438,"PHASE1":1440,"PHASE2":1442,"PHASE3":1444,"PHASE4":1456,"NA":1470},{"trials":1439,"activeCount":99},[],{"trials":1441,"activeCount":99},[],{"trials":1443,"activeCount":99},[],{"trials":1445,"activeCount":99},[1446],{"nctId":1447,"briefTitle":1448,"status":111,"phases":1449,"primaryCompletion":1450,"completion":1450,"start":1451,"enrollment":927,"conditions":1452,"interventions":1454},"NCT02230527","Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb Ischemia",[88,89],"2020-05","2014-10",[1453],"Peripheral Arterial Disease",[1436,1455],"Clopidogrel",{"trials":1457,"activeCount":99},[1458],{"nctId":1459,"briefTitle":1460,"status":111,"phases":1461,"primaryCompletion":1462,"completion":1462,"start":1463,"enrollment":1464,"conditions":1465,"interventions":1467},"NCT02291419","Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac Surgery",[90],"2016-06","2015-07",6,[1466],"Myocardial Injury",[1468,1469],"ticagrelor","aspirin",{"trials":1471,"activeCount":99},[],{"intervention":1473,"totalTrials":136,"cells":1474},"Atazanavir\u002Fritonavir",{"EARLY_PHASE1":1475,"PHASE1":1477,"PHASE2":1479,"PHASE3":1481,"PHASE4":1483,"NA":1494},{"trials":1476,"activeCount":99},[],{"trials":1478,"activeCount":99},[],{"trials":1480,"activeCount":99},[],{"trials":1482,"activeCount":99},[],{"trials":1484,"activeCount":99},[1485],{"nctId":1486,"briefTitle":1487,"status":111,"phases":1488,"primaryCompletion":903,"completion":903,"start":882,"enrollment":136,"conditions":1489,"interventions":1492},"NCT01194856","Switching From Efavirenz to Atazanavir\u002F Ritonavir in HIV-infected Subjects With Good Virologic Suppression",[90],[1490,1491],"HIV Infection","Mitochondrial Dysfunction",[1473,1493],"Efavirenz",{"trials":1495,"activeCount":99},[],{"intervention":1493,"totalTrials":136,"cells":1497},{"EARLY_PHASE1":1498,"PHASE1":1500,"PHASE2":1502,"PHASE3":1504,"PHASE4":1506,"NA":1512},{"trials":1499,"activeCount":99},[],{"trials":1501,"activeCount":99},[],{"trials":1503,"activeCount":99},[],{"trials":1505,"activeCount":99},[],{"trials":1507,"activeCount":99},[1508],{"nctId":1486,"briefTitle":1487,"status":111,"phases":1509,"primaryCompletion":903,"completion":903,"start":882,"enrollment":136,"conditions":1510,"interventions":1511},[90],[1490,1491],[1473,1493],{"trials":1513,"activeCount":99},[],{"intervention":1515,"totalTrials":136,"cells":1516},"Sufentanil",{"EARLY_PHASE1":1517,"PHASE1":1519,"PHASE2":1521,"PHASE3":1523,"PHASE4":1525,"NA":1538},{"trials":1518,"activeCount":99},[],{"trials":1520,"activeCount":99},[],{"trials":1522,"activeCount":99},[],{"trials":1524,"activeCount":99},[],{"trials":1526,"activeCount":99},[1527],{"nctId":1528,"briefTitle":1529,"status":111,"phases":1530,"primaryCompletion":1531,"completion":1531,"start":1532,"enrollment":1533,"conditions":1534,"interventions":1536},"NCT04561375","Assessing the Effects of Sublingual Sufentanil 30 µg on Postoperative Recovery",[90],"2022-07-01","2020-12-11",61,[1535],"Knee Arthroscopy",[1515,1537],"Fentanyl",{"trials":1539,"activeCount":99},[],{"intervention":1537,"totalTrials":136,"cells":1541},{"EARLY_PHASE1":1542,"PHASE1":1544,"PHASE2":1546,"PHASE3":1548,"PHASE4":1550,"NA":1556},{"trials":1543,"activeCount":99},[],{"trials":1545,"activeCount":99},[],{"trials":1547,"activeCount":99},[],{"trials":1549,"activeCount":99},[],{"trials":1551,"activeCount":99},[1552],{"nctId":1528,"briefTitle":1529,"status":111,"phases":1553,"primaryCompletion":1531,"completion":1531,"start":1532,"enrollment":1533,"conditions":1554,"interventions":1555},[90],[1535],[1515,1537],{"trials":1557,"activeCount":99},[],{"intervention":1559,"totalTrials":136,"cells":1560},"Selective Serotonin Reuptake Inhibitor",{"EARLY_PHASE1":1561,"PHASE1":1563,"PHASE2":1565,"PHASE3":1567,"PHASE4":1569,"NA":1582},{"trials":1562,"activeCount":99},[],{"trials":1564,"activeCount":99},[],{"trials":1566,"activeCount":99},[],{"trials":1568,"activeCount":99},[],{"trials":1570,"activeCount":99},[1571],{"nctId":1572,"briefTitle":1573,"status":652,"phases":1574,"primaryCompletion":1575,"completion":1575,"start":1576,"enrollment":1577,"conditions":1578,"interventions":1581},"NCT01811147","Differentiating Unipolar and Bipolar Depression in Young Adults Using fMRI",[90],"2018-06","2011-11",192,[1579,1580],"Bipolar Disorder","Major Depression",[1559],{"trials":1583,"activeCount":99},[],{"intervention":1387,"totalTrials":136,"cells":1585},{"EARLY_PHASE1":1586,"PHASE1":1588,"PHASE2":1590,"PHASE3":1592,"PHASE4":1594,"NA":1600},{"trials":1587,"activeCount":99},[],{"trials":1589,"activeCount":99},[],{"trials":1591,"activeCount":99},[],{"trials":1593,"activeCount":99},[],{"trials":1595,"activeCount":99},[1596],{"nctId":1379,"briefTitle":1380,"status":652,"phases":1597,"primaryCompletion":1382,"completion":1382,"start":1383,"enrollment":167,"conditions":1598,"interventions":1599},[90],[1385],[1387,1366],{"trials":1601,"activeCount":99},[],{"intervention":1603,"totalTrials":136,"cells":1604},"Golytely",{"EARLY_PHASE1":1605,"PHASE1":1607,"PHASE2":1609,"PHASE3":1611,"PHASE4":1613,"NA":1626},{"trials":1606,"activeCount":99},[],{"trials":1608,"activeCount":99},[],{"trials":1610,"activeCount":99},[],{"trials":1612,"activeCount":99},[],{"trials":1614,"activeCount":99},[1615],{"nctId":1616,"briefTitle":1617,"status":111,"phases":1618,"primaryCompletion":1619,"completion":1619,"start":1620,"enrollment":1621,"conditions":1622,"interventions":1624},"NCT03198221","Comparison of Clenpiq vs Golytely Bowel Preparation",[90],"2019-03-26","2018-07-11",14,[1623],"Bowel Preparation Solutions",[1603,1625],"Clenpiq",{"trials":1627,"activeCount":99},[],{"intervention":1625,"totalTrials":136,"cells":1629},{"EARLY_PHASE1":1630,"PHASE1":1632,"PHASE2":1634,"PHASE3":1636,"PHASE4":1638,"NA":1644},{"trials":1631,"activeCount":99},[],{"trials":1633,"activeCount":99},[],{"trials":1635,"activeCount":99},[],{"trials":1637,"activeCount":99},[],{"trials":1639,"activeCount":99},[1640],{"nctId":1616,"briefTitle":1617,"status":111,"phases":1641,"primaryCompletion":1619,"completion":1619,"start":1620,"enrollment":1621,"conditions":1642,"interventions":1643},[90],[1623],[1603,1625],{"trials":1645,"activeCount":99},[],{"intervention":1647,"totalTrials":136,"cells":1648},"Toviaz",{"EARLY_PHASE1":1649,"PHASE1":1651,"PHASE2":1653,"PHASE3":1655,"PHASE4":1657,"NA":1671},{"trials":1650,"activeCount":99},[],{"trials":1652,"activeCount":99},[],{"trials":1654,"activeCount":99},[],{"trials":1656,"activeCount":99},[],{"trials":1658,"activeCount":99},[1659],{"nctId":1660,"briefTitle":1661,"status":1662,"phases":1663,"primaryCompletion":1664,"completion":1665,"start":1666,"enrollment":1667,"conditions":1668,"interventions":1669},"NCT01613170","Premarin Versus Toviaz for Treatment of Overactive Bladder","UNKNOWN",[90],"2018-04","2018-12","2012-04",90,[609],[1647,1670],"Premarin",{"trials":1672,"activeCount":99},[],{"intervention":1670,"totalTrials":136,"cells":1674},{"EARLY_PHASE1":1675,"PHASE1":1677,"PHASE2":1679,"PHASE3":1681,"PHASE4":1683,"NA":1689},{"trials":1676,"activeCount":99},[],{"trials":1678,"activeCount":99},[],{"trials":1680,"activeCount":99},[],{"trials":1682,"activeCount":99},[],{"trials":1684,"activeCount":99},[1685],{"nctId":1660,"briefTitle":1661,"status":1662,"phases":1686,"primaryCompletion":1664,"completion":1665,"start":1666,"enrollment":1667,"conditions":1687,"interventions":1688},[90],[609],[1647,1670],{"trials":1690,"activeCount":99},[],{"intervention":1692,"totalTrials":136,"cells":1693},"Dexamethasone implant",{"EARLY_PHASE1":1694,"PHASE1":1696,"PHASE2":1698,"PHASE3":1700,"PHASE4":1702,"NA":1715},{"trials":1695,"activeCount":99},[],{"trials":1697,"activeCount":99},[],{"trials":1699,"activeCount":99},[],{"trials":1701,"activeCount":99},[],{"trials":1703,"activeCount":99},[1704],{"nctId":1705,"briefTitle":1706,"status":652,"phases":1707,"primaryCompletion":1708,"completion":1708,"start":1709,"enrollment":1710,"conditions":1711,"interventions":1713},"NCT04411693","Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema",[90],"2024-01-31","2020-04-10",23,[1712],"Diabetic Macular Edema",[1692,1714],"Aflibercept",{"trials":1716,"activeCount":99},[],{"intervention":1714,"totalTrials":136,"cells":1718},{"EARLY_PHASE1":1719,"PHASE1":1721,"PHASE2":1723,"PHASE3":1725,"PHASE4":1727,"NA":1733},{"trials":1720,"activeCount":99},[],{"trials":1722,"activeCount":99},[],{"trials":1724,"activeCount":99},[],{"trials":1726,"activeCount":99},[],{"trials":1728,"activeCount":99},[1729],{"nctId":1705,"briefTitle":1706,"status":652,"phases":1730,"primaryCompletion":1708,"completion":1708,"start":1709,"enrollment":1710,"conditions":1731,"interventions":1732},[90],[1712],[1692,1714],{"trials":1734,"activeCount":99},[],{"intervention":1736,"totalTrials":136,"cells":1737},"Naloxegol 25 MG",{"EARLY_PHASE1":1738,"PHASE1":1740,"PHASE2":1742,"PHASE3":1744,"PHASE4":1746,"NA":1758},{"trials":1739,"activeCount":99},[],{"trials":1741,"activeCount":99},[],{"trials":1743,"activeCount":99},[],{"trials":1745,"activeCount":99},[],{"trials":1747,"activeCount":99},[1748],{"nctId":1749,"briefTitle":1750,"status":652,"phases":1751,"primaryCompletion":1752,"completion":1753,"start":1754,"enrollment":1755,"conditions":1756,"interventions":1757},"NCT03235739","Ancillary Effects of Oral Naloxegol (Movantik)",[90],"2021-05-31","2022-05-23","2017-10-01",136,[871],[1736],{"trials":1759,"activeCount":99},[],{"intervention":1761,"totalTrials":136,"cells":1762},"hydrocortisone",{"EARLY_PHASE1":1763,"PHASE1":1765,"PHASE2":1767,"PHASE3":1769,"PHASE4":1771,"NA":1781},{"trials":1764,"activeCount":99},[],{"trials":1766,"activeCount":99},[],{"trials":1768,"activeCount":99},[],{"trials":1770,"activeCount":99},[],{"trials":1772,"activeCount":99},[1773],{"nctId":1774,"briefTitle":1775,"status":111,"phases":1776,"primaryCompletion":1777,"completion":1777,"start":905,"enrollment":25,"conditions":1778,"interventions":1779},"NCT01150409","Hemodynamic and Inflammatory Effects of Abrupt Versus Tapered Corticosteroid Discontinuation in Septic Shock",[90],"2010-08",[277],[1761,1780],"Normal Saline",{"trials":1782,"activeCount":99},[],{"intervention":1784,"totalTrials":136,"cells":1785},"Restalyne",{"EARLY_PHASE1":1786,"PHASE1":1788,"PHASE2":1790,"PHASE3":1792,"PHASE4":1794,"NA":1806},{"trials":1787,"activeCount":99},[],{"trials":1789,"activeCount":99},[],{"trials":1791,"activeCount":99},[],{"trials":1793,"activeCount":99},[],{"trials":1795,"activeCount":99},[1796],{"nctId":1797,"briefTitle":1798,"status":652,"phases":1799,"primaryCompletion":1800,"completion":1800,"start":895,"enrollment":1801,"conditions":1802,"interventions":1804},"NCT00852241","Rejuvenation of the Lower Eyelid Using a Combination of Two Hyaluronic Acid Fillers - a Pilot Study",[90],"2009-09",18,[1803],"Infraorbital Hollows",[1784,1805],"Perlane",{"trials":1807,"activeCount":99},[],{"intervention":1805,"totalTrials":136,"cells":1809},{"EARLY_PHASE1":1810,"PHASE1":1812,"PHASE2":1814,"PHASE3":1816,"PHASE4":1818,"NA":1824},{"trials":1811,"activeCount":99},[],{"trials":1813,"activeCount":99},[],{"trials":1815,"activeCount":99},[],{"trials":1817,"activeCount":99},[],{"trials":1819,"activeCount":99},[1820],{"nctId":1797,"briefTitle":1798,"status":652,"phases":1821,"primaryCompletion":1800,"completion":1800,"start":895,"enrollment":1801,"conditions":1822,"interventions":1823},[90],[1803],[1784,1805],{"trials":1825,"activeCount":99},[],{"intervention":1827,"totalTrials":136,"cells":1828},"morphine",{"EARLY_PHASE1":1829,"PHASE1":1831,"PHASE2":1833,"PHASE3":1835,"PHASE4":1837,"NA":1848},{"trials":1830,"activeCount":99},[],{"trials":1832,"activeCount":99},[],{"trials":1834,"activeCount":99},[],{"trials":1836,"activeCount":99},[],{"trials":1838,"activeCount":99},[1839],{"nctId":1840,"briefTitle":1841,"status":154,"phases":1842,"primaryCompletion":1843,"completion":1843,"start":1844,"enrollment":99,"conditions":1845,"interventions":1847},"NCT01037335","Effect of Local Administration of Morphine for Analgesia After Iliac Bone Graft Harvest",[90],"2017-03","2009-04",[1846],"Autogenous Bone Grafts",[1827],{"trials":1849,"activeCount":99},[],{"intervention":1851,"totalTrials":136,"cells":1852},"FDA approved anti arrhythmic drug",{"EARLY_PHASE1":1853,"PHASE1":1855,"PHASE2":1857,"PHASE3":1859,"PHASE4":1861,"NA":1873},{"trials":1854,"activeCount":99},[],{"trials":1856,"activeCount":99},[],{"trials":1858,"activeCount":99},[],{"trials":1860,"activeCount":99},[],{"trials":1862,"activeCount":99},[1863],{"nctId":1864,"briefTitle":1865,"status":111,"phases":1866,"primaryCompletion":1867,"completion":1868,"start":1462,"enrollment":911,"conditions":1869,"interventions":1872},"NCT02686749","Catheter Ablation vs. Medical Therapy in Congested Hearts With AF",[90],"2018-07-19","2018-10-01",[1870,1871,18],"Congestive Heart Failure","Left Ventricular Failure",[1851],{"trials":1874,"activeCount":99},[],{"intervention":1876,"totalTrials":136,"cells":1877},"H.P. Acthar Gel",{"EARLY_PHASE1":1878,"PHASE1":1880,"PHASE2":1882,"PHASE3":1884,"PHASE4":1886,"NA":1897},{"trials":1879,"activeCount":99},[],{"trials":1881,"activeCount":99},[],{"trials":1883,"activeCount":99},[],{"trials":1885,"activeCount":99},[],{"trials":1887,"activeCount":99},[1888],{"nctId":1889,"briefTitle":1890,"status":652,"phases":1891,"primaryCompletion":1892,"completion":1892,"start":1893,"enrollment":19,"conditions":1894,"interventions":1896},"NCT02245841","Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis",[90],"2021-07-14","2015-06-15",[995,1895],"Juvenile Dermatomyositis",[1876],{"trials":1898,"activeCount":99},[],{"intervention":1900,"totalTrials":136,"cells":1901},"inactivated split-virus influenza vaccine",{"EARLY_PHASE1":1902,"PHASE1":1904,"PHASE2":1906,"PHASE3":1908,"PHASE4":1910,"NA":1922},{"trials":1903,"activeCount":99},[],{"trials":1905,"activeCount":99},[],{"trials":1907,"activeCount":99},[],{"trials":1909,"activeCount":99},[],{"trials":1911,"activeCount":99},[1912],{"nctId":1913,"briefTitle":1914,"status":652,"phases":1915,"completion":1916,"start":1917,"enrollment":1918,"conditions":1919,"interventions":1921},"NCT00419224","Influenza Vaccination in Bone Marrow Transplantation",[90],"2003-04","2002-10",36,[1920],"Influenza",[1900],{"trials":1923,"activeCount":99},[],{"intervention":1925,"totalTrials":136,"cells":1926},"Semaglutide",{"EARLY_PHASE1":1927,"PHASE1":1929,"PHASE2":1931,"PHASE3":1933,"PHASE4":1935,"NA":1948},{"trials":1928,"activeCount":99},[],{"trials":1930,"activeCount":99},[],{"trials":1932,"activeCount":99},[],{"trials":1934,"activeCount":99},[],{"trials":1936,"activeCount":99},[1937],{"nctId":1938,"briefTitle":1939,"status":652,"phases":1940,"primaryCompletion":1941,"completion":1942,"start":1943,"enrollment":1135,"conditions":1944,"interventions":1945},"NCT04538352","Transition From Basal\u002FBolus to Once-weekly Subcutaneous Semaglutide and Basal Insulin in Patients With T2D",[90],"2023-03-31","2023-11-01","2021-01-18",[118],[1925,1946,1947],"Insulin Degludec","Insulin aspart",{"trials":1949,"activeCount":99},[],{"intervention":1946,"totalTrials":136,"cells":1951},{"EARLY_PHASE1":1952,"PHASE1":1954,"PHASE2":1956,"PHASE3":1958,"PHASE4":1960,"NA":1966},{"trials":1953,"activeCount":99},[],{"trials":1955,"activeCount":99},[],{"trials":1957,"activeCount":99},[],{"trials":1959,"activeCount":99},[],{"trials":1961,"activeCount":99},[1962],{"nctId":1938,"briefTitle":1939,"status":652,"phases":1963,"primaryCompletion":1941,"completion":1942,"start":1943,"enrollment":1135,"conditions":1964,"interventions":1965},[90],[118],[1925,1946,1947],{"trials":1967,"activeCount":99},[],{"intervention":1947,"totalTrials":136,"cells":1969},{"EARLY_PHASE1":1970,"PHASE1":1972,"PHASE2":1974,"PHASE3":1976,"PHASE4":1978,"NA":1984},{"trials":1971,"activeCount":99},[],{"trials":1973,"activeCount":99},[],{"trials":1975,"activeCount":99},[],{"trials":1977,"activeCount":99},[],{"trials":1979,"activeCount":99},[1980],{"nctId":1938,"briefTitle":1939,"status":652,"phases":1981,"primaryCompletion":1941,"completion":1942,"start":1943,"enrollment":1135,"conditions":1982,"interventions":1983},[90],[118],[1925,1946,1947],{"trials":1985,"activeCount":99},[],{"intervention":1987,"totalTrials":136,"cells":1988},"Bupivacain",{"EARLY_PHASE1":1989,"PHASE1":1991,"PHASE2":1993,"PHASE3":1995,"PHASE4":1997,"NA":2011},{"trials":1990,"activeCount":99},[],{"trials":1992,"activeCount":99},[],{"trials":1994,"activeCount":99},[],{"trials":1996,"activeCount":99},[],{"trials":1998,"activeCount":99},[1999],{"nctId":2000,"briefTitle":2001,"status":652,"phases":2002,"primaryCompletion":2003,"completion":2004,"start":2005,"enrollment":2006,"conditions":2007,"interventions":2008},"NCT02969187","Bupivacaine Liposomal Injection (Exparel) for Postsurgical Analgesia in Patient Undergoing Laparoscopic Bariatric Surgery",[90],"2018-01-31","2018-03-31","2016-11",126,[871],[2009,1987,2010],"Exparel","Saline",{"trials":2012,"activeCount":99},[],{"intervention":2014,"totalTrials":136,"cells":2015},"Exparel 266 MG Per 20 ML",{"EARLY_PHASE1":2016,"PHASE1":2018,"PHASE2":2020,"PHASE3":2022,"PHASE4":2024,"NA":2037},{"trials":2017,"activeCount":99},[],{"trials":2019,"activeCount":99},[],{"trials":2021,"activeCount":99},[],{"trials":2023,"activeCount":99},[],{"trials":2025,"activeCount":99},[2026],{"nctId":2027,"briefTitle":2028,"status":652,"phases":2029,"primaryCompletion":2030,"completion":2031,"start":2032,"enrollment":2033,"conditions":2034,"interventions":2036},"NCT03743194","Pectoralis and Serratus Muscle Blocks",[90],"2022-02-28","2022-03-14","2021-12-14",210,[2035],"Post Operative Pain Control",[2014],{"trials":2038,"activeCount":99},[],{"intervention":2040,"totalTrials":136,"cells":2041},"canagliflozin",{"EARLY_PHASE1":2042,"PHASE1":2044,"PHASE2":2046,"PHASE3":2048,"PHASE4":2050,"NA":2061},{"trials":2043,"activeCount":99},[],{"trials":2045,"activeCount":99},[],{"trials":2047,"activeCount":99},[],{"trials":2049,"activeCount":99},[],{"trials":2051,"activeCount":99},[2052],{"nctId":2053,"briefTitle":2054,"status":111,"phases":2055,"primaryCompletion":1867,"completion":1867,"start":2056,"enrollment":2057,"conditions":2058,"interventions":2060},"NCT02912455","CARAT: Canagliflozin vs. Placebo for Post Bariatric Patients With Persistent Type 2 Diabetes",[90],"2017-01-05",16,[2059,15],"Diabetes Mellitus, Type 2",[2040],{"trials":2062,"activeCount":99},[],{"intervention":120,"totalTrials":136,"cells":2064},{"EARLY_PHASE1":2065,"PHASE1":2067,"PHASE2":2069,"PHASE3":2071,"PHASE4":2073,"NA":2079},{"trials":2066,"activeCount":99},[],{"trials":2068,"activeCount":99},[],{"trials":2070,"activeCount":99},[],{"trials":2072,"activeCount":99},[],{"trials":2074,"activeCount":99},[2075],{"nctId":109,"briefTitle":110,"status":111,"phases":2076,"primaryCompletion":113,"completion":114,"start":115,"enrollment":116,"conditions":2077,"interventions":2078},[90],[118,15],[120,121,122,94],{"trials":2080,"activeCount":99},[],{"intervention":121,"totalTrials":136,"cells":2082},{"EARLY_PHASE1":2083,"PHASE1":2085,"PHASE2":2087,"PHASE3":2089,"PHASE4":2091,"NA":2097},{"trials":2084,"activeCount":99},[],{"trials":2086,"activeCount":99},[],{"trials":2088,"activeCount":99},[],{"trials":2090,"activeCount":99},[],{"trials":2092,"activeCount":99},[2093],{"nctId":109,"briefTitle":110,"status":111,"phases":2094,"primaryCompletion":113,"completion":114,"start":115,"enrollment":116,"conditions":2095,"interventions":2096},[90],[118,15],[120,121,122,94],{"trials":2098,"activeCount":99},[],{"intervention":122,"totalTrials":136,"cells":2100},{"EARLY_PHASE1":2101,"PHASE1":2103,"PHASE2":2105,"PHASE3":2107,"PHASE4":2109,"NA":2115},{"trials":2102,"activeCount":99},[],{"trials":2104,"activeCount":99},[],{"trials":2106,"activeCount":99},[],{"trials":2108,"activeCount":99},[],{"trials":2110,"activeCount":99},[2111],{"nctId":109,"briefTitle":110,"status":111,"phases":2112,"primaryCompletion":113,"completion":114,"start":115,"enrollment":116,"conditions":2113,"interventions":2114},[90],[118,15],[120,121,122,94],{"trials":2116,"activeCount":99},[],{"intervention":2118,"totalTrials":136,"cells":2119},"Ketolorac",{"EARLY_PHASE1":2120,"PHASE1":2122,"PHASE2":2124,"PHASE3":2126,"PHASE4":2128,"NA":2138},{"trials":2121,"activeCount":99},[],{"trials":2123,"activeCount":99},[],{"trials":2125,"activeCount":99},[],{"trials":2127,"activeCount":99},[],{"trials":2129,"activeCount":99},[2130],{"nctId":2131,"briefTitle":2132,"status":154,"phases":2133,"primaryCompletion":2134,"completion":2134,"start":2135,"enrollment":99,"conditions":2136,"interventions":2137},"NCT01374828","Ketolorac Versus Saline at Laparoscopic Incision Sites",[90],"2013-12","2012-01",[871],[2118],{"trials":2139,"activeCount":99},[],{"intervention":2141,"totalTrials":136,"cells":2142},"F-18 florbetapir",{"EARLY_PHASE1":2143,"PHASE1":2145,"PHASE2":2147,"PHASE3":2149,"PHASE4":2151,"NA":2162},{"trials":2144,"activeCount":99},[],{"trials":2146,"activeCount":99},[],{"trials":2148,"activeCount":99},[],{"trials":2150,"activeCount":99},[],{"trials":2152,"activeCount":99},[2153],{"nctId":2154,"briefTitle":2155,"status":111,"phases":2156,"primaryCompletion":2157,"completion":2157,"start":2158,"enrollment":22,"conditions":2159,"interventions":2161},"NCT03040427","The Role of F-18 Florbetapir in the Early Detection of Cardiac Amyloidosis",[90],"2019-08-21","2017-01",[2160],"Cardiac Amyloidosis",[2141],{"trials":2163,"activeCount":99},[],{"intervention":2165,"totalTrials":136,"cells":2166},"Phentermine 37.5 Mg",{"EARLY_PHASE1":2167,"PHASE1":2169,"PHASE2":2171,"PHASE3":2173,"PHASE4":2175,"NA":2186},{"trials":2168,"activeCount":99},[],{"trials":2170,"activeCount":99},[],{"trials":2172,"activeCount":99},[],{"trials":2174,"activeCount":99},[],{"trials":2176,"activeCount":99},[2177],{"nctId":2178,"briefTitle":2179,"status":652,"phases":2180,"primaryCompletion":2181,"completion":2182,"start":2183,"enrollment":436,"conditions":2184,"interventions":2185},"NCT04614545","Comparing a Virtual vs. Face to Face Weight Management Program Using Phentermine for Patients With Overweight or Obesity",[90],"2021-08-27","2022-09-29","2021-01-01",[15],[2165],{"trials":2187,"activeCount":99},[],{"intervention":2189,"totalTrials":136,"cells":2190},"Colace 100Mg",{"EARLY_PHASE1":2191,"PHASE1":2193,"PHASE2":2195,"PHASE3":2197,"PHASE4":2199,"NA":2212},{"trials":2192,"activeCount":99},[],{"trials":2194,"activeCount":99},[],{"trials":2196,"activeCount":99},[],{"trials":2198,"activeCount":99},[],{"trials":2200,"activeCount":99},[2201],{"nctId":2202,"briefTitle":2203,"status":652,"phases":2204,"primaryCompletion":2205,"completion":2205,"start":2206,"enrollment":656,"conditions":2207,"interventions":2210},"NCT03800745","Reduction of Postoperative Gastrointestinal Dysmotility Following Total Laparoscopic Hysterectomy.",[90],"2020-05-05","2018-11-09",[2208,2209],"Postoperative Passage of Flatus","Postoperative Bowel Movement",[2189,2211],"Miralax",{"trials":2213,"activeCount":99},[],{"intervention":2211,"totalTrials":136,"cells":2215},{"EARLY_PHASE1":2216,"PHASE1":2218,"PHASE2":2220,"PHASE3":2222,"PHASE4":2224,"NA":2230},{"trials":2217,"activeCount":99},[],{"trials":2219,"activeCount":99},[],{"trials":2221,"activeCount":99},[],{"trials":2223,"activeCount":99},[],{"trials":2225,"activeCount":99},[2226],{"nctId":2202,"briefTitle":2203,"status":652,"phases":2227,"primaryCompletion":2205,"completion":2205,"start":2206,"enrollment":656,"conditions":2228,"interventions":2229},[90],[2208,2209],[2189,2211],{"trials":2231,"activeCount":99},[],{"intervention":2233,"totalTrials":136,"cells":2234},"donepezil HCL",{"EARLY_PHASE1":2235,"PHASE1":2237,"PHASE2":2239,"PHASE3":2241,"PHASE4":2243,"NA":2255},{"trials":2236,"activeCount":99},[],{"trials":2238,"activeCount":99},[],{"trials":2240,"activeCount":99},[],{"trials":2242,"activeCount":99},[],{"trials":2244,"activeCount":99},[2245],{"nctId":2246,"briefTitle":2247,"status":652,"phases":2248,"primaryCompletion":2249,"completion":2249,"start":2250,"enrollment":2251,"conditions":2252,"interventions":2254},"NCT02087865","Effects of Donepezil HCL on Task-Activated fMRI Brain Activation in Healthy Older Adults at Genetic Risk for Alzheimer's Disease",[90],"2021-12-20","2014-05",89,[2253],"Genetic Risk for Alzheimer's Disease",[2233],{"trials":2256,"activeCount":99},[],{"intervention":2258,"totalTrials":136,"cells":2259},"Single-Dose Antibiotic",{"EARLY_PHASE1":2260,"PHASE1":2262,"PHASE2":2264,"PHASE3":2266,"PHASE4":2268,"NA":2281},{"trials":2261,"activeCount":99},[],{"trials":2263,"activeCount":99},[],{"trials":2265,"activeCount":99},[],{"trials":2267,"activeCount":99},[],{"trials":2269,"activeCount":99},[2270],{"nctId":2271,"briefTitle":2272,"status":652,"phases":2273,"primaryCompletion":2274,"completion":2274,"start":2275,"enrollment":682,"conditions":2276,"interventions":2279},"NCT05719285","Prophylactic Antibiotic Administration for Bladder OnabotulinumtoxinA Injection",[90],"2023-06-08","2022-12-06",[609,612,2277,2278],"Urge Incontinence","Urinary Incontinence, Urge",[2258,2280],"Multi-Dose Antibiotic",{"trials":2282,"activeCount":99},[],{"intervention":2280,"totalTrials":136,"cells":2284},{"EARLY_PHASE1":2285,"PHASE1":2287,"PHASE2":2289,"PHASE3":2291,"PHASE4":2293,"NA":2299},{"trials":2286,"activeCount":99},[],{"trials":2288,"activeCount":99},[],{"trials":2290,"activeCount":99},[],{"trials":2292,"activeCount":99},[],{"trials":2294,"activeCount":99},[2295],{"nctId":2271,"briefTitle":2272,"status":652,"phases":2296,"primaryCompletion":2274,"completion":2274,"start":2275,"enrollment":682,"conditions":2297,"interventions":2298},[90],[609,612,2277,2278],[2258,2280],{"trials":2300,"activeCount":99},[],{"intervention":2302,"totalTrials":136,"cells":2303},"Depobupivacaine",{"EARLY_PHASE1":2304,"PHASE1":2306,"PHASE2":2308,"PHASE3":2310,"PHASE4":2312,"NA":2325},{"trials":2305,"activeCount":99},[],{"trials":2307,"activeCount":99},[],{"trials":2309,"activeCount":99},[],{"trials":2311,"activeCount":99},[],{"trials":2313,"activeCount":99},[2314],{"nctId":2315,"briefTitle":2316,"status":652,"phases":2317,"primaryCompletion":2318,"completion":2318,"start":2319,"enrollment":2320,"conditions":2321,"interventions":2322},"NCT04284930","Comparison of Local Anesthetic Infusion Pump Versus Depofoam Bupivacaine for Pain Management",[90],"2017-11","2016-02",21,[871],[2302,2323,2324],"OnQ pump","0.25% Bupivacaine",{"trials":2326,"activeCount":99},[],{"intervention":2323,"totalTrials":136,"cells":2328},{"EARLY_PHASE1":2329,"PHASE1":2331,"PHASE2":2333,"PHASE3":2335,"PHASE4":2337,"NA":2343},{"trials":2330,"activeCount":99},[],{"trials":2332,"activeCount":99},[],{"trials":2334,"activeCount":99},[],{"trials":2336,"activeCount":99},[],{"trials":2338,"activeCount":99},[2339],{"nctId":2315,"briefTitle":2316,"status":652,"phases":2340,"primaryCompletion":2318,"completion":2318,"start":2319,"enrollment":2320,"conditions":2341,"interventions":2342},[90],[871],[2302,2323,2324],{"trials":2344,"activeCount":99},[],{"intervention":2324,"totalTrials":136,"cells":2346},{"EARLY_PHASE1":2347,"PHASE1":2349,"PHASE2":2351,"PHASE3":2353,"PHASE4":2355,"NA":2361},{"trials":2348,"activeCount":99},[],{"trials":2350,"activeCount":99},[],{"trials":2352,"activeCount":99},[],{"trials":2354,"activeCount":99},[],{"trials":2356,"activeCount":99},[2357],{"nctId":2315,"briefTitle":2316,"status":652,"phases":2358,"primaryCompletion":2318,"completion":2318,"start":2319,"enrollment":2320,"conditions":2359,"interventions":2360},[90],[871],[2302,2323,2324],{"trials":2362,"activeCount":99},[],{"intervention":2364,"totalTrials":136,"cells":2365},"GLP-1 medication",{"EARLY_PHASE1":2366,"PHASE1":2368,"PHASE2":2370,"PHASE3":2372,"PHASE4":2374,"NA":2385},{"trials":2367,"activeCount":99},[],{"trials":2369,"activeCount":99},[],{"trials":2371,"activeCount":99},[],{"trials":2373,"activeCount":99},[],{"trials":2375,"activeCount":99},[2376],{"nctId":2377,"briefTitle":2378,"status":652,"phases":2379,"primaryCompletion":2380,"completion":2380,"start":2381,"enrollment":1394,"conditions":2382,"interventions":2384},"NCT06533527","Holding vs. Continuing Incretin-based Therapies Before Upper Endoscopy",[90],"2025-05-20","2024-07-31",[2059,15,2383],"Gastroparesis",[2364],{"trials":2386,"activeCount":99},[],{"intervention":2388,"totalTrials":136,"cells":2389},"Lidocaine Hydrochloride",{"EARLY_PHASE1":2390,"PHASE1":2392,"PHASE2":2394,"PHASE3":2396,"PHASE4":2398,"NA":2408},{"trials":2391,"activeCount":99},[],{"trials":2393,"activeCount":99},[],{"trials":2395,"activeCount":99},[],{"trials":2397,"activeCount":99},[],{"trials":2399,"activeCount":99},[2400],{"nctId":2401,"briefTitle":2402,"status":652,"phases":2403,"primaryCompletion":2404,"completion":2404,"start":2405,"enrollment":1216,"conditions":2406,"interventions":2407},"NCT05670236","Effect of Knee Pain on Walking Biomechanics",[90],"2024-07-19","2023-01-25",[211],[2388],{"trials":2409,"activeCount":99},[],{"intervention":2411,"totalTrials":136,"cells":2412},"Bupivacaine Hcl 0.25% Inj",{"EARLY_PHASE1":2413,"PHASE1":2415,"PHASE2":2417,"PHASE3":2419,"PHASE4":2421,"NA":2433},{"trials":2414,"activeCount":99},[],{"trials":2416,"activeCount":99},[],{"trials":2418,"activeCount":99},[],{"trials":2420,"activeCount":99},[],{"trials":2422,"activeCount":99},[2423],{"nctId":2424,"briefTitle":2425,"status":652,"phases":2426,"primaryCompletion":2427,"completion":2427,"start":2428,"enrollment":2429,"conditions":2430,"interventions":2432},"NCT03541941","Exparel vs. Bupivacaine Hydrochloride vs. Placebo for Hernia Repair",[90],"2019-12-19","2018-07-03",164,[2431],"Analgesia, Postoperative",[2009,2411],{"trials":2434,"activeCount":99},[],{"intervention":1398,"totalTrials":136,"cells":2436},{"EARLY_PHASE1":2437,"PHASE1":2439,"PHASE2":2441,"PHASE3":2443,"PHASE4":2445,"NA":2451},{"trials":2438,"activeCount":99},[],{"trials":2440,"activeCount":99},[],{"trials":2442,"activeCount":99},[],{"trials":2444,"activeCount":99},[],{"trials":2446,"activeCount":99},[2447],{"nctId":1389,"briefTitle":1390,"status":652,"phases":2448,"primaryCompletion":925,"completion":1392,"start":1393,"enrollment":1394,"conditions":2449,"interventions":2450},[90],[1385,1396],[1398,1399,1366],{"trials":2452,"activeCount":99},[],{"intervention":1399,"totalTrials":136,"cells":2454},{"EARLY_PHASE1":2455,"PHASE1":2457,"PHASE2":2459,"PHASE3":2461,"PHASE4":2463,"NA":2469},{"trials":2456,"activeCount":99},[],{"trials":2458,"activeCount":99},[],{"trials":2460,"activeCount":99},[],{"trials":2462,"activeCount":99},[],{"trials":2464,"activeCount":99},[2465],{"nctId":1389,"briefTitle":1390,"status":652,"phases":2466,"primaryCompletion":925,"completion":1392,"start":1393,"enrollment":1394,"conditions":2467,"interventions":2468},[90],[1385,1396],[1398,1399,1366],{"trials":2470,"activeCount":99},[],{"intervention":161,"totalTrials":136,"cells":2472},{"EARLY_PHASE1":2473,"PHASE1":2475,"PHASE2":2477,"PHASE3":2479,"PHASE4":2481,"NA":2487},{"trials":2474,"activeCount":99},[],{"trials":2476,"activeCount":99},[],{"trials":2478,"activeCount":99},[],{"trials":2480,"activeCount":99},[],{"trials":2482,"activeCount":99},[2483],{"nctId":152,"briefTitle":153,"status":154,"phases":2484,"primaryCompletion":156,"completion":156,"start":157,"enrollment":99,"conditions":2485,"interventions":2486},[90],[159],[41,161],{"trials":2488,"activeCount":99},[],{"intervention":2490,"totalTrials":136,"cells":2491},"Selective Nerve Root Block",{"EARLY_PHASE1":2492,"PHASE1":2494,"PHASE2":2496,"PHASE3":2498,"PHASE4":2500,"NA":2514},{"trials":2493,"activeCount":99},[],{"trials":2495,"activeCount":99},[],{"trials":2497,"activeCount":99},[],{"trials":2499,"activeCount":99},[],{"trials":2501,"activeCount":99},[2502],{"nctId":2503,"briefTitle":2504,"status":111,"phases":2505,"primaryCompletion":2506,"completion":2507,"start":2508,"enrollment":25,"conditions":2509,"interventions":2513},"NCT03801356","Threshold Response of Lumbar Selective Nerve Root Block in Predicting Good Outcome Following Lumbar Foraminotomy",[90],"2020-11-05","2020-12-15","2018-08-23",[2510,2511,2512],"Back Pain","Radiculopathy Lumbar","Degenerative Lumbar Spinal Stenosis",[2490],{"trials":2515,"activeCount":99},[],{"intervention":2517,"totalTrials":136,"cells":2518},"atorvastatin",{"EARLY_PHASE1":2519,"PHASE1":2521,"PHASE2":2523,"PHASE3":2525,"PHASE4":2527,"NA":2539},{"trials":2520,"activeCount":99},[],{"trials":2522,"activeCount":99},[],{"trials":2524,"activeCount":99},[],{"trials":2526,"activeCount":99},[],{"trials":2528,"activeCount":99},[2529],{"nctId":2530,"briefTitle":2531,"status":111,"phases":2532,"primaryCompletion":2533,"completion":2533,"start":2534,"enrollment":2535,"conditions":2536,"interventions":2538},"NCT00590135","The Effect of Lipitor on Aortic Stenosis",[90],"2010-04-26","2000-08",59,[2537],"Aortic Valve Stenosis",[2517],{"trials":2540,"activeCount":99},[],{"intervention":2542,"totalTrials":136,"cells":2543},"Depofoam bupivacaine",{"EARLY_PHASE1":2544,"PHASE1":2546,"PHASE2":2548,"PHASE3":2550,"PHASE4":2552,"NA":2565},{"trials":2545,"activeCount":99},[],{"trials":2547,"activeCount":99},[],{"trials":2549,"activeCount":99},[],{"trials":2551,"activeCount":99},[],{"trials":2553,"activeCount":99},[2554],{"nctId":2555,"briefTitle":2556,"status":652,"phases":2557,"primaryCompletion":2558,"completion":2559,"start":2560,"enrollment":167,"conditions":2561,"interventions":2563},"NCT04278846","Efficacy of Liposomal Bupivacaine for Prolonged Postoperative Analgesia in Patient Undergoing Breast Reconstruction With Tissue Expander",[90],"2017-12-31","2019-05-15","2014-08-22",[871,2562],"Mammaplasty",[2542,2564],"Bupivacaine hydrochloride",{"trials":2566,"activeCount":99},[],{"intervention":2564,"totalTrials":136,"cells":2568},{"EARLY_PHASE1":2569,"PHASE1":2571,"PHASE2":2573,"PHASE3":2575,"PHASE4":2577,"NA":2583},{"trials":2570,"activeCount":99},[],{"trials":2572,"activeCount":99},[],{"trials":2574,"activeCount":99},[],{"trials":2576,"activeCount":99},[],{"trials":2578,"activeCount":99},[2579],{"nctId":2555,"briefTitle":2556,"status":652,"phases":2580,"primaryCompletion":2558,"completion":2559,"start":2560,"enrollment":167,"conditions":2581,"interventions":2582},[90],[871,2562],[2542,2564],{"trials":2584,"activeCount":99},[],{"intervention":2586,"totalTrials":136,"cells":2587},"Oliceridine",{"EARLY_PHASE1":2588,"PHASE1":2590,"PHASE2":2592,"PHASE3":2594,"PHASE4":2596,"NA":2609},{"trials":2589,"activeCount":99},[],{"trials":2591,"activeCount":99},[],{"trials":2593,"activeCount":99},[],{"trials":2595,"activeCount":99},[],{"trials":2597,"activeCount":99},[2598],{"nctId":2599,"briefTitle":2600,"status":652,"phases":2601,"primaryCompletion":2602,"completion":2603,"start":2604,"enrollment":2605,"conditions":2606,"interventions":2608},"NCT04979247","Intravenous Oliceridine and Opioid-related Complications",[90],"2023-12-21","2024-01-10","2021-09-15",204,[2607],"Major Surgery",[2586],{"trials":2610,"activeCount":99},[],{"intervention":2612,"totalTrials":136,"cells":2613},"Ozurdex",{"EARLY_PHASE1":2614,"PHASE1":2616,"PHASE2":2618,"PHASE3":2620,"PHASE4":2622,"NA":2633},{"trials":2615,"activeCount":99},[],{"trials":2617,"activeCount":99},[],{"trials":2619,"activeCount":99},[],{"trials":2621,"activeCount":99},[],{"trials":2623,"activeCount":99},[2624],{"nctId":2625,"briefTitle":2626,"status":652,"phases":2627,"primaryCompletion":2628,"completion":2629,"start":883,"enrollment":337,"conditions":2630,"interventions":2632},"NCT01613716","Ozurdex for Diabetic Macular Edema Treated With Pars Plana vitrEctomy and Membrane RemovAl (OPERA Study)",[90],"2016-12","2017-02",[1712,2631],"Epiretinal Membrane",[2612],{"trials":2634,"activeCount":99},[],{"intervention":2636,"totalTrials":136,"cells":2637},"Lacosamide",{"EARLY_PHASE1":2638,"PHASE1":2640,"PHASE2":2642,"PHASE3":2644,"PHASE4":2646,"NA":2656},{"trials":2639,"activeCount":99},[],{"trials":2641,"activeCount":99},[],{"trials":2643,"activeCount":99},[],{"trials":2645,"activeCount":99},[],{"trials":2647,"activeCount":99},[2648],{"nctId":2649,"briefTitle":2650,"status":652,"phases":2651,"primaryCompletion":2652,"completion":2652,"start":1777,"enrollment":2535,"conditions":2653,"interventions":2655},"NCT01190098","Randomized Controlled Trial to Assess Effects of Lacosamide on Sleep and Wake in Adults With Focal Epilepsy",[90],"2014-11",[2654],"Partial Epilepsy",[2636],{"trials":2657,"activeCount":99},[],{"intervention":2659,"totalTrials":136,"cells":2660},"Nicotine gum",{"EARLY_PHASE1":2661,"PHASE1":2663,"PHASE2":2665,"PHASE3":2667,"PHASE4":2669,"NA":2680},{"trials":2662,"activeCount":99},[],{"trials":2664,"activeCount":99},[],{"trials":2666,"activeCount":99},[],{"trials":2668,"activeCount":99},[],{"trials":2670,"activeCount":99},[2671],{"nctId":2672,"briefTitle":2673,"status":111,"phases":2674,"primaryCompletion":2675,"completion":2675,"start":2676,"enrollment":911,"conditions":2677,"interventions":2679},"NCT01662115","Nicotine Gum Recovery After Colorectal Surgery",[90],"2014-06","2012-08",[2678],"Post-operative Ileus",[2659],{"trials":2681,"activeCount":99},[],{"intervention":2683,"totalTrials":136,"cells":2684},"Bus and Dex",{"EARLY_PHASE1":2685,"PHASE1":2687,"PHASE2":2689,"PHASE3":2691,"PHASE4":2693,"NA":2708},{"trials":2686,"activeCount":99},[],{"trials":2688,"activeCount":99},[],{"trials":2690,"activeCount":99},[],{"trials":2692,"activeCount":99},[],{"trials":2694,"activeCount":99},[2695],{"nctId":2696,"briefTitle":2697,"status":652,"phases":2698,"primaryCompletion":2699,"completion":2699,"start":2700,"enrollment":2701,"conditions":2702,"interventions":2704},"NCT00334360","Dexmed\u002FBuspirone Synergism on Shivering",[90],"2007-08","2004-09",8,[2703],"Hypothermia",[2705,2706,2683,2707],"dexmedetomidine","buspirone","Control",{"trials":2709,"activeCount":99},[],{"intervention":2707,"totalTrials":136,"cells":2711},{"EARLY_PHASE1":2712,"PHASE1":2714,"PHASE2":2716,"PHASE3":2718,"PHASE4":2720,"NA":2726},{"trials":2713,"activeCount":99},[],{"trials":2715,"activeCount":99},[],{"trials":2717,"activeCount":99},[],{"trials":2719,"activeCount":99},[],{"trials":2721,"activeCount":99},[2722],{"nctId":2696,"briefTitle":2697,"status":652,"phases":2723,"primaryCompletion":2699,"completion":2699,"start":2700,"enrollment":2701,"conditions":2724,"interventions":2725},[90],[2703],[2705,2706,2683,2707],{"trials":2727,"activeCount":99},[],{"intervention":2729,"totalTrials":136,"cells":2730},"Early Glargine",{"EARLY_PHASE1":2731,"PHASE1":2733,"PHASE2":2735,"PHASE3":2737,"PHASE4":2739,"NA":2752},{"trials":2732,"activeCount":99},[],{"trials":2734,"activeCount":99},[],{"trials":2736,"activeCount":99},[],{"trials":2738,"activeCount":99},[],{"trials":2740,"activeCount":99},[2741],{"nctId":2742,"briefTitle":2743,"status":111,"phases":2744,"primaryCompletion":2181,"completion":2181,"start":2745,"enrollment":2746,"conditions":2747,"interventions":2750},"NCT04567225","Early Basal Insulin Administration in Adult Diabetic Ketoacidosis Management",[90],"2020-10-01",39,[2748,2749,118],"Diabetic Ketoacidosis","Type 1 Diabetes",[2729,2751],"Late Glargine",{"trials":2753,"activeCount":99},[],{"intervention":2751,"totalTrials":136,"cells":2755},{"EARLY_PHASE1":2756,"PHASE1":2758,"PHASE2":2760,"PHASE3":2762,"PHASE4":2764,"NA":2770},{"trials":2757,"activeCount":99},[],{"trials":2759,"activeCount":99},[],{"trials":2761,"activeCount":99},[],{"trials":2763,"activeCount":99},[],{"trials":2765,"activeCount":99},[2766],{"nctId":2742,"briefTitle":2743,"status":111,"phases":2767,"primaryCompletion":2181,"completion":2181,"start":2745,"enrollment":2746,"conditions":2768,"interventions":2769},[90],[2748,2749,118],[2729,2751],{"trials":2771,"activeCount":99},[],{"intervention":2773,"totalTrials":136,"cells":2774},"Eplerenone",{"EARLY_PHASE1":2775,"PHASE1":2777,"PHASE2":2779,"PHASE3":2781,"PHASE4":2783,"NA":2794},{"trials":2776,"activeCount":99},[],{"trials":2778,"activeCount":99},[],{"trials":2780,"activeCount":99},[],{"trials":2782,"activeCount":99},[],{"trials":2784,"activeCount":99},[2785],{"nctId":2786,"briefTitle":2787,"status":111,"phases":2788,"primaryCompletion":2789,"completion":2789,"start":2790,"enrollment":25,"conditions":2791,"interventions":2793},"NCT00293150","Reversing Endothelial and Diastolic Dysfunction and Improving Collagen Turnover in Diastolic Heart Failure",[90],"2007-09","2003-09",[2792],"Diastolic Heart Failure",[2773],{"trials":2795,"activeCount":99},[],{"intervention":2797,"totalTrials":136,"cells":2798},"nicardipine intravenous",{"EARLY_PHASE1":2799,"PHASE1":2801,"PHASE2":2803,"PHASE3":2805,"PHASE4":2807,"NA":2820},{"trials":2800,"activeCount":99},[],{"trials":2802,"activeCount":99},[],{"trials":2804,"activeCount":99},[],{"trials":2806,"activeCount":99},[],{"trials":2808,"activeCount":99},[2809],{"nctId":2810,"briefTitle":2811,"status":652,"phases":2812,"primaryCompletion":2813,"completion":2813,"start":2814,"enrollment":2815,"conditions":2816,"interventions":2818},"NCT00765648","Evaluation of Intravenous Cardene(Nicardipine)and Labetalol Use in the Emergency Department",[90],"2010-01","2008-10",226,[2817],"Hypertensive Urgency",[2797,2819],"Labetalol",{"trials":2821,"activeCount":99},[],{"intervention":2819,"totalTrials":136,"cells":2823},{"EARLY_PHASE1":2824,"PHASE1":2826,"PHASE2":2828,"PHASE3":2830,"PHASE4":2832,"NA":2838},{"trials":2825,"activeCount":99},[],{"trials":2827,"activeCount":99},[],{"trials":2829,"activeCount":99},[],{"trials":2831,"activeCount":99},[],{"trials":2833,"activeCount":99},[2834],{"nctId":2810,"briefTitle":2811,"status":652,"phases":2835,"primaryCompletion":2813,"completion":2813,"start":2814,"enrollment":2815,"conditions":2836,"interventions":2837},[90],[2817],[2797,2819],{"trials":2839,"activeCount":99},[],{"intervention":1469,"totalTrials":136,"cells":2841},{"EARLY_PHASE1":2842,"PHASE1":2844,"PHASE2":2846,"PHASE3":2848,"PHASE4":2850,"NA":2856},{"trials":2843,"activeCount":99},[],{"trials":2845,"activeCount":99},[],{"trials":2847,"activeCount":99},[],{"trials":2849,"activeCount":99},[],{"trials":2851,"activeCount":99},[2852],{"nctId":1459,"briefTitle":1460,"status":111,"phases":2853,"primaryCompletion":1462,"completion":1462,"start":1463,"enrollment":1464,"conditions":2854,"interventions":2855},[90],[1466],[1468,1469],{"trials":2857,"activeCount":99},[],{"intervention":661,"totalTrials":136,"cells":2859},{"EARLY_PHASE1":2860,"PHASE1":2862,"PHASE2":2864,"PHASE3":2866,"PHASE4":2868,"NA":2874},{"trials":2861,"activeCount":99},[],{"trials":2863,"activeCount":99},[],{"trials":2865,"activeCount":99},[],{"trials":2867,"activeCount":99},[],{"trials":2869,"activeCount":99},[2870],{"nctId":650,"briefTitle":651,"status":652,"phases":2871,"primaryCompletion":654,"completion":654,"start":655,"enrollment":656,"conditions":2872,"interventions":2873},[90],[658,659],[661,625],{"trials":2875,"activeCount":99},[],{"intervention":2877,"totalTrials":136,"cells":2878},"Treximet 85Mg-500Mg",{"EARLY_PHASE1":2879,"PHASE1":2881,"PHASE2":2883,"PHASE3":2885,"PHASE4":2887,"NA":2898},{"trials":2880,"activeCount":99},[],{"trials":2882,"activeCount":99},[],{"trials":2884,"activeCount":99},[],{"trials":2886,"activeCount":99},[],{"trials":2888,"activeCount":99},[2889],{"nctId":2890,"briefTitle":2891,"status":652,"phases":2892,"primaryCompletion":2893,"completion":2893,"start":1800,"enrollment":1135,"conditions":2894,"interventions":2896},"NCT01086358","Does Treximet Improve Productivity and Patient Satisfaction Due to Sustained Response and Consistency of Response?",[90],"2016-08",[2895],"Workplace Migraine Treatment",[2897,2877],"Triptan",{"trials":2899,"activeCount":99},[],{"intervention":2901,"totalTrials":2902,"cells":2903},"thalidomide",3,{"EARLY_PHASE1":2904,"PHASE1":2906,"PHASE2":2908,"PHASE3":2934,"PHASE4":2946,"NA":2948},{"trials":2905,"activeCount":99},[],{"trials":2907,"activeCount":99},[],{"trials":2909,"activeCount":99},[2910,2923],{"nctId":2911,"briefTitle":2912,"status":154,"phases":2913,"enrollment":99,"conditions":2914,"interventions":2919},"NCT00112879","Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma",[88],[2915,2916,2917,2918],"Stage I Multiple Myeloma","Stage II Multiple Myeloma","Stage III Multiple Myeloma","Refractory Plasma Cell Neoplasm",[2920,2921,2922,2901],"arsenic trioxide","ascorbic acid","dexamethasone",{"nctId":2924,"briefTitle":2925,"status":652,"phases":2926,"primaryCompletion":2927,"completion":2927,"start":2928,"enrollment":2929,"conditions":2930,"interventions":2932},"NCT00400517","GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer",[88],"2008-06","2003-03",28,[2931],"Prostate Cancer",[2933,2901],"sargramostim",{"trials":2935,"activeCount":99},[2936],{"nctId":2937,"briefTitle":2938,"status":154,"phases":2939,"primaryCompletion":2813,"completion":2813,"start":2940,"enrollment":99,"conditions":2941,"interventions":2944},"NCT00787436","Secondary Prophylaxis of Gastrointestinal Bleeding in Cirrhotic Patients Using THALIDOMIDE",[89],"2006-05",[2942,2943],"Gastrointestinal Hemorrhage","Portal Hypertension",[2945],"Thalidomide",{"trials":2947,"activeCount":99},[],{"trials":2949,"activeCount":99},[],{"intervention":2951,"totalTrials":136,"cells":2952},"human albumin 5%",{"EARLY_PHASE1":2953,"PHASE1":2955,"PHASE2":2957,"PHASE3":2959,"PHASE4":2973,"NA":2975},{"trials":2954,"activeCount":99},[],{"trials":2956,"activeCount":99},[],{"trials":2958,"activeCount":99},[],{"trials":2960,"activeCount":99},[2961],{"nctId":2962,"briefTitle":2963,"status":652,"phases":2964,"primaryCompletion":2965,"completion":2966,"start":2967,"enrollment":2968,"conditions":2969,"interventions":2971},"NCT02192502","Use of 6% Hydroxyethylstarch (130\u002F0.4) in Cardiac Surgical Patients",[89],"2018-02","2020-02","2015-03",149,[2970],"Postoperative Kidney Injury",[2951,2972],"HES 130\u002F0.4",{"trials":2974,"activeCount":99},[],{"trials":2976,"activeCount":99},[],{"intervention":2972,"totalTrials":136,"cells":2978},{"EARLY_PHASE1":2979,"PHASE1":2981,"PHASE2":2983,"PHASE3":2985,"PHASE4":2991,"NA":2993},{"trials":2980,"activeCount":99},[],{"trials":2982,"activeCount":99},[],{"trials":2984,"activeCount":99},[],{"trials":2986,"activeCount":99},[2987],{"nctId":2962,"briefTitle":2963,"status":652,"phases":2988,"primaryCompletion":2965,"completion":2966,"start":2967,"enrollment":2968,"conditions":2989,"interventions":2990},[89],[2970],[2951,2972],{"trials":2992,"activeCount":99},[],{"trials":2994,"activeCount":99},[],{"intervention":2996,"totalTrials":136,"cells":2997},"Mepivacaine",{"EARLY_PHASE1":2998,"PHASE1":3000,"PHASE2":3002,"PHASE3":3004,"PHASE4":3016,"NA":3018},{"trials":2999,"activeCount":99},[],{"trials":3001,"activeCount":99},[],{"trials":3003,"activeCount":99},[],{"trials":3005,"activeCount":99},[3006],{"nctId":3007,"briefTitle":3008,"status":652,"phases":3009,"primaryCompletion":1777,"completion":1777,"start":3010,"enrollment":3011,"conditions":3012,"interventions":3014},"NCT00825786","Ultrasound Guided Supraclavicular Nerve Block",[89],"2008-09",103,[3013],"Local Anesthetic",[3015,2996],"Ropivacaine",{"trials":3017,"activeCount":99},[],{"trials":3019,"activeCount":99},[],{"intervention":3021,"totalTrials":136,"cells":3022},"nitrogen",{"EARLY_PHASE1":3023,"PHASE1":3025,"PHASE2":3027,"PHASE3":3029,"PHASE4":3043,"NA":3045},{"trials":3024,"activeCount":99},[],{"trials":3026,"activeCount":99},[],{"trials":3028,"activeCount":99},[],{"trials":3030,"activeCount":99},[3031],{"nctId":3032,"briefTitle":3033,"status":652,"phases":3034,"primaryCompletion":3035,"completion":3036,"start":3037,"enrollment":3038,"conditions":3039,"interventions":3041},"NCT00781352","Nitrous Oxide and Risk of Cancer Recurrence After Colorectal Surgery: A Randomized, Blinded Study",[89],"2003-11","2007-03","1998-11",408,[3040],"Colorectal Cancer",[3042,3021],"nitrous oxide",{"trials":3044,"activeCount":99},[],{"trials":3046,"activeCount":99},[],{"intervention":3048,"totalTrials":136,"cells":3049},"Fluocinolone Acetonide (FA) implant",{"EARLY_PHASE1":3050,"PHASE1":3052,"PHASE2":3054,"PHASE3":3056,"PHASE4":3065,"NA":3067},{"trials":3051,"activeCount":99},[],{"trials":3053,"activeCount":99},[],{"trials":3055,"activeCount":99},[],{"trials":3057,"activeCount":99},[3058],{"nctId":3059,"briefTitle":3060,"status":154,"phases":3061,"primaryCompletion":1022,"completion":1022,"start":1014,"enrollment":99,"conditions":3062,"interventions":3064},"NCT03238157","Steroids for Early Treatment of Radiation Retinopathy",[88,89],[3063],"Radiation Retinopathy",[3048],{"trials":3066,"activeCount":99},[],{"trials":3068,"activeCount":99},[],{"intervention":1455,"totalTrials":136,"cells":3070},{"EARLY_PHASE1":3071,"PHASE1":3073,"PHASE2":3075,"PHASE3":3077,"PHASE4":3083,"NA":3085},{"trials":3072,"activeCount":99},[],{"trials":3074,"activeCount":99},[],{"trials":3076,"activeCount":99},[],{"trials":3078,"activeCount":99},[3079],{"nctId":1447,"briefTitle":1448,"status":111,"phases":3080,"primaryCompletion":1450,"completion":1450,"start":1451,"enrollment":927,"conditions":3081,"interventions":3082},[88,89],[1453],[1436,1455],{"trials":3084,"activeCount":99},[],{"trials":3086,"activeCount":99},[],{"intervention":3088,"totalTrials":136,"cells":3089},"Intravenous Acetaminophen",{"EARLY_PHASE1":3090,"PHASE1":3092,"PHASE2":3094,"PHASE3":3096,"PHASE4":3108,"NA":3110},{"trials":3091,"activeCount":99},[],{"trials":3093,"activeCount":99},[],{"trials":3095,"activeCount":99},[],{"trials":3097,"activeCount":99},[3098],{"nctId":3099,"briefTitle":3100,"status":652,"phases":3101,"primaryCompletion":3102,"completion":3103,"start":3104,"enrollment":3105,"conditions":3106,"interventions":3107},"NCT02156154","Effect of Intravenous Acetaminophen on Postoperative Opioid-related Complications",[89],"2019-03","2020-10","2014-12",580,[838],[3088],{"trials":3109,"activeCount":99},[],{"trials":3111,"activeCount":99},[],{"intervention":3113,"totalTrials":136,"cells":3114},"Routine opioid management",{"EARLY_PHASE1":3115,"PHASE1":3117,"PHASE2":3119,"PHASE3":3121,"PHASE4":3134,"NA":3136},{"trials":3116,"activeCount":99},[],{"trials":3118,"activeCount":99},[],{"trials":3120,"activeCount":99},[],{"trials":3122,"activeCount":99},[3123],{"nctId":3124,"briefTitle":3125,"status":652,"phases":3126,"primaryCompletion":3127,"completion":3128,"start":3129,"enrollment":3130,"conditions":3131,"interventions":3133},"NCT04679818","Postoperative Consequences of Intraoperative NOL Titration",[89],"2022-12-30","2023-01-10","2020-12-30",72,[3132],"Anesthesia; Adverse Effect",[3113],{"trials":3135,"activeCount":99},[],{"trials":3137,"activeCount":99},[],{"intervention":3139,"totalTrials":136,"cells":3140},"Sirolimus",{"EARLY_PHASE1":3141,"PHASE1":3143,"PHASE2":3145,"PHASE3":3147,"PHASE4":3158,"NA":3160},{"trials":3142,"activeCount":99},[],{"trials":3144,"activeCount":99},[],{"trials":3146,"activeCount":99},[],{"trials":3148,"activeCount":99},[3149],{"nctId":3150,"briefTitle":3151,"status":111,"phases":3152,"primaryCompletion":3104,"completion":3104,"start":3153,"enrollment":22,"conditions":3154,"interventions":3156},"NCT01166724","Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression-",[89],"2010-07",[3155],"Kidney Transplant",[3139,3157],"Tacrolimus",{"trials":3159,"activeCount":99},[],{"trials":3161,"activeCount":99},[],{"intervention":3157,"totalTrials":136,"cells":3163},{"EARLY_PHASE1":3164,"PHASE1":3166,"PHASE2":3168,"PHASE3":3170,"PHASE4":3176,"NA":3178},{"trials":3165,"activeCount":99},[],{"trials":3167,"activeCount":99},[],{"trials":3169,"activeCount":99},[],{"trials":3171,"activeCount":99},[3172],{"nctId":3150,"briefTitle":3151,"status":111,"phases":3173,"primaryCompletion":3104,"completion":3104,"start":3153,"enrollment":22,"conditions":3174,"interventions":3175},[89],[3155],[3139,3157],{"trials":3177,"activeCount":99},[],{"trials":3179,"activeCount":99},[],{"intervention":931,"totalTrials":136,"cells":3181},{"EARLY_PHASE1":3182,"PHASE1":3184,"PHASE2":3186,"PHASE3":3188,"PHASE4":3194,"NA":3196},{"trials":3183,"activeCount":99},[],{"trials":3185,"activeCount":99},[],{"trials":3187,"activeCount":99},[],{"trials":3189,"activeCount":99},[3190],{"nctId":922,"briefTitle":923,"status":652,"phases":3191,"primaryCompletion":925,"completion":925,"start":926,"enrollment":927,"conditions":3192,"interventions":3193},[89],[929],[931,841],{"trials":3195,"activeCount":99},[],{"trials":3197,"activeCount":99},[],{"intervention":3199,"totalTrials":136,"cells":3200},"Oxygen",{"EARLY_PHASE1":3201,"PHASE1":3203,"PHASE2":3205,"PHASE3":3207,"PHASE4":3220,"NA":3222},{"trials":3202,"activeCount":99},[],{"trials":3204,"activeCount":99},[],{"trials":3206,"activeCount":99},[],{"trials":3208,"activeCount":99},[3209],{"nctId":3210,"briefTitle":3211,"status":652,"phases":3212,"primaryCompletion":3213,"completion":3213,"start":3214,"enrollment":3215,"conditions":3216,"interventions":3218},"NCT03879538","Nitrous Oxide for the Treatment of Complex Regional Pain Syndrome",[89],"2022-07-28","2019-07-02",44,[3217],"Complex Regional Pain Syndrome",[3219,3199],"Nitrous Oxide",{"trials":3221,"activeCount":99},[],{"trials":3223,"activeCount":99},[],{"intervention":3225,"totalTrials":136,"cells":3226},"Ergocalciferol",{"EARLY_PHASE1":3227,"PHASE1":3229,"PHASE2":3231,"PHASE3":3233,"PHASE4":3245,"NA":3247},{"trials":3228,"activeCount":99},[],{"trials":3230,"activeCount":99},[],{"trials":3232,"activeCount":99},[],{"trials":3234,"activeCount":99},[3235],{"nctId":3236,"briefTitle":3237,"status":111,"phases":3238,"primaryCompletion":3239,"completion":3240,"start":3153,"enrollment":19,"conditions":3241,"interventions":3243},"NCT01173848","Vitamin D Supplement Study for Stage Three and Four Chronic Kidney Disease (CKD) Patients",[89],"2011-09","2011-10-18",[3242],"Chronic Kidney Disease Stage 3 and 4",[3225,3244],"Cholecalciferol",{"trials":3246,"activeCount":99},[],{"trials":3248,"activeCount":99},[],{"intervention":3244,"totalTrials":136,"cells":3250},{"EARLY_PHASE1":3251,"PHASE1":3253,"PHASE2":3255,"PHASE3":3257,"PHASE4":3263,"NA":3265},{"trials":3252,"activeCount":99},[],{"trials":3254,"activeCount":99},[],{"trials":3256,"activeCount":99},[],{"trials":3258,"activeCount":99},[3259],{"nctId":3236,"briefTitle":3237,"status":111,"phases":3260,"primaryCompletion":3239,"completion":3240,"start":3153,"enrollment":19,"conditions":3261,"interventions":3262},[89],[3242],[3225,3244],{"trials":3264,"activeCount":99},[],{"trials":3266,"activeCount":99},[],{"intervention":3268,"totalTrials":136,"cells":3269},"Norepinephrine",{"EARLY_PHASE1":3270,"PHASE1":3272,"PHASE2":3274,"PHASE3":3276,"PHASE4":3289,"NA":3291},{"trials":3271,"activeCount":99},[],{"trials":3273,"activeCount":99},[],{"trials":3275,"activeCount":99},[],{"trials":3277,"activeCount":99},[3278],{"nctId":3279,"briefTitle":3280,"status":652,"phases":3281,"primaryCompletion":3282,"completion":3283,"start":2506,"enrollment":3284,"conditions":3285,"interventions":3287},"NCT04501861","Hemodynamic Effect of Norepinephrine Versus Vasopressin on the Pulmonary Circulation in Cardiac Surgery Patients:",[89],"2023-08-22","2024-12-31",153,[3286],"Cardiac Disease",[3288,3268],"Vasopressin",{"trials":3290,"activeCount":99},[],{"trials":3292,"activeCount":99},[],{"intervention":3294,"totalTrials":136,"cells":3295},"5-Fluorouracil",{"EARLY_PHASE1":3296,"PHASE1":3298,"PHASE2":3300,"PHASE3":3302,"PHASE4":3312,"NA":3314},{"trials":3297,"activeCount":99},[],{"trials":3299,"activeCount":99},[],{"trials":3301,"activeCount":99},[],{"trials":3303,"activeCount":99},[3304],{"nctId":3305,"briefTitle":3306,"status":111,"phases":3307,"primaryCompletion":2005,"completion":2628,"start":3239,"enrollment":1801,"conditions":3308,"interventions":3311},"NCT01525329","Combination Therapy With 5-Fluorouracil and Photodynamic Therapy in Post-transplant Premalignant Skin Disease",[89],[3309,3310],"Actinic Keratosis","Organ or Tissue Transplant; Complications",[3294],{"trials":3313,"activeCount":99},[],{"trials":3315,"activeCount":99},[],{"intervention":3317,"totalTrials":136,"cells":3318},"dietary supplement--echinacea, propolis, and vitamin c",{"EARLY_PHASE1":3319,"PHASE1":3321,"PHASE2":3323,"PHASE3":3325,"PHASE4":3338,"NA":3340},{"trials":3320,"activeCount":99},[],{"trials":3322,"activeCount":99},[],{"trials":3324,"activeCount":99},[],{"trials":3326,"activeCount":99},[3327],{"nctId":3328,"briefTitle":3329,"status":652,"phases":3330,"completion":3331,"start":3332,"enrollment":3333,"conditions":3334,"interventions":3337},"NCT00231218","Echinacea, Propolis and Vitamin C for URI Prevention in Preschoolers",[89],"2006-03","2006-01",104,[3335,3336],"Common Cold","Gastroenteritis",[3317],{"trials":3339,"activeCount":99},[],{"trials":3341,"activeCount":99},[],{"intervention":3343,"totalTrials":136,"cells":3344},"CMV-Ig",{"EARLY_PHASE1":3345,"PHASE1":3347,"PHASE2":3349,"PHASE3":3351,"PHASE4":3361,"NA":3363},{"trials":3346,"activeCount":99},[],{"trials":3348,"activeCount":99},[],{"trials":3350,"activeCount":99},[],{"trials":3352,"activeCount":99},[3353],{"nctId":3354,"briefTitle":3355,"status":652,"phases":3356,"primaryCompletion":3332,"completion":3332,"start":3357,"enrollment":167,"conditions":3358,"interventions":3360},"NCT00137748","Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients",[88,89],"2001-01",[3359],"Hypogammaglobulinemia",[3343],{"trials":3362,"activeCount":99},[],{"trials":3364,"activeCount":99},[],{"intervention":697,"totalTrials":136,"cells":3366},{"EARLY_PHASE1":3367,"PHASE1":3369,"PHASE2":3371,"PHASE3":3373,"PHASE4":3379,"NA":3381},{"trials":3368,"activeCount":99},[],{"trials":3370,"activeCount":99},[],{"trials":3372,"activeCount":99},[],{"trials":3374,"activeCount":99},[3375],{"nctId":688,"briefTitle":689,"status":652,"phases":3376,"primaryCompletion":691,"completion":691,"start":692,"enrollment":693,"conditions":3377,"interventions":3378},[89],[695],[665,697],{"trials":3380,"activeCount":99},[],{"trials":3382,"activeCount":99},[],{"intervention":3384,"totalTrials":136,"cells":3385},"General anesthesia and opioids",{"EARLY_PHASE1":3386,"PHASE1":3388,"PHASE2":3390,"PHASE3":3392,"PHASE4":3405,"NA":3407},{"trials":3387,"activeCount":99},[],{"trials":3389,"activeCount":99},[],{"trials":3391,"activeCount":99},[],{"trials":3393,"activeCount":99},[3394],{"nctId":3395,"briefTitle":3396,"status":652,"phases":3397,"primaryCompletion":2965,"completion":3398,"start":3399,"enrollment":3400,"conditions":3401,"interventions":3403},"NCT00418457","Regional Anesthesia and Breast Cancer Recurrence",[89],"2019-12","2007-01",2108,[3402],"Breast Neoplasms",[3384,3404],"Regional analgesia and propofol",{"trials":3406,"activeCount":99},[],{"trials":3408,"activeCount":99},[],{"intervention":3404,"totalTrials":136,"cells":3410},{"EARLY_PHASE1":3411,"PHASE1":3413,"PHASE2":3415,"PHASE3":3417,"PHASE4":3423,"NA":3425},{"trials":3412,"activeCount":99},[],{"trials":3414,"activeCount":99},[],{"trials":3416,"activeCount":99},[],{"trials":3418,"activeCount":99},[3419],{"nctId":3395,"briefTitle":3396,"status":652,"phases":3420,"primaryCompletion":2965,"completion":3398,"start":3399,"enrollment":3400,"conditions":3421,"interventions":3422},[89],[3402],[3384,3404],{"trials":3424,"activeCount":99},[],{"trials":3426,"activeCount":99},[],{"intervention":2933,"totalTrials":911,"cells":3428},{"EARLY_PHASE1":3429,"PHASE1":3431,"PHASE2":3451,"PHASE3":3478,"PHASE4":3480,"NA":3482},{"trials":3430,"activeCount":99},[],{"trials":3432,"activeCount":99},[3433],{"nctId":3434,"briefTitle":3435,"status":1662,"phases":3436,"start":3437,"enrollment":337,"conditions":3438,"interventions":3447},"NCT00004036","Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer",[87],"1997-11",[3439,3440,3441,3442,3443,3444,3445,3446],"Chronic Myeloproliferative Disorders","Drug\u002FAgent Toxicity by Tissue\u002FOrgan","Leukemia","Lymphoma","Multiple Myeloma and Plasma Cell Neoplasm","Myelodysplastic Syndromes","Precancerous Condition","Unspecified Adult Solid Tumor, Protocol Specific",[2933,3448,3449,3450],"amifostine trihydrate","carboplatin","cyclophosphamide",{"trials":3452,"activeCount":99},[3453,3464,3474],{"nctId":3454,"briefTitle":3455,"status":652,"phases":3456,"completion":3457,"start":3458,"enrollment":693,"conditions":3459,"interventions":3461},"NCT00003185","Biological Therapy in Treating Patients With Glioblastoma Multiforme",[88],"1998-07","1997-08",[3460],"Brain and Central Nervous System Tumors",[3462,2933,3463,3450],"autologous tumor cell vaccine","tumor-draining lymph node lymphocyte therapy",{"nctId":3465,"briefTitle":3466,"status":652,"phases":3467,"completion":3468,"start":3469,"enrollment":337,"conditions":3470,"interventions":3471},"NCT00003490","Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma",[88],"2003-08","1998-10",[3443],[2933,3450,3472,3473],"prednisone","vincristine sulfate",{"nctId":2924,"briefTitle":2925,"status":652,"phases":3475,"primaryCompletion":2927,"completion":2927,"start":2928,"enrollment":2929,"conditions":3476,"interventions":3477},[88],[2931],[2933,2901],{"trials":3479,"activeCount":99},[],{"trials":3481,"activeCount":99},[],{"trials":3483,"activeCount":99},[],{"intervention":3472,"totalTrials":2902,"cells":3485},{"EARLY_PHASE1":3486,"PHASE1":3488,"PHASE2":3490,"PHASE3":3515,"PHASE4":3517,"NA":3519},{"trials":3487,"activeCount":99},[],{"trials":3489,"activeCount":99},[],{"trials":3491,"activeCount":99},[3492,3501,3505],{"nctId":3493,"briefTitle":3494,"status":652,"phases":3495,"completion":3496,"start":3037,"conditions":3497,"interventions":3498},"NCT00003554","Rituximab in Treating Patients With Multiple Myeloma",[88],"2004-04",[3443],[3499,3500,3472],"rituximab","melphalan",{"nctId":3465,"briefTitle":3466,"status":652,"phases":3502,"completion":3468,"start":3469,"enrollment":337,"conditions":3503,"interventions":3504},[88],[3443],[2933,3450,3472,3473],{"nctId":3506,"briefTitle":3507,"status":652,"phases":3508,"completion":3509,"start":3510,"enrollment":274,"conditions":3511,"interventions":3513},"NCT00004686","Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis",[88],"1999-09","1994-02",[3512],"Giant Cell Arteritis",[3514,3472],"methotrexate",{"trials":3516,"activeCount":99},[],{"trials":3518,"activeCount":99},[],{"trials":3520,"activeCount":99},[],{"intervention":3450,"totalTrials":2902,"cells":3522},{"EARLY_PHASE1":3523,"PHASE1":3525,"PHASE2":3531,"PHASE3":3541,"PHASE4":3543,"NA":3545},{"trials":3524,"activeCount":99},[],{"trials":3526,"activeCount":99},[3527],{"nctId":3434,"briefTitle":3435,"status":1662,"phases":3528,"start":3437,"enrollment":337,"conditions":3529,"interventions":3530},[87],[3439,3440,3441,3442,3443,3444,3445,3446],[2933,3448,3449,3450],{"trials":3532,"activeCount":99},[3533,3537],{"nctId":3454,"briefTitle":3455,"status":652,"phases":3534,"completion":3457,"start":3458,"enrollment":693,"conditions":3535,"interventions":3536},[88],[3460],[3462,2933,3463,3450],{"nctId":3465,"briefTitle":3466,"status":652,"phases":3538,"completion":3468,"start":3469,"enrollment":337,"conditions":3539,"interventions":3540},[88],[3443],[2933,3450,3472,3473],{"trials":3542,"activeCount":99},[],{"trials":3544,"activeCount":99},[],{"trials":3546,"activeCount":99},[],{"intervention":3548,"totalTrials":2902,"cells":3549},"Placebos",{"EARLY_PHASE1":3550,"PHASE1":3552,"PHASE2":3566,"PHASE3":3592,"PHASE4":3594,"NA":3596},{"trials":3551,"activeCount":99},[],{"trials":3553,"activeCount":99},[3554],{"nctId":3555,"briefTitle":3556,"status":154,"phases":3557,"primaryCompletion":3558,"completion":3558,"start":3559,"enrollment":99,"conditions":3560,"interventions":3564},"NCT03122678","Thiamine Supplementation in Patients With Septic Shock",[87],"2019-03-14","2016-11-05",[277,3561,3562,3563],"Shock, Septic","Lactic Acidosis","Thiamine Deficiency",[3565,3548],"Thiamine",{"trials":3567,"activeCount":99},[3568,3581],{"nctId":3569,"briefTitle":3570,"status":652,"phases":3571,"primaryCompletion":3572,"completion":3573,"start":3574,"enrollment":869,"conditions":3575,"interventions":3578},"NCT04365153","Canakinumab in Covid-19 Cardiac Injury (The Three C Study)",[88],"2021-02-02","2021-04-01","2020-04-24",[3576,3577],"COVID-19","SARS-CoV 2",[3579,3580,3548],"Canakinumab Injection 600mg","Canakinumab Injection 300mg",{"nctId":3582,"briefTitle":3583,"status":652,"phases":3584,"primaryCompletion":3585,"completion":3585,"start":3586,"enrollment":693,"conditions":3587,"interventions":3590},"NCT04399980","Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation",[88],"2021-04-23","2020-05-20",[3588,3577,3589],"COVID 19","Pneumonia",[3591,3548],"Mavrilimumab",{"trials":3593,"activeCount":99},[],{"trials":3595,"activeCount":99},[],{"trials":3597,"activeCount":99},[],{"intervention":3599,"totalTrials":95,"cells":3600},"Gemcitabine Hydrochloride",{"EARLY_PHASE1":3601,"PHASE1":3603,"PHASE2":3605,"PHASE3":3626,"PHASE4":3628,"NA":3630},{"trials":3602,"activeCount":99},[],{"trials":3604,"activeCount":99},[],{"trials":3606,"activeCount":99},[3607,3615],{"nctId":3608,"briefTitle":3609,"status":111,"phases":3610,"primaryCompletion":1777,"completion":3611,"start":3332,"enrollment":16,"conditions":3612,"interventions":3613},"NCT00268242","Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia",[88],"2011-07",[3441],[3599,3614],"Mitoxantrone Hydrochloride",{"nctId":3616,"briefTitle":3617,"status":652,"phases":3618,"primaryCompletion":3619,"completion":3619,"start":3620,"enrollment":35,"conditions":3621,"interventions":3623},"NCT00401128","Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer",[88],"2007-02","2004-05",[3622],"Kidney Cancer",[3624,3625],"gemcitabine hydrochloride","irinotecan hydrochloride",{"trials":3627,"activeCount":99},[],{"trials":3629,"activeCount":99},[],{"trials":3631,"activeCount":99},[],{"intervention":3614,"totalTrials":95,"cells":3633},{"EARLY_PHASE1":3634,"PHASE1":3636,"PHASE2":3638,"PHASE3":3656,"PHASE4":3658,"NA":3660},{"trials":3635,"activeCount":99},[],{"trials":3637,"activeCount":99},[],{"trials":3639,"activeCount":99},[3640,3644],{"nctId":3608,"briefTitle":3609,"status":111,"phases":3641,"primaryCompletion":1777,"completion":3611,"start":3332,"enrollment":16,"conditions":3642,"interventions":3643},[88],[3441],[3599,3614],{"nctId":3645,"briefTitle":3646,"status":652,"phases":3647,"primaryCompletion":3648,"completion":905,"start":3649,"enrollment":693,"conditions":3650,"interventions":3651},"NCT00274807","Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia",[88],"2007-04","2001-06",[3441],[3652,3653,3654,3655],"filgrastim","cytarabine","etoposide","mitoxantrone hydrochloride",{"trials":3657,"activeCount":99},[],{"trials":3659,"activeCount":99},[],{"trials":3661,"activeCount":99},[],{"intervention":3663,"totalTrials":95,"cells":3664},"Methotrexate",{"EARLY_PHASE1":3665,"PHASE1":3667,"PHASE2":3669,"PHASE3":3686,"PHASE4":3688,"NA":3690},{"trials":3666,"activeCount":99},[],{"trials":3668,"activeCount":99},[],{"trials":3670,"activeCount":99},[3671,3682],{"nctId":3672,"briefTitle":3673,"status":652,"phases":3674,"primaryCompletion":3675,"completion":3675,"start":3676,"enrollment":35,"conditions":3677,"interventions":3679},"NCT00354393","Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma",[88],"2009-06","2002-08",[3678],"Malignant Mesothelioma",[3680,3663,3681],"Cisplatin","Vinorelbine ditartrate",{"nctId":3506,"briefTitle":3507,"status":652,"phases":3683,"completion":3509,"start":3510,"enrollment":274,"conditions":3684,"interventions":3685},[88],[3512],[3514,3472],{"trials":3687,"activeCount":99},[],{"trials":3689,"activeCount":99},[],{"trials":3691,"activeCount":99},[],{"intervention":3693,"totalTrials":95,"cells":3694},"cyclosporine",{"EARLY_PHASE1":3695,"PHASE1":3697,"PHASE2":3699,"PHASE3":3723,"PHASE4":3725,"NA":3727},{"trials":3696,"activeCount":99},[],{"trials":3698,"activeCount":99},[],{"trials":3700,"activeCount":99},[3701,3712],{"nctId":3702,"briefTitle":3703,"status":652,"phases":3704,"primaryCompletion":3705,"completion":3705,"start":3706,"enrollment":3707,"conditions":3708,"interventions":3710},"NCT01231841","Anti-thymocyte Globulin and Cyclosporine as First-Line Therapy in Treating Patients With Severe Aplastic Anemia",[88],"2010-12","2005-03",20,[3709],"Aplastic Anemia",[3693,3711],"anti-thymocyte globulin",{"nctId":3713,"briefTitle":3714,"status":652,"phases":3715,"primaryCompletion":3716,"completion":3717,"start":3718,"enrollment":3719,"conditions":3720,"interventions":3721},"NCT01990898","Cyclosporine in Interstitial Cystitis: Efficacy, Safety and Mechanism of Action",[88],"2015-10","2016-04","2013-11",26,[615],[3722],"Cyclosporine",{"trials":3724,"activeCount":99},[],{"trials":3726,"activeCount":99},[],{"trials":3728,"activeCount":99},[],{"intervention":3653,"totalTrials":95,"cells":3730},{"EARLY_PHASE1":3731,"PHASE1":3733,"PHASE2":3745,"PHASE3":3751,"PHASE4":3753,"NA":3755},{"trials":3732,"activeCount":99},[],{"trials":3734,"activeCount":99},[3735],{"nctId":3736,"briefTitle":3737,"status":652,"phases":3738,"primaryCompletion":3739,"completion":3739,"start":3740,"enrollment":2320,"conditions":3741,"interventions":3742},"NCT00268229","Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia",[87],"2011-08","2003-07",[3441],[3653,3743,3744],"daunorubicin hydrochloride","imatinib mesylate",{"trials":3746,"activeCount":99},[3747],{"nctId":3645,"briefTitle":3646,"status":652,"phases":3748,"primaryCompletion":3648,"completion":905,"start":3649,"enrollment":693,"conditions":3749,"interventions":3750},[88],[3441],[3652,3653,3654,3655],{"trials":3752,"activeCount":99},[],{"trials":3754,"activeCount":99},[],{"trials":3756,"activeCount":99},[],{"intervention":3758,"totalTrials":95,"cells":3759},"Remestemcel-L",{"EARLY_PHASE1":3760,"PHASE1":3762,"PHASE2":3764,"PHASE3":3784,"PHASE4":3786,"NA":3788},{"trials":3761,"activeCount":99},[],{"trials":3763,"activeCount":99},[],{"trials":3765,"activeCount":99},[3766,3776],{"nctId":3767,"briefTitle":3768,"status":111,"phases":3769,"primaryCompletion":3770,"completion":3770,"start":3771,"enrollment":3772,"conditions":3773,"interventions":3775},"NCT04543994","Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)",[87,88],"2023-11-15","2020-11-10",7,[3774],"Ulcerative Colitis",[3758,3758],{"nctId":3777,"briefTitle":3778,"status":111,"phases":3779,"primaryCompletion":3770,"completion":3770,"start":3780,"enrollment":3772,"conditions":3781,"interventions":3783},"NCT04548583","Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis",[87,88],"2020-11-04",[3782],"Crohn Colitis",[3758,3758],{"trials":3785,"activeCount":99},[],{"trials":3787,"activeCount":99},[],{"trials":3789,"activeCount":99},[],{"intervention":2920,"totalTrials":95,"cells":3791},{"EARLY_PHASE1":3792,"PHASE1":3794,"PHASE2":3796,"PHASE3":3812,"PHASE4":3814,"NA":3816},{"trials":3793,"activeCount":99},[],{"trials":3795,"activeCount":99},[],{"trials":3797,"activeCount":99},[3798,3802],{"nctId":2911,"briefTitle":2912,"status":154,"phases":3799,"enrollment":99,"conditions":3800,"interventions":3801},[88],[2915,2916,2917,2918],[2920,2921,2922,2901],{"nctId":3803,"briefTitle":3804,"status":652,"phases":3805,"primaryCompletion":3806,"completion":3807,"start":3808,"enrollment":337,"conditions":3809,"interventions":3810},"NCT00274781","Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndromes",[88],"2008-12","2010-11","2004-02",[3441,3444],[2920,3811],"gemtuzumab ozogamicin",{"trials":3813,"activeCount":99},[],{"trials":3815,"activeCount":99},[],{"trials":3817,"activeCount":99},[],{"intervention":3473,"totalTrials":95,"cells":3819},{"EARLY_PHASE1":3820,"PHASE1":3822,"PHASE2":3824,"PHASE3":3837,"PHASE4":3839,"NA":3841},{"trials":3821,"activeCount":99},[],{"trials":3823,"activeCount":99},[],{"trials":3825,"activeCount":99},[3826,3830],{"nctId":3465,"briefTitle":3466,"status":652,"phases":3827,"completion":3468,"start":3469,"enrollment":337,"conditions":3828,"interventions":3829},[88],[3443],[2933,3450,3472,3473],{"nctId":3831,"briefTitle":3832,"status":652,"phases":3833,"completion":3496,"start":3037,"conditions":3834,"interventions":3835},"NCT00003493","Combination Chemotherapy in Treating Patients With Multiple Myeloma",[88],[3443],[2922,3836,3473],"pegylated liposomal doxorubicin hydrochloride",{"trials":3838,"activeCount":99},[],{"trials":3840,"activeCount":99},[],{"trials":3842,"activeCount":99},[],{"intervention":3844,"totalTrials":95,"cells":3845},"temozolomide",{"EARLY_PHASE1":3846,"PHASE1":3848,"PHASE2":3859,"PHASE3":3873,"PHASE4":3875,"NA":3877},{"trials":3847,"activeCount":99},[],{"trials":3849,"activeCount":99},[3850],{"nctId":3851,"briefTitle":3852,"status":652,"phases":3853,"primaryCompletion":884,"completion":884,"start":3854,"enrollment":3855,"conditions":3856,"interventions":3857},"NCT00401180","Docetaxel and Temozolomide in Treating Patients With Metastatic Cancer",[87],"2002-06",25,[3446],[3858,3844],"docetaxel",{"trials":3860,"activeCount":99},[3861],{"nctId":3862,"briefTitle":3863,"status":652,"phases":3864,"primaryCompletion":3865,"completion":3866,"start":3867,"enrollment":3868,"conditions":3869,"interventions":3872},"NCT00400816","Temozolomide in Treating Patients With Newly Diagnosed Anaplastic Oligodendroglioma or Mixed Oligoastrocytoma",[88],"2008-01-17","2016-01-06","2005-08",29,[3870,3871],"Central Nervous System Tumors","Brain Tumor",[3844],{"trials":3874,"activeCount":99},[],{"trials":3876,"activeCount":99},[],{"trials":3878,"activeCount":99},[],{"intervention":3880,"totalTrials":95,"cells":3881},"lenalidomide",{"EARLY_PHASE1":3882,"PHASE1":3884,"PHASE2":3894,"PHASE3":3903,"PHASE4":3905,"NA":3907},{"trials":3883,"activeCount":99},[],{"trials":3885,"activeCount":99},[3886],{"nctId":3887,"briefTitle":3888,"status":652,"phases":3889,"primaryCompletion":3890,"completion":3890,"start":3891,"enrollment":1621,"conditions":3892,"interventions":3893},"NCT00415116","Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors",[87],"2007-07","2004-08",[3446],[3449,3858,3880],{"trials":3895,"activeCount":99},[3896],{"nctId":3897,"briefTitle":3898,"status":652,"phases":3899,"primaryCompletion":3900,"completion":3900,"start":3891,"enrollment":3719,"conditions":3901,"interventions":3902},"NCT00403169","Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer",[88],"2009-05",[3622],[3880],{"trials":3904,"activeCount":99},[],{"trials":3906,"activeCount":99},[],{"trials":3908,"activeCount":99},[],{"intervention":3910,"totalTrials":136,"cells":3911},"Enbrel",{"EARLY_PHASE1":3912,"PHASE1":3914,"PHASE2":3916,"PHASE3":3927,"PHASE4":3929,"NA":3931},{"trials":3913,"activeCount":99},[],{"trials":3915,"activeCount":99},[],{"trials":3917,"activeCount":99},[3918],{"nctId":3919,"briefTitle":3920,"status":652,"phases":3921,"completion":3922,"start":3923,"enrollment":1135,"conditions":3924,"interventions":3926},"NCT00224393","Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis",[88],"2005-08-31","2001-02",[3925],"Primary Systemic Amyloidosis",[3910],{"trials":3928,"activeCount":99},[],{"trials":3930,"activeCount":99},[],{"trials":3932,"activeCount":99},[],{"intervention":3934,"totalTrials":136,"cells":3935},"Abatacept",{"EARLY_PHASE1":3936,"PHASE1":3938,"PHASE2":3940,"PHASE3":3952,"PHASE4":3954,"NA":3956},{"trials":3937,"activeCount":99},[],{"trials":3939,"activeCount":99},[],{"trials":3941,"activeCount":99},[3942],{"nctId":3943,"briefTitle":3944,"status":154,"phases":3945,"primaryCompletion":1451,"completion":1451,"start":3718,"enrollment":99,"conditions":3946,"interventions":3951},"NCT02027298","Abatacept for Patients With Inflammatory Arthritis Associated With Sjögren's Syndrome: an Open-Label Phase II Study",[88],[3947,3948,3949,3950],"Primary Sjogren's Syndrome","Secondary Sjogren's Syndrome","Inflammatory Arthritis","Rheumatoid Arthritis",[3934],{"trials":3953,"activeCount":99},[],{"trials":3955,"activeCount":99},[],{"trials":3957,"activeCount":99},[],{"intervention":3959,"totalTrials":136,"cells":3960},"Rilonacept",{"EARLY_PHASE1":3961,"PHASE1":3963,"PHASE2":3965,"PHASE3":3975,"PHASE4":3977,"NA":3979},{"trials":3962,"activeCount":99},[],{"trials":3964,"activeCount":99},[],{"trials":3966,"activeCount":99},[3967],{"nctId":3968,"briefTitle":3969,"status":652,"phases":3970,"primaryCompletion":3239,"completion":3239,"start":3971,"enrollment":1621,"conditions":3972,"interventions":3974},"NCT00582907","Rilonacept for Treatment of Familial Mediterranean Fever (FMF)",[88],"2008-08",[3973],"Familial Mediterranean Fever",[3959],{"trials":3976,"activeCount":99},[],{"trials":3978,"activeCount":99},[],{"trials":3980,"activeCount":99},[],{"intervention":3680,"totalTrials":136,"cells":3982},{"EARLY_PHASE1":3983,"PHASE1":3985,"PHASE2":3987,"PHASE3":3993,"PHASE4":3995,"NA":3997},{"trials":3984,"activeCount":99},[],{"trials":3986,"activeCount":99},[],{"trials":3988,"activeCount":99},[3989],{"nctId":3672,"briefTitle":3673,"status":652,"phases":3990,"primaryCompletion":3675,"completion":3675,"start":3676,"enrollment":35,"conditions":3991,"interventions":3992},[88],[3678],[3680,3663,3681],{"trials":3994,"activeCount":99},[],{"trials":3996,"activeCount":99},[],{"trials":3998,"activeCount":99},[],{"intervention":3681,"totalTrials":136,"cells":4000},{"EARLY_PHASE1":4001,"PHASE1":4003,"PHASE2":4005,"PHASE3":4011,"PHASE4":4013,"NA":4015},{"trials":4002,"activeCount":99},[],{"trials":4004,"activeCount":99},[],{"trials":4006,"activeCount":99},[4007],{"nctId":3672,"briefTitle":3673,"status":652,"phases":4008,"primaryCompletion":3675,"completion":3675,"start":3676,"enrollment":35,"conditions":4009,"interventions":4010},[88],[3678],[3680,3663,3681],{"trials":4012,"activeCount":99},[],{"trials":4014,"activeCount":99},[],{"trials":4016,"activeCount":99},[],{"intervention":3500,"totalTrials":136,"cells":4018},{"EARLY_PHASE1":4019,"PHASE1":4021,"PHASE2":4023,"PHASE3":4029,"PHASE4":4031,"NA":4033},{"trials":4020,"activeCount":99},[],{"trials":4022,"activeCount":99},[],{"trials":4024,"activeCount":99},[4025],{"nctId":3493,"briefTitle":3494,"status":652,"phases":4026,"completion":3496,"start":3037,"conditions":4027,"interventions":4028},[88],[3443],[3499,3500,3472],{"trials":4030,"activeCount":99},[],{"trials":4032,"activeCount":99},[],{"trials":4034,"activeCount":99},[],{"intervention":3462,"totalTrials":136,"cells":4036},{"EARLY_PHASE1":4037,"PHASE1":4039,"PHASE2":4041,"PHASE3":4047,"PHASE4":4049,"NA":4051},{"trials":4038,"activeCount":99},[],{"trials":4040,"activeCount":99},[],{"trials":4042,"activeCount":99},[4043],{"nctId":3454,"briefTitle":3455,"status":652,"phases":4044,"completion":3457,"start":3458,"enrollment":693,"conditions":4045,"interventions":4046},[88],[3460],[3462,2933,3463,3450],{"trials":4048,"activeCount":99},[],{"trials":4050,"activeCount":99},[],{"trials":4052,"activeCount":99},[],{"intervention":3463,"totalTrials":136,"cells":4054},{"EARLY_PHASE1":4055,"PHASE1":4057,"PHASE2":4059,"PHASE3":4065,"PHASE4":4067,"NA":4069},{"trials":4056,"activeCount":99},[],{"trials":4058,"activeCount":99},[],{"trials":4060,"activeCount":99},[4061],{"nctId":3454,"briefTitle":3455,"status":652,"phases":4062,"completion":3457,"start":3458,"enrollment":693,"conditions":4063,"interventions":4064},[88],[3460],[3462,2933,3463,3450],{"trials":4066,"activeCount":99},[],{"trials":4068,"activeCount":99},[],{"trials":4070,"activeCount":99},[],{"intervention":4072,"totalTrials":136,"cells":4073},"carboplatin, paclitaxel, and bevacizumab",{"EARLY_PHASE1":4074,"PHASE1":4076,"PHASE2":4078,"PHASE3":4088,"PHASE4":4090,"NA":4092},{"trials":4075,"activeCount":99},[],{"trials":4077,"activeCount":99},[],{"trials":4079,"activeCount":99},[4080],{"nctId":4081,"briefTitle":4082,"status":652,"phases":4083,"primaryCompletion":904,"completion":904,"start":4084,"enrollment":950,"conditions":4085,"interventions":4087},"NCT00879359","Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer",[88],"2007-12",[4086],"Endometrial Carcinoma",[4072],{"trials":4089,"activeCount":99},[],{"trials":4091,"activeCount":99},[],{"trials":4093,"activeCount":99},[],{"intervention":3579,"totalTrials":136,"cells":4095},{"EARLY_PHASE1":4096,"PHASE1":4098,"PHASE2":4100,"PHASE3":4106,"PHASE4":4108,"NA":4110},{"trials":4097,"activeCount":99},[],{"trials":4099,"activeCount":99},[],{"trials":4101,"activeCount":99},[4102],{"nctId":3569,"briefTitle":3570,"status":652,"phases":4103,"primaryCompletion":3572,"completion":3573,"start":3574,"enrollment":869,"conditions":4104,"interventions":4105},[88],[3576,3577],[3579,3580,3548],{"trials":4107,"activeCount":99},[],{"trials":4109,"activeCount":99},[],{"trials":4111,"activeCount":99},[],{"intervention":3580,"totalTrials":136,"cells":4113},{"EARLY_PHASE1":4114,"PHASE1":4116,"PHASE2":4118,"PHASE3":4124,"PHASE4":4126,"NA":4128},{"trials":4115,"activeCount":99},[],{"trials":4117,"activeCount":99},[],{"trials":4119,"activeCount":99},[4120],{"nctId":3569,"briefTitle":3570,"status":652,"phases":4121,"primaryCompletion":3572,"completion":3573,"start":3574,"enrollment":869,"conditions":4122,"interventions":4123},[88],[3576,3577],[3579,3580,3548],{"trials":4125,"activeCount":99},[],{"trials":4127,"activeCount":99},[],{"trials":4129,"activeCount":99},[],{"intervention":3711,"totalTrials":136,"cells":4131},{"EARLY_PHASE1":4132,"PHASE1":4134,"PHASE2":4136,"PHASE3":4142,"PHASE4":4144,"NA":4146},{"trials":4133,"activeCount":99},[],{"trials":4135,"activeCount":99},[],{"trials":4137,"activeCount":99},[4138],{"nctId":3702,"briefTitle":3703,"status":652,"phases":4139,"primaryCompletion":3705,"completion":3705,"start":3706,"enrollment":3707,"conditions":4140,"interventions":4141},[88],[3709],[3693,3711],{"trials":4143,"activeCount":99},[],{"trials":4145,"activeCount":99},[],{"trials":4147,"activeCount":99},[],{"intervention":4149,"totalTrials":136,"cells":4150},"Pomalidomide Oral Product",{"EARLY_PHASE1":4151,"PHASE1":4153,"PHASE2":4155,"PHASE3":4167,"PHASE4":4169,"NA":4171},{"trials":4152,"activeCount":99},[],{"trials":4154,"activeCount":99},[],{"trials":4156,"activeCount":99},[4157],{"nctId":4158,"briefTitle":4159,"status":652,"phases":4160,"primaryCompletion":4161,"completion":4161,"start":4162,"enrollment":4163,"conditions":4164,"interventions":4166},"NCT03910244","Pomalidomide for the Treatment of Bleeding in HHT",[88],"2023-09-08","2019-10-17",145,[4165],"Telangiectasia, Hereditary Hemorrhagic",[4149],{"trials":4168,"activeCount":99},[],{"trials":4170,"activeCount":99},[],{"trials":4172,"activeCount":99},[],{"intervention":4174,"totalTrials":136,"cells":4175},"Thymoglobulin",{"EARLY_PHASE1":4176,"PHASE1":4178,"PHASE2":4180,"PHASE3":4193,"PHASE4":4195,"NA":4197},{"trials":4177,"activeCount":99},[],{"trials":4179,"activeCount":99},[],{"trials":4181,"activeCount":99},[4182],{"nctId":4183,"briefTitle":4184,"status":652,"phases":4185,"primaryCompletion":4186,"completion":4187,"start":4188,"enrollment":4189,"conditions":4190,"interventions":4192},"NCT02544113","A Randomized Controlled Clinical Trial of Thymoglobulin® After Liver Transplantation",[88],"2018-06-26","2020-01-03","2015-12",110,[4191],"Liver Failure",[4174],{"trials":4194,"activeCount":99},[],{"trials":4196,"activeCount":99},[],{"trials":4198,"activeCount":99},[],{"intervention":4200,"totalTrials":136,"cells":4201},"Hydroxychloroquine",{"EARLY_PHASE1":4202,"PHASE1":4204,"PHASE2":4206,"PHASE3":4217,"PHASE4":4219,"NA":4221},{"trials":4203,"activeCount":99},[],{"trials":4205,"activeCount":99},[],{"trials":4207,"activeCount":99},[4208],{"nctId":4209,"briefTitle":4210,"status":652,"phases":4211,"primaryCompletion":4212,"completion":4212,"start":4213,"enrollment":35,"conditions":4214,"interventions":4216},"NCT03283566","Hydroxychloroquine and Metabolic Outcomes in Patients Undergoing TPAIT",[88],"2020-05-31","2017-10-03",[695,4215],"Insulin Dependent Diabetes",[4200],{"trials":4218,"activeCount":99},[],{"trials":4220,"activeCount":99},[],{"trials":4222,"activeCount":99},[],{"intervention":4224,"totalTrials":136,"cells":4225},"Bexarotene",{"EARLY_PHASE1":4226,"PHASE1":4228,"PHASE2":4230,"PHASE3":4241,"PHASE4":4243,"NA":4245},{"trials":4227,"activeCount":99},[],{"trials":4229,"activeCount":99},[],{"trials":4231,"activeCount":99},[4232],{"nctId":4233,"briefTitle":4234,"status":652,"phases":4235,"primaryCompletion":4236,"completion":3104,"start":4237,"enrollment":3707,"conditions":4238,"interventions":4240},"NCT01782742","Bexarotene Amyloid Treatment for Alzheimer's Disease",[88],"2014-08","2013-02",[4239],"Alzheimer's Disease",[4224],{"trials":4242,"activeCount":99},[],{"trials":4244,"activeCount":99},[],{"trials":4246,"activeCount":99},[],{"intervention":4248,"totalTrials":136,"cells":4249},"Propylene Glycol",{"EARLY_PHASE1":4250,"PHASE1":4252,"PHASE2":4254,"PHASE3":4267,"PHASE4":4269,"NA":4271},{"trials":4251,"activeCount":99},[],{"trials":4253,"activeCount":99},[],{"trials":4255,"activeCount":99},[4256],{"nctId":4257,"briefTitle":4258,"status":652,"phases":4259,"primaryCompletion":4260,"completion":4260,"start":4261,"enrollment":4262,"conditions":4263,"interventions":4265},"NCT04380090","Post-Operative Constipation Following Total Knee Arthroplasty",[88],"2020-07-15","2020-02-21",154,[4264],"Constipation",[4248,4266],"Docusate Sodium",{"trials":4268,"activeCount":99},[],{"trials":4270,"activeCount":99},[],{"trials":4272,"activeCount":99},[],{"intervention":4266,"totalTrials":136,"cells":4274},{"EARLY_PHASE1":4275,"PHASE1":4277,"PHASE2":4279,"PHASE3":4285,"PHASE4":4287,"NA":4289},{"trials":4276,"activeCount":99},[],{"trials":4278,"activeCount":99},[],{"trials":4280,"activeCount":99},[4281],{"nctId":4257,"briefTitle":4258,"status":652,"phases":4282,"primaryCompletion":4260,"completion":4260,"start":4261,"enrollment":4262,"conditions":4283,"interventions":4284},[88],[4264],[4248,4266],{"trials":4286,"activeCount":99},[],{"trials":4288,"activeCount":99},[],{"trials":4290,"activeCount":99},[],{"intervention":4292,"totalTrials":136,"cells":4293},"erlotinib hydrochloride",{"EARLY_PHASE1":4294,"PHASE1":4296,"PHASE2":4298,"PHASE3":4307,"PHASE4":4309,"NA":4311},{"trials":4295,"activeCount":99},[],{"trials":4297,"activeCount":99},[],{"trials":4299,"activeCount":99},[4300],{"nctId":4301,"briefTitle":4302,"status":1662,"phases":4303,"start":3676,"enrollment":4304,"conditions":4305,"interventions":4306},"NCT00054496","Erlotinib in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme",[88],73,[3460],[4292],{"trials":4308,"activeCount":99},[],{"trials":4310,"activeCount":99},[],{"trials":4312,"activeCount":99},[],{"intervention":4314,"totalTrials":136,"cells":4315},"Nicotinamide",{"EARLY_PHASE1":4316,"PHASE1":4318,"PHASE2":4320,"PHASE3":4333,"PHASE4":4335,"NA":4337},{"trials":4317,"activeCount":99},[],{"trials":4319,"activeCount":99},[],{"trials":4321,"activeCount":99},[4322],{"nctId":4323,"briefTitle":4324,"status":652,"phases":4325,"primaryCompletion":4326,"completion":4327,"start":2967,"enrollment":4328,"conditions":4329,"interventions":4331},"NCT02258074","The COMBINE Study: The CKD Optimal Management With BInders and NicotinamidE",[88],"2018-11","2019-09",205,[4330],"Chronic Kidney Disease",[4314,4332],"Lanthanum Carbonate",{"trials":4334,"activeCount":99},[],{"trials":4336,"activeCount":99},[],{"trials":4338,"activeCount":99},[],{"intervention":4332,"totalTrials":136,"cells":4340},{"EARLY_PHASE1":4341,"PHASE1":4343,"PHASE2":4345,"PHASE3":4351,"PHASE4":4353,"NA":4355},{"trials":4342,"activeCount":99},[],{"trials":4344,"activeCount":99},[],{"trials":4346,"activeCount":99},[4347],{"nctId":4323,"briefTitle":4324,"status":652,"phases":4348,"primaryCompletion":4326,"completion":4327,"start":2967,"enrollment":4328,"conditions":4349,"interventions":4350},[88],[4330],[4314,4332],{"trials":4352,"activeCount":99},[],{"trials":4354,"activeCount":99},[],{"trials":4356,"activeCount":99},[],{"intervention":2921,"totalTrials":136,"cells":4358},{"EARLY_PHASE1":4359,"PHASE1":4361,"PHASE2":4363,"PHASE3":4369,"PHASE4":4371,"NA":4373},{"trials":4360,"activeCount":99},[],{"trials":4362,"activeCount":99},[],{"trials":4364,"activeCount":99},[4365],{"nctId":2911,"briefTitle":2912,"status":154,"phases":4366,"enrollment":99,"conditions":4367,"interventions":4368},[88],[2915,2916,2917,2918],[2920,2921,2922,2901],{"trials":4370,"activeCount":99},[],{"trials":4372,"activeCount":99},[],{"trials":4374,"activeCount":99},[],{"intervention":4376,"totalTrials":136,"cells":4377},"Raptiva",{"EARLY_PHASE1":4378,"PHASE1":4380,"PHASE2":4382,"PHASE3":4391,"PHASE4":4393,"NA":4395},{"trials":4379,"activeCount":99},[],{"trials":4381,"activeCount":99},[],{"trials":4383,"activeCount":99},[4384],{"nctId":4385,"briefTitle":4386,"status":154,"phases":4387,"primaryCompletion":2699,"completion":2699,"start":3331,"enrollment":99,"conditions":4388,"interventions":4390},"NCT00308204","Discoid Lupus Erythematosus of the Scalp and a Trial of Biologic Therapy With Raptiva",[88],[4389],"Discoid Lupus Erthematosus of the Scalp",[4376],{"trials":4392,"activeCount":99},[],{"trials":4394,"activeCount":99},[],{"trials":4396,"activeCount":99},[],{"intervention":3591,"totalTrials":136,"cells":4398},{"EARLY_PHASE1":4399,"PHASE1":4401,"PHASE2":4403,"PHASE3":4409,"PHASE4":4411,"NA":4413},{"trials":4400,"activeCount":99},[],{"trials":4402,"activeCount":99},[],{"trials":4404,"activeCount":99},[4405],{"nctId":3582,"briefTitle":3583,"status":652,"phases":4406,"primaryCompletion":3585,"completion":3585,"start":3586,"enrollment":693,"conditions":4407,"interventions":4408},[88],[3588,3577,3589],[3591,3548],{"trials":4410,"activeCount":99},[],{"trials":4412,"activeCount":99},[],{"trials":4414,"activeCount":99},[],{"intervention":4416,"totalTrials":136,"cells":4417},"arzoxifene hydrochloride",{"EARLY_PHASE1":4418,"PHASE1":4420,"PHASE2":4422,"PHASE3":4435,"PHASE4":4437,"NA":4439},{"trials":4419,"activeCount":99},[],{"trials":4421,"activeCount":99},[],{"trials":4423,"activeCount":99},[4424],{"nctId":4425,"briefTitle":4426,"status":652,"phases":4427,"primaryCompletion":4428,"completion":4428,"start":4429,"enrollment":2902,"conditions":4430,"interventions":4433},"NCT00253539","Arzoxifene or Tamoxifen in Preventing Breast Cancer in Premenopausal Women at High Risk for Breast Cancer",[88],"2005-04","2002-01",[4431,4432],"Breast Cancer","Hereditary Breast\u002FOvarian Cancer (brca1, brca2)",[4416,4434],"tamoxifen citrate",{"trials":4436,"activeCount":99},[],{"trials":4438,"activeCount":99},[],{"trials":4440,"activeCount":99},[],{"intervention":4434,"totalTrials":136,"cells":4442},{"EARLY_PHASE1":4443,"PHASE1":4445,"PHASE2":4447,"PHASE3":4453,"PHASE4":4455,"NA":4457},{"trials":4444,"activeCount":99},[],{"trials":4446,"activeCount":99},[],{"trials":4448,"activeCount":99},[4449],{"nctId":4425,"briefTitle":4426,"status":652,"phases":4450,"primaryCompletion":4428,"completion":4428,"start":4429,"enrollment":2902,"conditions":4451,"interventions":4452},[88],[4431,4432],[4416,4434],{"trials":4454,"activeCount":99},[],{"trials":4456,"activeCount":99},[],{"trials":4458,"activeCount":99},[],{"intervention":4460,"totalTrials":136,"cells":4461},"Rosuvastatin",{"EARLY_PHASE1":4462,"PHASE1":4464,"PHASE2":4466,"PHASE3":4477,"PHASE4":4479,"NA":4481},{"trials":4463,"activeCount":99},[],{"trials":4465,"activeCount":99},[],{"trials":4467,"activeCount":99},[4468],{"nctId":4469,"briefTitle":4470,"status":652,"phases":4471,"primaryCompletion":4472,"completion":4472,"start":3585,"enrollment":4473,"conditions":4474,"interventions":4476},"NCT04846231","Supplements, Placebo, or Rosuvastatin Study",[88],"2022-07-19",203,[4475],"Hypercholesterolemia",[4460],{"trials":4478,"activeCount":99},[],{"trials":4480,"activeCount":99},[],{"trials":4482,"activeCount":99},[],{"intervention":3625,"totalTrials":136,"cells":4484},{"EARLY_PHASE1":4485,"PHASE1":4487,"PHASE2":4489,"PHASE3":4495,"PHASE4":4497,"NA":4499},{"trials":4486,"activeCount":99},[],{"trials":4488,"activeCount":99},[],{"trials":4490,"activeCount":99},[4491],{"nctId":3616,"briefTitle":3617,"status":652,"phases":4492,"primaryCompletion":3619,"completion":3619,"start":3620,"enrollment":35,"conditions":4493,"interventions":4494},[88],[3622],[3624,3625],{"trials":4496,"activeCount":99},[],{"trials":4498,"activeCount":99},[],{"trials":4500,"activeCount":99},[],{"intervention":4502,"totalTrials":136,"cells":4503},"Pentoxifylline",{"EARLY_PHASE1":4504,"PHASE1":4506,"PHASE2":4508,"PHASE3":4519,"PHASE4":4521,"NA":4523},{"trials":4505,"activeCount":99},[],{"trials":4507,"activeCount":99},[],{"trials":4509,"activeCount":99},[4510],{"nctId":4511,"briefTitle":4512,"status":652,"phases":4513,"primaryCompletion":4514,"completion":4515,"start":3807,"enrollment":3707,"conditions":4516,"interventions":4518},"NCT01249092","Pentoxifylline for Primary Biliary Cirrhosis",[88],"2012-06","2013-03",[4517],"Primary Biliary Cirrhosis",[4502],{"trials":4520,"activeCount":99},[],{"trials":4522,"activeCount":99},[],{"trials":4524,"activeCount":99},[],{"intervention":3654,"totalTrials":136,"cells":4526},{"EARLY_PHASE1":4527,"PHASE1":4529,"PHASE2":4531,"PHASE3":4537,"PHASE4":4539,"NA":4541},{"trials":4528,"activeCount":99},[],{"trials":4530,"activeCount":99},[],{"trials":4532,"activeCount":99},[4533],{"nctId":3645,"briefTitle":3646,"status":652,"phases":4534,"primaryCompletion":3648,"completion":905,"start":3649,"enrollment":693,"conditions":4535,"interventions":4536},[88],[3441],[3652,3653,3654,3655],{"trials":4538,"activeCount":99},[],{"trials":4540,"activeCount":99},[],{"trials":4542,"activeCount":99},[],{"intervention":3811,"totalTrials":136,"cells":4544},{"EARLY_PHASE1":4545,"PHASE1":4547,"PHASE2":4549,"PHASE3":4555,"PHASE4":4557,"NA":4559},{"trials":4546,"activeCount":99},[],{"trials":4548,"activeCount":99},[],{"trials":4550,"activeCount":99},[4551],{"nctId":3803,"briefTitle":3804,"status":652,"phases":4552,"primaryCompletion":3806,"completion":3807,"start":3808,"enrollment":337,"conditions":4553,"interventions":4554},[88],[3441,3444],[2920,3811],{"trials":4556,"activeCount":99},[],{"trials":4558,"activeCount":99},[],{"trials":4560,"activeCount":99},[],{"intervention":4562,"totalTrials":136,"cells":4563},"Rapamune",{"EARLY_PHASE1":4564,"PHASE1":4566,"PHASE2":4568,"PHASE3":4578,"PHASE4":4580,"NA":4582},{"trials":4565,"activeCount":99},[],{"trials":4567,"activeCount":99},[],{"trials":4569,"activeCount":99},[4570],{"nctId":4571,"briefTitle":4572,"status":652,"phases":4573,"primaryCompletion":4574,"completion":3104,"start":1419,"enrollment":337,"conditions":4575,"interventions":4577},"NCT00286156","Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)",[87,88],"2012-03",[4576],"Polycystic Kidney Diseases",[4562],{"trials":4579,"activeCount":99},[],{"trials":4581,"activeCount":99},[],{"trials":4583,"activeCount":99},[],{"intervention":4585,"totalTrials":136,"cells":4586},"pregabalin",{"EARLY_PHASE1":4587,"PHASE1":4589,"PHASE2":4591,"PHASE3":4602,"PHASE4":4604,"NA":4606},{"trials":4588,"activeCount":99},[],{"trials":4590,"activeCount":99},[],{"trials":4592,"activeCount":99},[4593],{"nctId":4594,"briefTitle":4595,"status":111,"phases":4596,"primaryCompletion":4597,"completion":4597,"start":895,"enrollment":2057,"conditions":4598,"interventions":4601},"NCT00853229","Pregabalin for the Treatment of Vulvodynia",[88],"2013-04",[4599,4600],"Vulvodynia","Vulvar Vestibulitis",[4585],{"trials":4603,"activeCount":99},[],{"trials":4605,"activeCount":99},[],{"trials":4607,"activeCount":99},[],{"intervention":3836,"totalTrials":136,"cells":4609},{"EARLY_PHASE1":4610,"PHASE1":4612,"PHASE2":4614,"PHASE3":4620,"PHASE4":4622,"NA":4624},{"trials":4611,"activeCount":99},[],{"trials":4613,"activeCount":99},[],{"trials":4615,"activeCount":99},[4616],{"nctId":3831,"briefTitle":3832,"status":652,"phases":4617,"completion":3496,"start":3037,"conditions":4618,"interventions":4619},[88],[3443],[2922,3836,3473],{"trials":4621,"activeCount":99},[],{"trials":4623,"activeCount":99},[],{"trials":4625,"activeCount":99},[],{"intervention":4627,"totalTrials":136,"cells":4628},"Rasagiline",{"EARLY_PHASE1":4629,"PHASE1":4631,"PHASE2":4633,"PHASE3":4644,"PHASE4":4646,"NA":4648},{"trials":4630,"activeCount":99},[],{"trials":4632,"activeCount":99},[],{"trials":4634,"activeCount":99},[4635],{"nctId":4636,"briefTitle":4637,"status":652,"phases":4638,"primaryCompletion":4639,"completion":4640,"start":4641,"enrollment":167,"conditions":4642,"interventions":4643},"NCT02359552","Rasagiline Rescue in Alzheimer's Disease Clinical Trial",[88],"2018-08-29","2019-01-04","2015-05",[4239],[4627],{"trials":4645,"activeCount":99},[],{"trials":4647,"activeCount":99},[],{"trials":4649,"activeCount":99},[],{"intervention":4651,"totalTrials":136,"cells":4652},"[F-18] RDG-K5",{"EARLY_PHASE1":4653,"PHASE1":4655,"PHASE2":4657,"PHASE3":4667,"PHASE4":4669,"NA":4671},{"trials":4654,"activeCount":99},[],{"trials":4656,"activeCount":99},[],{"trials":4658,"activeCount":99},[4659],{"nctId":4660,"briefTitle":4661,"status":111,"phases":4662,"primaryCompletion":1462,"completion":1462,"start":3718,"enrollment":2902,"conditions":4663,"interventions":4666},"NCT01968226","TRACER RGD-K5 Carotid Plaque Imaging Study",[88],[4664,4665],"Carotid Artery Disease","Carotid Stenosis",[4651],{"trials":4668,"activeCount":99},[],{"trials":4670,"activeCount":99},[],{"trials":4672,"activeCount":99},[],{"intervention":4674,"totalTrials":136,"cells":4675},"GM-CSF",{"EARLY_PHASE1":4676,"PHASE1":4678,"PHASE2":4680,"PHASE3":4692,"PHASE4":4694,"NA":4696},{"trials":4677,"activeCount":99},[],{"trials":4679,"activeCount":99},[],{"trials":4681,"activeCount":99},[4682],{"nctId":4683,"briefTitle":4684,"status":111,"phases":4685,"completion":4686,"start":4687,"enrollment":4688,"conditions":4689,"interventions":4691},"NCT00030056","GM-CSF in Patients With Pulmonary Alveolar Proteinosis",[88],"2005-12","2001-09",48,[4690],"Pulmonary Alveolar Proteinosis",[4674],{"trials":4693,"activeCount":99},[],{"trials":4695,"activeCount":99},[],{"trials":4697,"activeCount":99},[],{"intervention":4699,"totalTrials":95,"cells":4700},"mesenchymal stem cells",{"EARLY_PHASE1":4701,"PHASE1":4703,"PHASE2":4731,"PHASE3":4733,"PHASE4":4735,"NA":4737},{"trials":4702,"activeCount":99},[],{"trials":4704,"activeCount":99},[4705,4719],{"nctId":4706,"briefTitle":4707,"status":154,"phases":4708,"primaryCompletion":4709,"completion":4710,"start":4711,"enrollment":99,"conditions":4712,"interventions":4718},"NCT04073472","Mesenchymal Stem Cells for the Treatment of Pouch Fistulas in Crohn's",[87],"2022-06-01","2023-06-01","2021-06-01",[4713,4714,4715,4716,4717],"Crohn's Disease","Fistula","Anal Fistula","Pouch, Ileal","Pouches, Ileoanal",[4699],{"nctId":4720,"briefTitle":4721,"status":154,"phases":4722,"primaryCompletion":4723,"completion":4723,"start":4724,"enrollment":99,"conditions":4725,"interventions":4729},"NCT05578508","Stem Cells for the Treatment of Pouchitis",[87],"2024-02","2022-04",[4726,4713,4727,4728,4716],"Pouchitis","Ulcerative Colitis Chronic","Inflammatory Bowel Diseases",[4730],"Mesenchymal Stem Cells",{"trials":4732,"activeCount":99},[],{"trials":4734,"activeCount":99},[],{"trials":4736,"activeCount":99},[],{"trials":4738,"activeCount":99},[],{"intervention":3858,"totalTrials":95,"cells":4740},{"EARLY_PHASE1":4741,"PHASE1":4743,"PHASE2":4753,"PHASE3":4755,"PHASE4":4757,"NA":4759},{"trials":4742,"activeCount":99},[],{"trials":4744,"activeCount":99},[4745,4749],{"nctId":3851,"briefTitle":3852,"status":652,"phases":4746,"primaryCompletion":884,"completion":884,"start":3854,"enrollment":3855,"conditions":4747,"interventions":4748},[87],[3446],[3858,3844],{"nctId":3887,"briefTitle":3888,"status":652,"phases":4750,"primaryCompletion":3890,"completion":3890,"start":3891,"enrollment":1621,"conditions":4751,"interventions":4752},[87],[3446],[3449,3858,3880],{"trials":4754,"activeCount":99},[],{"trials":4756,"activeCount":99},[],{"trials":4758,"activeCount":99},[],{"trials":4760,"activeCount":99},[],{"intervention":3449,"totalTrials":95,"cells":4762},{"EARLY_PHASE1":4763,"PHASE1":4765,"PHASE2":4775,"PHASE3":4777,"PHASE4":4779,"NA":4781},{"trials":4764,"activeCount":99},[],{"trials":4766,"activeCount":99},[4767,4771],{"nctId":3434,"briefTitle":3435,"status":1662,"phases":4768,"start":3437,"enrollment":337,"conditions":4769,"interventions":4770},[87],[3439,3440,3441,3442,3443,3444,3445,3446],[2933,3448,3449,3450],{"nctId":3887,"briefTitle":3888,"status":652,"phases":4772,"primaryCompletion":3890,"completion":3890,"start":3891,"enrollment":1621,"conditions":4773,"interventions":4774},[87],[3446],[3449,3858,3880],{"trials":4776,"activeCount":99},[],{"trials":4778,"activeCount":99},[],{"trials":4780,"activeCount":99},[],{"trials":4782,"activeCount":99},[],{"intervention":4784,"totalTrials":136,"cells":4785},"Alefacept",{"EARLY_PHASE1":4786,"PHASE1":4788,"PHASE2":4799,"PHASE3":4801,"PHASE4":4803,"NA":4805},{"trials":4787,"activeCount":99},[],{"trials":4789,"activeCount":99},[4790],{"nctId":4791,"briefTitle":4792,"status":111,"phases":4793,"primaryCompletion":4794,"completion":4795,"start":4796,"enrollment":911,"conditions":4797,"interventions":4798},"NCT01267643","Alefacept in Patients With Relapsed\u002FRefractory Aplastic Anemia",[87],"2011-12-16","2013-04-16","2011-05",[3709],[4784],{"trials":4800,"activeCount":99},[],{"trials":4802,"activeCount":99},[],{"trials":4804,"activeCount":99},[],{"trials":4806,"activeCount":99},[],{"intervention":4808,"totalTrials":136,"cells":4809},"perillyl alcohol",{"EARLY_PHASE1":4810,"PHASE1":4812,"PHASE2":4820,"PHASE3":4822,"PHASE4":4824,"NA":4826},{"trials":4811,"activeCount":99},[],{"trials":4813,"activeCount":99},[4814],{"nctId":4815,"briefTitle":4816,"status":1662,"phases":4817,"start":3649,"conditions":4818,"interventions":4819},"NCT00022425","Perillyl Alcohol in Preventing Recurrent Breast Cancer in Women Who Have Been Treated With Surgery With or Without Adjuvant Therapy",[87],[4431],[4808],{"trials":4821,"activeCount":99},[],{"trials":4823,"activeCount":99},[],{"trials":4825,"activeCount":99},[],{"trials":4827,"activeCount":99},[],{"intervention":3743,"totalTrials":136,"cells":4829},{"EARLY_PHASE1":4830,"PHASE1":4832,"PHASE2":4838,"PHASE3":4840,"PHASE4":4842,"NA":4844},{"trials":4831,"activeCount":99},[],{"trials":4833,"activeCount":99},[4834],{"nctId":3736,"briefTitle":3737,"status":652,"phases":4835,"primaryCompletion":3739,"completion":3739,"start":3740,"enrollment":2320,"conditions":4836,"interventions":4837},[87],[3441],[3653,3743,3744],{"trials":4839,"activeCount":99},[],{"trials":4841,"activeCount":99},[],{"trials":4843,"activeCount":99},[],{"trials":4845,"activeCount":99},[],{"intervention":3744,"totalTrials":136,"cells":4847},{"EARLY_PHASE1":4848,"PHASE1":4850,"PHASE2":4856,"PHASE3":4858,"PHASE4":4860,"NA":4862},{"trials":4849,"activeCount":99},[],{"trials":4851,"activeCount":99},[4852],{"nctId":3736,"briefTitle":3737,"status":652,"phases":4853,"primaryCompletion":3739,"completion":3739,"start":3740,"enrollment":2320,"conditions":4854,"interventions":4855},[87],[3441],[3653,3743,3744],{"trials":4857,"activeCount":99},[],{"trials":4859,"activeCount":99},[],{"trials":4861,"activeCount":99},[],{"trials":4863,"activeCount":99},[],{"intervention":4865,"totalTrials":136,"cells":4866},"recombinant interferon alpha-1b",{"EARLY_PHASE1":4867,"PHASE1":4869,"PHASE2":4883,"PHASE3":4885,"PHASE4":4887,"NA":4889},{"trials":4868,"activeCount":99},[],{"trials":4870,"activeCount":99},[4871],{"nctId":4872,"briefTitle":4873,"status":652,"phases":4874,"primaryCompletion":4875,"completion":4875,"start":3357,"enrollment":4876,"conditions":4877,"interventions":4881},"NCT00276536","Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma",[87],"2004-01",35,[4431,3622,3442,4878,4879,4880,3446],"Melanoma","Multiple Myeloma","Sarcoma",[4865,4882],"IFN",{"trials":4884,"activeCount":99},[],{"trials":4886,"activeCount":99},[],{"trials":4888,"activeCount":99},[],{"trials":4890,"activeCount":99},[],{"intervention":4882,"totalTrials":136,"cells":4892},{"EARLY_PHASE1":4893,"PHASE1":4895,"PHASE2":4901,"PHASE3":4903,"PHASE4":4905,"NA":4907},{"trials":4894,"activeCount":99},[],{"trials":4896,"activeCount":99},[4897],{"nctId":4872,"briefTitle":4873,"status":652,"phases":4898,"primaryCompletion":4875,"completion":4875,"start":3357,"enrollment":4876,"conditions":4899,"interventions":4900},[87],[4431,3622,3442,4878,4879,4880,3446],[4865,4882],{"trials":4902,"activeCount":99},[],{"trials":4904,"activeCount":99},[],{"trials":4906,"activeCount":99},[],{"trials":4908,"activeCount":99},[],{"intervention":4910,"totalTrials":136,"cells":4911},"Autologous mesenchymal stem cell transplantation",{"EARLY_PHASE1":4912,"PHASE1":4914,"PHASE2":4927,"PHASE3":4929,"PHASE4":4931,"NA":4933},{"trials":4913,"activeCount":99},[],{"trials":4915,"activeCount":99},[4916],{"nctId":4917,"briefTitle":4918,"status":652,"phases":4919,"primaryCompletion":4920,"completion":2250,"start":4921,"enrollment":16,"conditions":4922,"interventions":4926},"NCT00813969","Autologous Mesenchymal Stem Cell (MSC) Transplantation in MS",[87],"2014-01","2011-03",[4923,4924,4925],"Relapsing-Remitting Multiple Sclerosis","Secondary Progressive Multiple Sclerosis","Progressive Relapsing Multiple Sclerosis",[4910],{"trials":4928,"activeCount":99},[],{"trials":4930,"activeCount":99},[],{"trials":4932,"activeCount":99},[],{"trials":4934,"activeCount":99},[],{"intervention":4936,"totalTrials":136,"cells":4937},"Pomalidomide",{"EARLY_PHASE1":4938,"PHASE1":4940,"PHASE2":4952,"PHASE3":4954,"PHASE4":4956,"NA":4958},{"trials":4939,"activeCount":99},[],{"trials":4941,"activeCount":99},[4942],{"nctId":4943,"briefTitle":4944,"status":652,"phases":4945,"primaryCompletion":4946,"completion":4946,"start":4947,"enrollment":35,"conditions":4948,"interventions":4951},"NCT02287558","Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study",[87],"2019-06-01","2015-01-27",[4949,4950],"Hereditary Hemorrhagic Telangiectasia","Idiopathic Vascular Ectasia",[4936],{"trials":4953,"activeCount":99},[],{"trials":4955,"activeCount":99},[],{"trials":4957,"activeCount":99},[],{"trials":4959,"activeCount":99},[],{"intervention":3565,"totalTrials":136,"cells":4961},{"EARLY_PHASE1":4962,"PHASE1":4964,"PHASE2":4970,"PHASE3":4972,"PHASE4":4974,"NA":4976},{"trials":4963,"activeCount":99},[],{"trials":4965,"activeCount":99},[4966],{"nctId":3555,"briefTitle":3556,"status":154,"phases":4967,"primaryCompletion":3558,"completion":3558,"start":3559,"enrollment":99,"conditions":4968,"interventions":4969},[87],[277,3561,3562,3563],[3565,3548],{"trials":4971,"activeCount":99},[],{"trials":4973,"activeCount":99},[],{"trials":4975,"activeCount":99},[],{"trials":4977,"activeCount":99},[],{"intervention":4979,"totalTrials":136,"cells":4980},"Black raspberry (BRB) Slurry",{"EARLY_PHASE1":4981,"PHASE1":4983,"PHASE2":4995,"PHASE3":4997,"PHASE4":4999,"NA":5001},{"trials":4982,"activeCount":99},[],{"trials":4984,"activeCount":99},[4985],{"nctId":4986,"briefTitle":4987,"status":652,"phases":4988,"primaryCompletion":3010,"completion":3806,"start":4686,"enrollment":4989,"conditions":4990,"interventions":4992},"NCT00770991","Lyophilized Black Raspberries in Adults With Familial Adenomatous Polyposis (FAP)",[87],34,[4991],"Familial Adenomatous Polyposis",[4979,4993,4994],"Black Raspberry (BRB) Suppositories","Black Raspberry (BRB) Placebo Slurry",{"trials":4996,"activeCount":99},[],{"trials":4998,"activeCount":99},[],{"trials":5000,"activeCount":99},[],{"trials":5002,"activeCount":99},[],{"intervention":4993,"totalTrials":136,"cells":5004},{"EARLY_PHASE1":5005,"PHASE1":5007,"PHASE2":5013,"PHASE3":5015,"PHASE4":5017,"NA":5019},{"trials":5006,"activeCount":99},[],{"trials":5008,"activeCount":99},[5009],{"nctId":4986,"briefTitle":4987,"status":652,"phases":5010,"primaryCompletion":3010,"completion":3806,"start":4686,"enrollment":4989,"conditions":5011,"interventions":5012},[87],[4991],[4979,4993,4994],{"trials":5014,"activeCount":99},[],{"trials":5016,"activeCount":99},[],{"trials":5018,"activeCount":99},[],{"trials":5020,"activeCount":99},[],{"intervention":4994,"totalTrials":136,"cells":5022},{"EARLY_PHASE1":5023,"PHASE1":5025,"PHASE2":5031,"PHASE3":5033,"PHASE4":5035,"NA":5037},{"trials":5024,"activeCount":99},[],{"trials":5026,"activeCount":99},[5027],{"nctId":4986,"briefTitle":4987,"status":652,"phases":5028,"primaryCompletion":3010,"completion":3806,"start":4686,"enrollment":4989,"conditions":5029,"interventions":5030},[87],[4991],[4979,4993,4994],{"trials":5032,"activeCount":99},[],{"trials":5034,"activeCount":99},[],{"trials":5036,"activeCount":99},[],{"trials":5038,"activeCount":99},[],{"intervention":3448,"totalTrials":136,"cells":5040},{"EARLY_PHASE1":5041,"PHASE1":5043,"PHASE2":5049,"PHASE3":5051,"PHASE4":5053,"NA":5055},{"trials":5042,"activeCount":99},[],{"trials":5044,"activeCount":99},[5045],{"nctId":3434,"briefTitle":3435,"status":1662,"phases":5046,"start":3437,"enrollment":337,"conditions":5047,"interventions":5048},[87],[3439,3440,3441,3442,3443,3444,3445,3446],[2933,3448,3449,3450],{"trials":5050,"activeCount":99},[],{"trials":5052,"activeCount":99},[],{"trials":5054,"activeCount":99},[],{"trials":5056,"activeCount":99},[],{"intervention":5058,"totalTrials":136,"cells":5059},"recombinant interferon alfa-2b",{"EARLY_PHASE1":5060,"PHASE1":5062,"PHASE2":5074,"PHASE3":5076,"PHASE4":5078,"NA":5080},{"trials":5061,"activeCount":99},[],{"trials":5063,"activeCount":99},[5064],{"nctId":5065,"briefTitle":5066,"status":111,"phases":5067,"primaryCompletion":4796,"completion":2135,"start":5068,"enrollment":1801,"conditions":5069,"interventions":5071},"NCT00311558","Sodium Stibogluconate and Interferon in Treating Patients With Advanced Solid Tumors, Lymphoma, or Myeloma",[87],"2005-10",[5070],"Cancer",[5058,5072,5073],"sodium stibogluconate","SSG & interferon",{"trials":5075,"activeCount":99},[],{"trials":5077,"activeCount":99},[],{"trials":5079,"activeCount":99},[],{"trials":5081,"activeCount":99},[],{"intervention":5072,"totalTrials":136,"cells":5083},{"EARLY_PHASE1":5084,"PHASE1":5086,"PHASE2":5092,"PHASE3":5094,"PHASE4":5096,"NA":5098},{"trials":5085,"activeCount":99},[],{"trials":5087,"activeCount":99},[5088],{"nctId":5065,"briefTitle":5066,"status":111,"phases":5089,"primaryCompletion":4796,"completion":2135,"start":5068,"enrollment":1801,"conditions":5090,"interventions":5091},[87],[5070],[5058,5072,5073],{"trials":5093,"activeCount":99},[],{"trials":5095,"activeCount":99},[],{"trials":5097,"activeCount":99},[],{"trials":5099,"activeCount":99},[],{"intervention":5073,"totalTrials":136,"cells":5101},{"EARLY_PHASE1":5102,"PHASE1":5104,"PHASE2":5110,"PHASE3":5112,"PHASE4":5114,"NA":5116},{"trials":5103,"activeCount":99},[],{"trials":5105,"activeCount":99},[5106],{"nctId":5065,"briefTitle":5066,"status":111,"phases":5107,"primaryCompletion":4796,"completion":2135,"start":5068,"enrollment":1801,"conditions":5108,"interventions":5109},[87],[5070],[5058,5072,5073],{"trials":5111,"activeCount":99},[],{"trials":5113,"activeCount":99},[],{"trials":5115,"activeCount":99},[],{"trials":5117,"activeCount":99},[],{"intervention":5119,"totalTrials":136,"cells":5120},"Tamsulosin 0.4Mg",{"EARLY_PHASE1":5121,"PHASE1":5132,"PHASE2":5134,"PHASE3":5136,"PHASE4":5138,"NA":5140},{"trials":5122,"activeCount":99},[5123],{"nctId":5124,"briefTitle":5125,"status":652,"phases":5126,"primaryCompletion":5127,"completion":5127,"start":5128,"enrollment":682,"conditions":5129,"interventions":5131},"NCT04232683","Preoperative Tamsulosin to Prevent Postoperative Urinary Retention After Surgery For Pelvic Floor Disorders",[86],"2025-10-11","2019-12-18",[5130],"Urinary Retention",[5119],{"trials":5133,"activeCount":99},[],{"trials":5135,"activeCount":99},[],{"trials":5137,"activeCount":99},[],{"trials":5139,"activeCount":99},[],{"trials":5141,"activeCount":99},[],{"intervention":5143,"totalTrials":136,"cells":5144},"iNO administered",{"EARLY_PHASE1":5145,"PHASE1":5156,"PHASE2":5158,"PHASE3":5160,"PHASE4":5162,"NA":5164},{"trials":5146,"activeCount":99},[5147],{"nctId":5148,"briefTitle":5149,"status":111,"phases":5150,"primaryCompletion":5151,"completion":5151,"start":5152,"enrollment":1801,"conditions":5153,"interventions":5155},"NCT00543933","Pilot Study of Inhaled Nitric Oxide to Treat Pulmonary Insufficiency in Congenital Heart Disease",[86],"2010-06","2007-10",[5154],"Pulmonary Insufficiency",[5143],{"trials":5157,"activeCount":99},[],{"trials":5159,"activeCount":99},[],{"trials":5161,"activeCount":99},[],{"trials":5163,"activeCount":99},[],{"trials":5165,"activeCount":99},[],{"intervention":5167,"totalTrials":136,"cells":5168},"L-arginine",{"EARLY_PHASE1":5169,"PHASE1":5178,"PHASE2":5180,"PHASE3":5182,"PHASE4":5184,"NA":5186},{"trials":5170,"activeCount":99},[5171],{"nctId":5172,"briefTitle":5173,"status":652,"phases":5174,"primaryCompletion":691,"completion":691,"start":1800,"enrollment":3855,"conditions":5175,"interventions":5177},"NCT00848302","Endothelial Function in Human Arteries",[86],[5176],"Endothelial Dysfunction",[5167],{"trials":5179,"activeCount":99},[],{"trials":5181,"activeCount":99},[],{"trials":5183,"activeCount":99},[],{"trials":5185,"activeCount":99},[],{"trials":5187,"activeCount":99},[],{"intervention":5189,"totalTrials":136,"cells":5190},"Aminolevulinic Acid",{"EARLY_PHASE1":5191,"PHASE1":5201,"PHASE2":5203,"PHASE3":5205,"PHASE4":5207,"NA":5209},{"trials":5192,"activeCount":99},[5193],{"nctId":5194,"briefTitle":5195,"status":111,"phases":5196,"primaryCompletion":5197,"completion":5197,"start":692,"enrollment":1801,"conditions":5198,"interventions":5200},"NCT00663910","Topical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer",[86],"2009-10",[5199],"Non-melanomatous Skin Cancer",[5189],{"trials":5202,"activeCount":99},[],{"trials":5204,"activeCount":99},[],{"trials":5206,"activeCount":99},[],{"trials":5208,"activeCount":99},[],{"trials":5210,"activeCount":99},[],{"intervention":5212,"totalTrials":136,"cells":5213},"Tetracycline",{"EARLY_PHASE1":5214,"PHASE1":5225,"PHASE2":5227,"PHASE3":5229,"PHASE4":5231,"NA":5233},{"trials":5215,"activeCount":99},[5216],{"nctId":5217,"briefTitle":5218,"status":154,"phases":5219,"primaryCompletion":2967,"completion":2967,"start":5220,"enrollment":99,"conditions":5221,"interventions":5224},"NCT01763437","Intralesional Tetracycline Injection in the Treatment of Chalazia",[86],"2014-03",[5222,5223],"Chalazia","Chalazion",[5212],{"trials":5226,"activeCount":99},[],{"trials":5228,"activeCount":99},[],{"trials":5230,"activeCount":99},[],{"trials":5232,"activeCount":99},[],{"trials":5234,"activeCount":99},[],{"intervention":5236,"totalTrials":136,"cells":5237},"Bupi HCI and lipo bupi",{"EARLY_PHASE1":5238,"PHASE1":5251,"PHASE2":5253,"PHASE3":5255,"PHASE4":5257,"NA":5259},{"trials":5239,"activeCount":99},[5240],{"nctId":5241,"briefTitle":5242,"status":652,"phases":5243,"primaryCompletion":5244,"completion":5244,"start":5245,"enrollment":5246,"conditions":5247,"interventions":5249},"NCT03731221","Pectoral Fascial Plane and Serratus Anterior Plane Blocks With Bupivacaine v. Liposomal Bupivacaine",[86],"2024-09-19","2018-11-01",196,[5248],"Video Assisted Thoracic Surgery",[5236,5250],"Bupi HCI",{"trials":5252,"activeCount":99},[],{"trials":5254,"activeCount":99},[],{"trials":5256,"activeCount":99},[],{"trials":5258,"activeCount":99},[],{"trials":5260,"activeCount":99},[],{"intervention":5250,"totalTrials":136,"cells":5262},{"EARLY_PHASE1":5263,"PHASE1":5269,"PHASE2":5271,"PHASE3":5273,"PHASE4":5275,"NA":5277},{"trials":5264,"activeCount":99},[5265],{"nctId":5241,"briefTitle":5242,"status":652,"phases":5266,"primaryCompletion":5244,"completion":5244,"start":5245,"enrollment":5246,"conditions":5267,"interventions":5268},[86],[5248],[5236,5250],{"trials":5270,"activeCount":99},[],{"trials":5272,"activeCount":99},[],{"trials":5274,"activeCount":99},[],{"trials":5276,"activeCount":99},[],{"trials":5278,"activeCount":99},[],{"intervention":5280,"totalTrials":1464,"cells":5281},"Dexamethasone",{"EARLY_PHASE1":5282,"PHASE1":5284,"PHASE2":5286,"PHASE3":5309,"PHASE4":5321,"NA":5323},{"trials":5283,"activeCount":99},[],{"trials":5285,"activeCount":99},[],{"trials":5287,"activeCount":99},[5288,5301,5305],{"nctId":5289,"briefTitle":5290,"status":652,"phases":5291,"primaryCompletion":5292,"completion":5292,"start":5293,"enrollment":11,"conditions":5294,"interventions":5299},"NCT03338400","Dexamethasone Administration To Improve Patient Recovery In Ambulatory Vaginal Prolapse Surgery: Is There A Role?",[88],"2018-08-21","2017-05-01",[5295,5296,5297,5298],"Quality of Recovery","Same Day Surgery","Nausea and Vomiting, Postoperative","Vaginal Prolapse",[5280,5300],"Normal saline",{"nctId":2911,"briefTitle":2912,"status":154,"phases":5302,"enrollment":99,"conditions":5303,"interventions":5304},[88],[2915,2916,2917,2918],[2920,2921,2922,2901],{"nctId":3831,"briefTitle":3832,"status":652,"phases":5306,"completion":3496,"start":3037,"conditions":5307,"interventions":5308},[88],[3443],[2922,3836,3473],{"trials":5310,"activeCount":99},[5311],{"nctId":5312,"briefTitle":5313,"status":652,"phases":5314,"primaryCompletion":4084,"completion":4084,"start":5315,"enrollment":5316,"conditions":5317,"interventions":5320},"NCT00273377","The Effects of Hypercapnia, Supplemental Oxygen, and Dexamethasone on Surgical Wound Infection",[89],"2002-05",2000,[5318,5319],"Surgical Wound Infection","Surgery, Colon",[5280],{"trials":5322,"activeCount":99},[],{"trials":5324,"activeCount":99},[5325,5338],{"nctId":5326,"briefTitle":5327,"status":111,"phases":5328,"primaryCompletion":3807,"completion":3807,"start":5329,"enrollment":5330,"conditions":5331,"interventions":5334},"NCT00801138","The Effect of Dexamethasone on the Duration of Interscalene Nerve Blocks With Ropivacaine or Bupivacaine",[91],"2008-11",218,[5332,5333],"Anesthesia, Local","Shoulder Surgery",[5335,5280,5336,5337],"saline","ropivacaine","Bupivacaine",{"nctId":5339,"briefTitle":5340,"status":154,"phases":5341,"primaryCompletion":3398,"completion":3398,"start":2628,"enrollment":99,"conditions":5342,"interventions":5346},"NCT03094442","Does Dexamethasone Administration Improve Recovery In Patients Undergoing Minimally Invasive Sacrocolpopexy?",[91],[5343,5344,5345],"Quality of Life","Pelvic Organ Prolapse","Prolapses, Vaginal Vault",[5280,5300],{"intervention":5337,"totalTrials":1464,"cells":5348},{"EARLY_PHASE1":5349,"PHASE1":5351,"PHASE2":5353,"PHASE3":5355,"PHASE4":5357,"NA":5359},{"trials":5350,"activeCount":99},[],{"trials":5352,"activeCount":99},[],{"trials":5354,"activeCount":99},[],{"trials":5356,"activeCount":99},[],{"trials":5358,"activeCount":99},[],{"trials":5360,"activeCount":99},[5361,5365,5373,5380,5388,5398],{"nctId":5326,"briefTitle":5327,"status":111,"phases":5362,"primaryCompletion":3807,"completion":3807,"start":5329,"enrollment":5330,"conditions":5363,"interventions":5364},[91],[5332,5333],[5335,5280,5336,5337],{"nctId":5366,"briefTitle":5367,"status":154,"phases":5368,"primaryCompletion":3675,"completion":3675,"start":5369,"enrollment":99,"conditions":5370,"interventions":5372},"NCT00557843","Continuous Bupivacaine Infusion Following Colonic Surgery",[91],"2007-11",[5371],"Abdominal Surgery",[5337,2010],{"nctId":5374,"briefTitle":5375,"status":652,"phases":5376,"primaryCompletion":5377,"completion":5377,"start":5220,"enrollment":927,"conditions":5378,"interventions":5379},"NCT02037061","Reducing Post-Op Pain After Sacrospinous Ligament Colpopexy",[91],"2016-07",[29],[5337],{"nctId":5381,"briefTitle":5382,"status":111,"phases":5383,"primaryCompletion":5384,"completion":5384,"start":3890,"enrollment":5330,"conditions":5385,"interventions":5386},"NCT00519584","Interscalene Nerve Blocks With Ropivacaine Alone, With Dexamethasone, Plus Systemic Dexamethasone",[91],"2009-03",[29],[3015,5387,5337,2010],"dex",{"nctId":5389,"briefTitle":5390,"status":154,"phases":5391,"primaryCompletion":5392,"completion":5393,"start":4597,"enrollment":99,"conditions":5394,"interventions":5396},"NCT01847339","A Study of Epidural Bupivacain-soaked Absorbable Gelatin Sponge on Post-operative Pain in Lumbar Laminectomy",[91],"2015-02","2015-02-12",[5395],"Lumbar Laminectomy",[5397],"bupivacaine",{"nctId":5399,"briefTitle":5400,"status":652,"phases":5401,"primaryCompletion":5402,"completion":5403,"start":2628,"enrollment":5404,"conditions":5405,"interventions":5407},"NCT02996227","Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine",[91],"2019-06","2019-10",514,[871,5406],"Major Abdominal Surgery",[5408,5337],"EXPAREL",{"intervention":2010,"totalTrials":847,"cells":5410},{"EARLY_PHASE1":5411,"PHASE1":5413,"PHASE2":5415,"PHASE3":5417,"PHASE4":5419,"NA":5425},{"trials":5412,"activeCount":99},[],{"trials":5414,"activeCount":99},[],{"trials":5416,"activeCount":99},[],{"trials":5418,"activeCount":99},[],{"trials":5420,"activeCount":99},[5421],{"nctId":2000,"briefTitle":2001,"status":652,"phases":5422,"primaryCompletion":2003,"completion":2004,"start":2005,"enrollment":2006,"conditions":5423,"interventions":5424},[90],[871],[2009,1987,2010],{"trials":5426,"activeCount":99},[5427,5431,5435,5439],{"nctId":5326,"briefTitle":5327,"status":111,"phases":5428,"primaryCompletion":3807,"completion":3807,"start":5329,"enrollment":5330,"conditions":5429,"interventions":5430},[91],[5332,5333],[5335,5280,5336,5337],{"nctId":5366,"briefTitle":5367,"status":154,"phases":5432,"primaryCompletion":3675,"completion":3675,"start":5369,"enrollment":99,"conditions":5433,"interventions":5434},[91],[5371],[5337,2010],{"nctId":5381,"briefTitle":5382,"status":111,"phases":5436,"primaryCompletion":5384,"completion":5384,"start":3890,"enrollment":5330,"conditions":5437,"interventions":5438},[91],[29],[3015,5387,5337,2010],{"nctId":5440,"briefTitle":5441,"status":111,"phases":5442,"primaryCompletion":5197,"completion":5197,"start":895,"enrollment":1801,"conditions":5443,"interventions":5444},"NCT00851747","A Study of the Efficacy of Subcutaneous Phosphatidylcholine and Deoxycholate Injections for Localized Fat Removal",[91],[15],[5445,2010],"Phosphatidylcholine Deoxycholate",{"intervention":5447,"totalTrials":847,"cells":5448},"Dexmedetomidine",{"EARLY_PHASE1":5449,"PHASE1":5451,"PHASE2":5453,"PHASE3":5455,"PHASE4":5457,"NA":5483},{"trials":5450,"activeCount":99},[],{"trials":5452,"activeCount":99},[],{"trials":5454,"activeCount":99},[],{"trials":5456,"activeCount":99},[],{"trials":5458,"activeCount":99},[5459,5469,5479],{"nctId":5460,"briefTitle":5461,"status":652,"phases":5462,"primaryCompletion":1665,"completion":5463,"start":5464,"enrollment":5465,"conditions":5466,"interventions":5468},"NCT02004613","Ancillary Effects of Dexmedetomidine Sedation After Cardiac Surgery",[90],"2020-12-18","2013-06",798,[5467],"Heart Disease",[5447],{"nctId":5470,"briefTitle":5471,"status":111,"phases":5472,"primaryCompletion":905,"completion":905,"start":5473,"enrollment":5474,"conditions":5475,"interventions":5477},"NCT00335972","The Effects of Dexmedetomidine and Remifentanil on Carotid Patients",[90],"2006-06",142,[5476],"Carotid Artery Stenosis",[5478,5447],"Remifentanil",{"nctId":2696,"briefTitle":2697,"status":652,"phases":5480,"primaryCompletion":2699,"completion":2699,"start":2700,"enrollment":2701,"conditions":5481,"interventions":5482},[90],[2703],[2705,2706,2683,2707],{"trials":5484,"activeCount":99},[5485,5494],{"nctId":5486,"briefTitle":5487,"status":652,"phases":5488,"primaryCompletion":5489,"completion":5489,"start":882,"enrollment":3215,"conditions":5490,"interventions":5492},"NCT01200433","The Effects of Dexmedetomidine and Propofol on Cerebral Blood Flow and Brain Oxygenation During Deep Brain Stimulation",[91],"2013-08",[5491],"Intracranial Neurosurgery",[2705,5493],"propofol",{"nctId":5495,"briefTitle":5496,"status":652,"phases":5497,"primaryCompletion":5220,"completion":5220,"start":3611,"enrollment":5474,"conditions":5498,"interventions":5501},"NCT01269918","A Comparison of Remifentanil and Dexmedetomidine for Craniotomy Perioperative Hemodynamics and Postoperative Pain",[91],[5499,5500],"Adult Intracranial Tumor","Adult Solid Tumor",[5478,5447],{"intervention":5336,"totalTrials":911,"cells":5503},{"EARLY_PHASE1":5504,"PHASE1":5506,"PHASE2":5508,"PHASE3":5510,"PHASE4":5516,"NA":5518},{"trials":5505,"activeCount":99},[],{"trials":5507,"activeCount":99},[],{"trials":5509,"activeCount":99},[],{"trials":5511,"activeCount":99},[5512],{"nctId":3007,"briefTitle":3008,"status":652,"phases":5513,"primaryCompletion":1777,"completion":1777,"start":3010,"enrollment":3011,"conditions":5514,"interventions":5515},[89],[3013],[3015,2996],{"trials":5517,"activeCount":99},[],{"trials":5519,"activeCount":99},[5520,5524,5533],{"nctId":5326,"briefTitle":5327,"status":111,"phases":5521,"primaryCompletion":3807,"completion":3807,"start":5329,"enrollment":5330,"conditions":5522,"interventions":5523},[91],[5332,5333],[5335,5280,5336,5337],{"nctId":5525,"briefTitle":5526,"status":111,"phases":5527,"primaryCompletion":5528,"completion":5528,"start":884,"enrollment":22,"conditions":5529,"interventions":5531},"NCT00720330","Lidocaine and Ketamine Versus Standard Care on Acute and Chronic Pain",[91],"2010-02",[29,5530],"Nausea",[5336,5532],"Lidocaine\u002FKetamine",{"nctId":5381,"briefTitle":5382,"status":111,"phases":5534,"primaryCompletion":5384,"completion":5384,"start":3890,"enrollment":5330,"conditions":5535,"interventions":5536},[91],[29],[3015,5387,5337,2010],{"intervention":5300,"totalTrials":911,"cells":5538},{"EARLY_PHASE1":5539,"PHASE1":5541,"PHASE2":5543,"PHASE3":5549,"PHASE4":5551,"NA":5557},{"trials":5540,"activeCount":99},[],{"trials":5542,"activeCount":99},[],{"trials":5544,"activeCount":99},[5545],{"nctId":5289,"briefTitle":5290,"status":652,"phases":5546,"primaryCompletion":5292,"completion":5292,"start":5293,"enrollment":11,"conditions":5547,"interventions":5548},[88],[5295,5296,5297,5298],[5280,5300],{"trials":5550,"activeCount":99},[],{"trials":5552,"activeCount":99},[5553],{"nctId":1774,"briefTitle":1775,"status":111,"phases":5554,"primaryCompletion":1777,"completion":1777,"start":905,"enrollment":25,"conditions":5555,"interventions":5556},[90],[277],[1761,1780],{"trials":5558,"activeCount":99},[5559,5563],{"nctId":5339,"briefTitle":5340,"status":154,"phases":5560,"primaryCompletion":3398,"completion":3398,"start":2628,"enrollment":99,"conditions":5561,"interventions":5562},[91],[5343,5344,5345],[5280,5300],{"nctId":5564,"briefTitle":5565,"status":652,"phases":5566,"primaryCompletion":5567,"completion":5568,"start":5569,"enrollment":5570,"conditions":5571,"interventions":5573},"NCT05280197","Does an Abdominal Wall Nerve Block During Surgery Help Reduce Pain From Kidney Transplantation?",[91],"2023-03-24","2023-11-08","2022-01-08",224,[5572],"Kidney Transplantation",[5574,5575],"liposomal bupivacaine plus free bupivacaine","normal saline",{"intervention":3219,"totalTrials":911,"cells":5577},{"EARLY_PHASE1":5578,"PHASE1":5580,"PHASE2":5582,"PHASE3":5584,"PHASE4":5594,"NA":5596},{"trials":5579,"activeCount":99},[],{"trials":5581,"activeCount":99},[],{"trials":5583,"activeCount":99},[],{"trials":5585,"activeCount":99},[5586,5590],{"nctId":3032,"briefTitle":3033,"status":652,"phases":5587,"primaryCompletion":3035,"completion":3036,"start":3037,"enrollment":3038,"conditions":5588,"interventions":5589},[89],[3040],[3042,3021],{"nctId":3210,"briefTitle":3211,"status":652,"phases":5591,"primaryCompletion":3213,"completion":3213,"start":3214,"enrollment":3215,"conditions":5592,"interventions":5593},[89],[3217],[3219,3199],{"trials":5595,"activeCount":99},[],{"trials":5597,"activeCount":99},[5598,5607],{"nctId":5599,"briefTitle":5600,"status":154,"phases":5601,"primaryCompletion":5602,"completion":5602,"start":5603,"enrollment":99,"conditions":5604,"interventions":5606},"NCT01622322","Nitrous Oxide On Acute Postoperative Pain and Opioid Consumption and Chronic Pain After Inguinal Hernia Repair Surgery",[91],"2023-12","2012-05",[5605,467],"Inguinal Hernia Repair",[3219],{"nctId":5608,"briefTitle":5609,"status":154,"phases":5610,"primaryCompletion":165,"completion":5602,"start":5603,"enrollment":99,"conditions":5611,"interventions":5613},"NCT01622335","Effect OF Nitrous Oxide On Acute Pain and Opioid Consumption, and Chronic Pain After Hysterectomy",[91],[887,3219,5612],"General Anesthesia",[5614],"Nitrous oxide",{"intervention":5616,"totalTrials":2902,"cells":5617},"Sevoflurane",{"EARLY_PHASE1":5618,"PHASE1":5620,"PHASE2":5622,"PHASE3":5624,"PHASE4":5632,"NA":5634},{"trials":5619,"activeCount":99},[],{"trials":5621,"activeCount":99},[],{"trials":5623,"activeCount":99},[],{"trials":5625,"activeCount":99},[5626],{"nctId":5627,"briefTitle":5628,"status":154,"phases":5629,"primaryCompletion":5369,"completion":5369,"start":5369,"enrollment":99,"conditions":5630,"interventions":5631},"NCT00531349","Regional Anesthesia and Endometrial Cancer Recurrence",[89],[5070],[5616],{"trials":5633,"activeCount":99},[],{"trials":5635,"activeCount":99},[5636,5645],{"nctId":5637,"briefTitle":5638,"status":111,"phases":5639,"primaryCompletion":2250,"completion":2250,"start":5640,"enrollment":1667,"conditions":5641,"interventions":5643},"NCT00712517","Propofol Versus Volatile Anesthesia in Post Operative Pain Management",[91],"2010-09",[5642,838],"Varicose Vein",[5493,5644],"sevoflurane",{"nctId":5646,"briefTitle":5647,"status":652,"phases":5648,"primaryCompletion":4597,"completion":4597,"start":3611,"enrollment":5649,"conditions":5650,"interventions":5652},"NCT01379664","Volatile Anesthetic Choice and Duration of Hospitalization: A Quality Improvement and Cost-control Project",[91],1584,[5651],"Duration of Hospitalization",[5653,5616],"Isoflurane",{"intervention":2009,"totalTrials":2902,"cells":5655},{"EARLY_PHASE1":5656,"PHASE1":5658,"PHASE2":5660,"PHASE3":5662,"PHASE4":5664,"NA":5674},{"trials":5657,"activeCount":99},[],{"trials":5659,"activeCount":99},[],{"trials":5661,"activeCount":99},[],{"trials":5663,"activeCount":99},[],{"trials":5665,"activeCount":99},[5666,5670],{"nctId":2000,"briefTitle":2001,"status":652,"phases":5667,"primaryCompletion":2003,"completion":2004,"start":2005,"enrollment":2006,"conditions":5668,"interventions":5669},[90],[871],[2009,1987,2010],{"nctId":2424,"briefTitle":2425,"status":652,"phases":5671,"primaryCompletion":2427,"completion":2427,"start":2428,"enrollment":2429,"conditions":5672,"interventions":5673},[90],[2431],[2009,2411],{"trials":5675,"activeCount":99},[5676],{"nctId":5399,"briefTitle":5400,"status":652,"phases":5677,"primaryCompletion":5402,"completion":5403,"start":2628,"enrollment":5404,"conditions":5678,"interventions":5679},[91],[871,5406],[5408,5337],{"intervention":3652,"totalTrials":2902,"cells":5681},{"EARLY_PHASE1":5682,"PHASE1":5684,"PHASE2":5686,"PHASE3":5700,"PHASE4":5702,"NA":5704},{"trials":5683,"activeCount":99},[],{"trials":5685,"activeCount":99},[],{"trials":5687,"activeCount":99},[5688,5696],{"nctId":5689,"briefTitle":5690,"status":652,"phases":5691,"completion":3619,"conditions":5692,"interventions":5694},"NCT00215124","A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction",[87,88],[5693],"Acute Myocardial Infarction",[5695],"Filgrastim",{"nctId":3645,"briefTitle":3646,"status":652,"phases":5697,"primaryCompletion":3648,"completion":905,"start":3649,"enrollment":693,"conditions":5698,"interventions":5699},[88],[3441],[3652,3653,3654,3655],{"trials":5701,"activeCount":99},[],{"trials":5703,"activeCount":99},[],{"trials":5705,"activeCount":99},[5706],{"nctId":5707,"briefTitle":5708,"status":652,"phases":5709,"primaryCompletion":2940,"completion":2940,"start":5710,"enrollment":1216,"conditions":5711,"interventions":5712},"NCT00274794","VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL",[91],"2000-02",[3442],[3652,3499],{"intervention":3288,"totalTrials":95,"cells":5714},{"EARLY_PHASE1":5715,"PHASE1":5717,"PHASE2":5719,"PHASE3":5721,"PHASE4":5727,"NA":5729},{"trials":5716,"activeCount":99},[],{"trials":5718,"activeCount":99},[],{"trials":5720,"activeCount":99},[],{"trials":5722,"activeCount":99},[5723],{"nctId":3279,"briefTitle":3280,"status":652,"phases":5724,"primaryCompletion":3282,"completion":3283,"start":2506,"enrollment":3284,"conditions":5725,"interventions":5726},[89],[3286],[3288,3268],{"trials":5728,"activeCount":99},[],{"trials":5730,"activeCount":99},[5731],{"nctId":5732,"briefTitle":5733,"status":111,"phases":5734,"primaryCompletion":1171,"completion":1171,"start":5735,"enrollment":95,"conditions":5736,"interventions":5737},"NCT06426407","Vasopressin Hemodynamic Response as a Septic Shock Subphenotype Indicator",[],"2025-10-01",[3561],[3288],{"intervention":5739,"totalTrials":95,"cells":5740},"Repository Corticotropin",{"EARLY_PHASE1":5741,"PHASE1":5743,"PHASE2":5745,"PHASE3":5747,"PHASE4":5749,"NA":5760},{"trials":5742,"activeCount":99},[],{"trials":5744,"activeCount":99},[],{"trials":5746,"activeCount":99},[],{"trials":5748,"activeCount":99},[],{"trials":5750,"activeCount":99},[5751],{"nctId":5752,"briefTitle":5753,"status":154,"phases":5754,"primaryCompletion":5755,"completion":5755,"start":5756,"enrollment":99,"conditions":5757,"interventions":5759},"NCT02920710","ACTHAR Therapy for Central Nervous System Sarcoidosis",[90],"2020-11-02","2019-02-01",[5758],"Sarcoidosis",[5739],{"trials":5761,"activeCount":99},[5762],{"nctId":5763,"briefTitle":5764,"status":652,"phases":5765,"primaryCompletion":5766,"completion":40,"start":5377,"enrollment":35,"conditions":5767,"interventions":5771},"NCT02725177","Ocular Sarcoidosis Open Label Trial of ACTHAR Gel",[91],"2021-12",[5768,5769,5770],"Ocular Sarcoidosis","Panuveitis","Anterior Uveitis",[5739,5772],"Repository Corticotropin Injection -Treatment Extension",{"intervention":3499,"totalTrials":95,"cells":5774},{"EARLY_PHASE1":5775,"PHASE1":5777,"PHASE2":5779,"PHASE3":5785,"PHASE4":5787,"NA":5789},{"trials":5776,"activeCount":99},[],{"trials":5778,"activeCount":99},[],{"trials":5780,"activeCount":99},[5781],{"nctId":3493,"briefTitle":3494,"status":652,"phases":5782,"completion":3496,"start":3037,"conditions":5783,"interventions":5784},[88],[3443],[3499,3500,3472],{"trials":5786,"activeCount":99},[],{"trials":5788,"activeCount":99},[],{"trials":5790,"activeCount":99},[5791],{"nctId":5707,"briefTitle":5708,"status":652,"phases":5792,"primaryCompletion":2940,"completion":2940,"start":5710,"enrollment":1216,"conditions":5793,"interventions":5794},[91],[3442],[3652,3499],{"intervention":5653,"totalTrials":95,"cells":5796},{"EARLY_PHASE1":5797,"PHASE1":5799,"PHASE2":5801,"PHASE3":5803,"PHASE4":5805,"NA":5807},{"trials":5798,"activeCount":99},[],{"trials":5800,"activeCount":99},[],{"trials":5802,"activeCount":99},[],{"trials":5804,"activeCount":99},[],{"trials":5806,"activeCount":99},[],{"trials":5808,"activeCount":99},[5809,5818],{"nctId":5810,"briefTitle":5811,"status":154,"phases":5812,"primaryCompletion":5813,"completion":5813,"start":5814,"enrollment":99,"conditions":5815,"interventions":5816},"NCT06252207","Desflurane Versus Isoflurane for Speeding Postanesthetic Recovery and Hospital Discharge",[91],"2026-03-02","2023-12-08",[21],[5817,5653],"Desflurane",{"nctId":5646,"briefTitle":5647,"status":652,"phases":5819,"primaryCompletion":4597,"completion":4597,"start":3611,"enrollment":5649,"conditions":5820,"interventions":5821},[91],[5651],[5653,5616],{"intervention":5478,"totalTrials":95,"cells":5823},{"EARLY_PHASE1":5824,"PHASE1":5826,"PHASE2":5828,"PHASE3":5830,"PHASE4":5832,"NA":5838},{"trials":5825,"activeCount":99},[],{"trials":5827,"activeCount":99},[],{"trials":5829,"activeCount":99},[],{"trials":5831,"activeCount":99},[],{"trials":5833,"activeCount":99},[5834],{"nctId":5470,"briefTitle":5471,"status":111,"phases":5835,"primaryCompletion":905,"completion":905,"start":5473,"enrollment":5474,"conditions":5836,"interventions":5837},[90],[5476],[5478,5447],{"trials":5839,"activeCount":99},[5840],{"nctId":5495,"briefTitle":5496,"status":652,"phases":5841,"primaryCompletion":5220,"completion":5220,"start":3611,"enrollment":5474,"conditions":5842,"interventions":5843},[91],[5499,5500],[5478,5447],{"intervention":5845,"totalTrials":95,"cells":5846},"Buspirone",{"EARLY_PHASE1":5847,"PHASE1":5849,"PHASE2":5851,"PHASE3":5853,"PHASE4":5855,"NA":5861},{"trials":5848,"activeCount":99},[],{"trials":5850,"activeCount":99},[],{"trials":5852,"activeCount":99},[],{"trials":5854,"activeCount":99},[],{"trials":5856,"activeCount":99},[5857],{"nctId":2696,"briefTitle":2697,"status":652,"phases":5858,"primaryCompletion":2699,"completion":2699,"start":2700,"enrollment":2701,"conditions":5859,"interventions":5860},[90],[2703],[2705,2706,2683,2707],{"trials":5862,"activeCount":99},[5863],{"nctId":5864,"briefTitle":5865,"status":652,"phases":5866,"primaryCompletion":5867,"completion":5867,"start":2319,"enrollment":32,"conditions":5868,"interventions":5871},"NCT02674412","Buspirone for Functional Dysphagia",[91],"2017-04-12",[5869,5870],"Functional Dysphagia","Ineffective Esophageal Motility",[5845],{"intervention":5493,"totalTrials":95,"cells":5873},{"EARLY_PHASE1":5874,"PHASE1":5876,"PHASE2":5878,"PHASE3":5880,"PHASE4":5882,"NA":5884},{"trials":5875,"activeCount":99},[],{"trials":5877,"activeCount":99},[],{"trials":5879,"activeCount":99},[],{"trials":5881,"activeCount":99},[],{"trials":5883,"activeCount":99},[],{"trials":5885,"activeCount":99},[5886,5890],{"nctId":5486,"briefTitle":5487,"status":652,"phases":5887,"primaryCompletion":5489,"completion":5489,"start":882,"enrollment":3215,"conditions":5888,"interventions":5889},[91],[5491],[2705,5493],{"nctId":5637,"briefTitle":5638,"status":111,"phases":5891,"primaryCompletion":2250,"completion":2250,"start":5640,"enrollment":1667,"conditions":5892,"interventions":5893},[91],[5642,838],[5493,5644],{"intervention":5895,"totalTrials":95,"cells":5896},"zoledronic acid",{"EARLY_PHASE1":5897,"PHASE1":5899,"PHASE2":5909,"PHASE3":5911,"PHASE4":5913,"NA":5915},{"trials":5898,"activeCount":99},[],{"trials":5900,"activeCount":99},[5901],{"nctId":5902,"briefTitle":5903,"status":652,"phases":5904,"completion":3036,"start":4686,"enrollment":911,"conditions":5905,"interventions":5908},"NCT00264420","Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation",[87],[5906,4431,5907,2931],"Bone Metastases","Lung Cancer",[5895],{"trials":5910,"activeCount":99},[],{"trials":5912,"activeCount":99},[],{"trials":5914,"activeCount":99},[],{"trials":5916,"activeCount":99},[5917],{"nctId":5918,"briefTitle":5919,"status":652,"phases":5920,"primaryCompletion":5921,"completion":5921,"start":5922,"enrollment":4876,"conditions":5923,"interventions":5925},"NCT00361595","Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women",[91],"2008-04","2006-08",[5924],"Osteoporosis",[5895],{"intervention":2897,"totalTrials":95,"cells":5927},{"EARLY_PHASE1":5928,"PHASE1":5930,"PHASE2":5932,"PHASE3":5934,"PHASE4":5936,"NA":5942},{"trials":5929,"activeCount":99},[],{"trials":5931,"activeCount":99},[],{"trials":5933,"activeCount":99},[],{"trials":5935,"activeCount":99},[],{"trials":5937,"activeCount":99},[5938],{"nctId":2890,"briefTitle":2891,"status":652,"phases":5939,"primaryCompletion":2893,"completion":2893,"start":1800,"enrollment":1135,"conditions":5940,"interventions":5941},[90],[2895],[2897,2877],{"trials":5943,"activeCount":99},[5944],{"nctId":5945,"briefTitle":5946,"status":154,"phases":5947,"primaryCompletion":5948,"completion":5948,"start":883,"enrollment":99,"conditions":5949,"interventions":5955},"NCT01653522","The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine",[91],"2014-07",[611,5950,614,5951,5952,5953,5954],"Headache, Migraine","Migraine Headache","Migraine With Aura","Migraine Without Aura","Headache Disorders, Primary",[2897,5956],"Doxycycline",{"intervention":5772,"totalTrials":136,"cells":5958},{"EARLY_PHASE1":5959,"PHASE1":5961,"PHASE2":5963,"PHASE3":5965,"PHASE4":5967,"NA":5969},{"trials":5960,"activeCount":99},[],{"trials":5962,"activeCount":99},[],{"trials":5964,"activeCount":99},[],{"trials":5966,"activeCount":99},[],{"trials":5968,"activeCount":99},[],{"trials":5970,"activeCount":99},[5971],{"nctId":5763,"briefTitle":5764,"status":652,"phases":5972,"primaryCompletion":5766,"completion":40,"start":5377,"enrollment":35,"conditions":5973,"interventions":5974},[91],[5768,5769,5770],[5739,5772],{"intervention":5976,"totalTrials":136,"cells":5977},"Midodrine",{"EARLY_PHASE1":5978,"PHASE1":5980,"PHASE2":5982,"PHASE3":5984,"PHASE4":5986,"NA":5988},{"trials":5979,"activeCount":99},[],{"trials":5981,"activeCount":99},[],{"trials":5983,"activeCount":99},[],{"trials":5985,"activeCount":99},[],{"trials":5987,"activeCount":99},[],{"trials":5989,"activeCount":99},[5990],{"nctId":5991,"briefTitle":5992,"status":154,"phases":5993,"primaryCompletion":883,"completion":883,"start":5994,"enrollment":99,"conditions":5995,"interventions":5999},"NCT01331785","Mechanism and the Effect of Midodrine on Portal Pressures in Patients With Cirrhosis",[91],"2011-04",[1049,5996,5997,5998],"End Stage Liver Disease","Ascites","Hypotension",[5976],{"intervention":6001,"totalTrials":136,"cells":6002},"Supraovulation clomiphene citrate",{"EARLY_PHASE1":6003,"PHASE1":6005,"PHASE2":6007,"PHASE3":6009,"PHASE4":6011,"NA":6013},{"trials":6004,"activeCount":99},[],{"trials":6006,"activeCount":99},[],{"trials":6008,"activeCount":99},[],{"trials":6010,"activeCount":99},[],{"trials":6012,"activeCount":99},[],{"trials":6014,"activeCount":99},[6015],{"nctId":6016,"briefTitle":6017,"status":154,"phases":6018,"primaryCompletion":6019,"completion":6019,"start":6020,"enrollment":99,"conditions":6021,"interventions":6024},"NCT02520505","SO+IUI After Operative Laparoscopy in Patients With Advanced Stage Endometriosis",[91],"2017-12","2015-04",[6022,6023],"Endometriosis","Infertility",[6001],{"intervention":6026,"totalTrials":136,"cells":6027},"fospropofol",{"EARLY_PHASE1":6028,"PHASE1":6030,"PHASE2":6032,"PHASE3":6034,"PHASE4":6036,"NA":6038},{"trials":6029,"activeCount":99},[],{"trials":6031,"activeCount":99},[],{"trials":6033,"activeCount":99},[],{"trials":6035,"activeCount":99},[],{"trials":6037,"activeCount":99},[],{"trials":6039,"activeCount":99},[6040],{"nctId":6041,"briefTitle":6042,"status":154,"phases":6043,"primaryCompletion":5994,"completion":5994,"start":6044,"enrollment":99,"conditions":6045,"interventions":6047},"NCT01289483","Fospropofol for Sedation During Elective Awake Intubation",[91],"2011-02",[6046],"Impaired Airway Clearance",[6026,6026,6026,6026],{"intervention":6049,"totalTrials":136,"cells":6050},"Phenoxybenzamine",{"EARLY_PHASE1":6051,"PHASE1":6053,"PHASE2":6055,"PHASE3":6057,"PHASE4":6059,"NA":6061},{"trials":6052,"activeCount":99},[],{"trials":6054,"activeCount":99},[],{"trials":6056,"activeCount":99},[],{"trials":6058,"activeCount":99},[],{"trials":6060,"activeCount":99},[],{"trials":6062,"activeCount":99},[6063],{"nctId":6064,"briefTitle":6065,"status":111,"phases":6066,"primaryCompletion":895,"completion":895,"start":5473,"enrollment":6067,"conditions":6068,"interventions":6071},"NCT00620945","Use of Phenoxybenzamine [PBZ] IV to Assist High Flow Low Pressure Perfusion [HFLPP] on Cardio-pulmonary Bypass",[91],87,[6069,6070],"Congenital Heart Surgery","Cardiopulmonary Bypass",[6049],{"intervention":889,"totalTrials":136,"cells":6073},{"EARLY_PHASE1":6074,"PHASE1":6076,"PHASE2":6078,"PHASE3":6080,"PHASE4":6082,"NA":6084},{"trials":6075,"activeCount":99},[],{"trials":6077,"activeCount":99},[],{"trials":6079,"activeCount":99},[],{"trials":6081,"activeCount":99},[],{"trials":6083,"activeCount":99},[],{"trials":6085,"activeCount":99},[6086],{"nctId":879,"briefTitle":880,"status":111,"phases":6087,"primaryCompletion":882,"completion":883,"start":884,"enrollment":885,"conditions":6088,"interventions":6089},[91],[887],[840,841,889],{"intervention":6091,"totalTrials":136,"cells":6092},"Succinylcholine",{"EARLY_PHASE1":6093,"PHASE1":6095,"PHASE2":6097,"PHASE3":6099,"PHASE4":6101,"NA":6103},{"trials":6094,"activeCount":99},[],{"trials":6096,"activeCount":99},[],{"trials":6098,"activeCount":99},[],{"trials":6100,"activeCount":99},[],{"trials":6102,"activeCount":99},[],{"trials":6104,"activeCount":99},[6105],{"nctId":6106,"briefTitle":6107,"status":652,"phases":6108,"primaryCompletion":3153,"completion":3153,"start":1800,"enrollment":436,"conditions":6109,"interventions":6110},"NCT00986583","Effect of Succinylcholine on Patients Using Statins",[91],[29],[6091],{"intervention":6112,"totalTrials":136,"cells":6113},"PGx-guided post-operative pain management",{"EARLY_PHASE1":6114,"PHASE1":6116,"PHASE2":6118,"PHASE3":6120,"PHASE4":6122,"NA":6124},{"trials":6115,"activeCount":99},[],{"trials":6117,"activeCount":99},[],{"trials":6119,"activeCount":99},[],{"trials":6121,"activeCount":99},[],{"trials":6123,"activeCount":99},[],{"trials":6125,"activeCount":99},[6126],{"nctId":6127,"briefTitle":6128,"status":111,"phases":6129,"primaryCompletion":6130,"completion":6130,"start":6131,"enrollment":32,"conditions":6132,"interventions":6135},"NCT03455751","Precision Pain Management for Major Abdominal Surgery in Colorectal Surgery",[91],"2019-01-09","2018-04-17",[3040,6133,6134,3774],"Diverticular Disease","Crohn Disease",[6112],{"intervention":6137,"totalTrials":136,"cells":6138},"Exelon [rivastigmine] transdermal patch",{"EARLY_PHASE1":6139,"PHASE1":6141,"PHASE2":6143,"PHASE3":6145,"PHASE4":6147,"NA":6149},{"trials":6140,"activeCount":99},[],{"trials":6142,"activeCount":99},[],{"trials":6144,"activeCount":99},[],{"trials":6146,"activeCount":99},[],{"trials":6148,"activeCount":99},[],{"trials":6150,"activeCount":99},[6151],{"nctId":6152,"briefTitle":6153,"status":111,"phases":6154,"primaryCompletion":6155,"completion":6155,"start":6156,"enrollment":136,"conditions":6157,"interventions":6160},"NCT01602198","Study of Exelon Transdermal Patch in Amnestic Mild Cognitive Impairment Patients",[91],"2013-01","2011-06",[6158,6159],"Mild Cognitive Disorder","Mild Cognitive Impairment",[6137],{"intervention":5817,"totalTrials":136,"cells":6162},{"EARLY_PHASE1":6163,"PHASE1":6165,"PHASE2":6167,"PHASE3":6169,"PHASE4":6171,"NA":6173},{"trials":6164,"activeCount":99},[],{"trials":6166,"activeCount":99},[],{"trials":6168,"activeCount":99},[],{"trials":6170,"activeCount":99},[],{"trials":6172,"activeCount":99},[],{"trials":6174,"activeCount":99},[6175],{"nctId":5810,"briefTitle":5811,"status":154,"phases":6176,"primaryCompletion":5813,"completion":5813,"start":5814,"enrollment":99,"conditions":6177,"interventions":6178},[91],[21],[5817,5653],{"intervention":6180,"totalTrials":136,"cells":6181},"Nortriptyline",{"EARLY_PHASE1":6182,"PHASE1":6184,"PHASE2":6186,"PHASE3":6188,"PHASE4":6190,"NA":6192},{"trials":6183,"activeCount":99},[],{"trials":6185,"activeCount":99},[],{"trials":6187,"activeCount":99},[],{"trials":6189,"activeCount":99},[],{"trials":6191,"activeCount":99},[],{"trials":6193,"activeCount":99},[6194],{"nctId":6195,"briefTitle":6196,"status":111,"phases":6197,"primaryCompletion":6198,"completion":5151,"start":6199,"enrollment":847,"conditions":6200,"interventions":6202},"NCT00547703","Effect of Nortriptyline on Abdominal Pain\u002FDiscomfort and Quality of Life in Patients With Nonulcer Dyspepsia",[91],"2010-04","2008-02",[6201],"Non Ulcer Dyspepsia",[6180],{"intervention":6204,"totalTrials":136,"cells":6205},"Oral sildenafil 20 mg",{"EARLY_PHASE1":6206,"PHASE1":6208,"PHASE2":6210,"PHASE3":6212,"PHASE4":6214,"NA":6216},{"trials":6207,"activeCount":99},[],{"trials":6209,"activeCount":99},[],{"trials":6211,"activeCount":99},[],{"trials":6213,"activeCount":99},[],{"trials":6215,"activeCount":99},[],{"trials":6217,"activeCount":99},[6218],{"nctId":6219,"briefTitle":6220,"status":652,"phases":6221,"primaryCompletion":4514,"completion":4514,"start":3675,"enrollment":950,"conditions":6222,"interventions":6225},"NCT01948518","Effect of Sildenafil on Diffusion Capacity in Patients With PH and Parenchymal Lung Disease",[91],[6223,6224],"Diffuse Parenchymal Lung Disease","Pulmonary Hypertension",[6204],{"intervention":6227,"totalTrials":136,"cells":6228},"3,4 DAP",{"EARLY_PHASE1":6229,"PHASE1":6231,"PHASE2":6233,"PHASE3":6235,"PHASE4":6237,"NA":6239},{"trials":6230,"activeCount":99},[],{"trials":6232,"activeCount":99},[],{"trials":6234,"activeCount":99},[],{"trials":6236,"activeCount":99},[],{"trials":6238,"activeCount":99},[],{"trials":6240,"activeCount":99},[6241],{"nctId":6242,"briefTitle":6243,"status":6244,"phases":6245,"primaryCompletion":6246,"start":6247,"conditions":6248,"interventions":6250},"NCT01373333","Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome","NO_LONGER_AVAILABLE",[],"2012-09","1997-09",[6249],"Lambert-Eaton Myasthenic Syndrome",[6227],{"intervention":6252,"totalTrials":136,"cells":6253},"Estrogens, Conjugated",{"EARLY_PHASE1":6254,"PHASE1":6256,"PHASE2":6258,"PHASE3":6260,"PHASE4":6262,"NA":6264},{"trials":6255,"activeCount":99},[],{"trials":6257,"activeCount":99},[],{"trials":6259,"activeCount":99},[],{"trials":6261,"activeCount":99},[],{"trials":6263,"activeCount":99},[],{"trials":6265,"activeCount":99},[6266],{"nctId":6267,"briefTitle":6268,"status":652,"phases":6269,"primaryCompletion":1665,"completion":1665,"start":6270,"enrollment":1394,"conditions":6271,"interventions":6274},"NCT02691936","Comparison of Vaginal Laser Therapy to Vaginal Estrogen Therapy",[91],"2016-03",[6272,6273],"Atrophic Vaginitis","Menopause",[6252],{"intervention":6276,"totalTrials":136,"cells":6277},"Genomic sequencing",{"EARLY_PHASE1":6278,"PHASE1":6280,"PHASE2":6282,"PHASE3":6284,"PHASE4":6286,"NA":6288},{"trials":6279,"activeCount":99},[],{"trials":6281,"activeCount":99},[],{"trials":6283,"activeCount":99},[],{"trials":6285,"activeCount":99},[],{"trials":6287,"activeCount":99},[],{"trials":6289,"activeCount":99},[6290],{"nctId":6291,"briefTitle":6292,"status":652,"phases":6293,"primaryCompletion":6294,"completion":6295,"start":6296,"enrollment":3855,"conditions":6297,"interventions":6301},"NCT03043209","Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy",[],"2020-12-04","2022-12-28","2018-08-30",[6298,6299,6300],"Hypertrophic Cardiomyopathy","Genetic Disease","Gene Product Sequence Variation",[6276],{"intervention":6303,"totalTrials":136,"cells":6304},"30% oxygen",{"EARLY_PHASE1":6305,"PHASE1":6307,"PHASE2":6309,"PHASE3":6311,"PHASE4":6313,"NA":6315},{"trials":6306,"activeCount":99},[],{"trials":6308,"activeCount":99},[],{"trials":6310,"activeCount":99},[],{"trials":6312,"activeCount":99},[],{"trials":6314,"activeCount":99},[],{"trials":6316,"activeCount":99},[6317],{"nctId":6318,"briefTitle":6319,"status":652,"phases":6320,"primaryCompletion":2005,"completion":2005,"start":6321,"enrollment":6322,"conditions":6323,"interventions":6326},"NCT01777568","Supplemental Oxygen in Colorectal Surgery: A Quality Improvement Project",[91],"2012-11",5749,[6324,6325],"30% Oxygen Concentration During Colorectal Surgery","80% Oxygen Concentration During Colorectal Surgery",[6303,6327],"80% oxygen",{"intervention":6327,"totalTrials":136,"cells":6329},{"EARLY_PHASE1":6330,"PHASE1":6332,"PHASE2":6334,"PHASE3":6336,"PHASE4":6338,"NA":6340},{"trials":6331,"activeCount":99},[],{"trials":6333,"activeCount":99},[],{"trials":6335,"activeCount":99},[],{"trials":6337,"activeCount":99},[],{"trials":6339,"activeCount":99},[],{"trials":6341,"activeCount":99},[6342],{"nctId":6318,"briefTitle":6319,"status":652,"phases":6343,"primaryCompletion":2005,"completion":2005,"start":6321,"enrollment":6322,"conditions":6344,"interventions":6345},[91],[6324,6325],[6303,6327],{"intervention":6347,"totalTrials":136,"cells":6348},"Fondaparinux",{"EARLY_PHASE1":6349,"PHASE1":6351,"PHASE2":6353,"PHASE3":6355,"PHASE4":6357,"NA":6359},{"trials":6350,"activeCount":99},[],{"trials":6352,"activeCount":99},[],{"trials":6354,"activeCount":99},[],{"trials":6356,"activeCount":99},[],{"trials":6358,"activeCount":99},[],{"trials":6360,"activeCount":99},[6361],{"nctId":6362,"briefTitle":6363,"status":154,"phases":6364,"primaryCompletion":3648,"completion":3648,"start":5922,"enrollment":99,"conditions":6365,"interventions":6367},"NCT00378027","Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous Fondaparinux",[],[6366],"Pulmonary Embolism",[6347],{"intervention":6369,"totalTrials":136,"cells":6370},"general anesthesia followed by opioid analgesia",{"EARLY_PHASE1":6371,"PHASE1":6373,"PHASE2":6375,"PHASE3":6377,"PHASE4":6379,"NA":6381},{"trials":6372,"activeCount":99},[],{"trials":6374,"activeCount":99},[],{"trials":6376,"activeCount":99},[],{"trials":6378,"activeCount":99},[],{"trials":6380,"activeCount":99},[],{"trials":6382,"activeCount":99},[6383],{"nctId":6384,"briefTitle":6385,"status":154,"phases":6386,"primaryCompletion":3718,"completion":3718,"start":4084,"enrollment":99,"conditions":6387,"interventions":6389},"NCT00684229","Regional Anesthesia in Colon Rectal Surgery",[91],[6388],"Colon Cancer",[6369],{"intervention":6391,"totalTrials":136,"cells":6392},"Levetiracetam",{"EARLY_PHASE1":6393,"PHASE1":6395,"PHASE2":6397,"PHASE3":6399,"PHASE4":6401,"NA":6403},{"trials":6394,"activeCount":99},[],{"trials":6396,"activeCount":99},[],{"trials":6398,"activeCount":99},[],{"trials":6400,"activeCount":99},[],{"trials":6402,"activeCount":99},[],{"trials":6404,"activeCount":99},[6405],{"nctId":6406,"briefTitle":6407,"status":652,"phases":6408,"primaryCompletion":4084,"completion":4084,"start":6409,"enrollment":3707,"conditions":6410,"interventions":6414},"NCT00361010","A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy",[91],"2006-12",[6411,6412,6413],"Epilepsy","Childhood Absence Epilepsy","Seizures",[6391],{"intervention":6416,"totalTrials":136,"cells":6417},"Thymoglobulin 3mg total",{"EARLY_PHASE1":6418,"PHASE1":6420,"PHASE2":6422,"PHASE3":6424,"PHASE4":6426,"NA":6428},{"trials":6419,"activeCount":99},[],{"trials":6421,"activeCount":99},[],{"trials":6423,"activeCount":99},[],{"trials":6425,"activeCount":99},[],{"trials":6427,"activeCount":99},[],{"trials":6429,"activeCount":99},[6430],{"nctId":6431,"briefTitle":6432,"status":652,"phases":6433,"primaryCompletion":1893,"completion":4188,"start":6434,"enrollment":337,"conditions":6435,"interventions":6437},"NCT00970073","Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant",[91],"2009-08",[6436],"Liver Transplantation",[6416,6438,6439,6440,6441],"Thymoglobulin 4.5mg total","Mycophenolate mofetil","tacrolimus 3-8","tacrolimus 8-12",{"intervention":6438,"totalTrials":136,"cells":6443},{"EARLY_PHASE1":6444,"PHASE1":6446,"PHASE2":6448,"PHASE3":6450,"PHASE4":6452,"NA":6454},{"trials":6445,"activeCount":99},[],{"trials":6447,"activeCount":99},[],{"trials":6449,"activeCount":99},[],{"trials":6451,"activeCount":99},[],{"trials":6453,"activeCount":99},[],{"trials":6455,"activeCount":99},[6456],{"nctId":6431,"briefTitle":6432,"status":652,"phases":6457,"primaryCompletion":1893,"completion":4188,"start":6434,"enrollment":337,"conditions":6458,"interventions":6459},[91],[6436],[6416,6438,6439,6440,6441],{"intervention":6439,"totalTrials":136,"cells":6461},{"EARLY_PHASE1":6462,"PHASE1":6464,"PHASE2":6466,"PHASE3":6468,"PHASE4":6470,"NA":6472},{"trials":6463,"activeCount":99},[],{"trials":6465,"activeCount":99},[],{"trials":6467,"activeCount":99},[],{"trials":6469,"activeCount":99},[],{"trials":6471,"activeCount":99},[],{"trials":6473,"activeCount":99},[6474],{"nctId":6431,"briefTitle":6432,"status":652,"phases":6475,"primaryCompletion":1893,"completion":4188,"start":6434,"enrollment":337,"conditions":6476,"interventions":6477},[91],[6436],[6416,6438,6439,6440,6441],{"intervention":6440,"totalTrials":136,"cells":6479},{"EARLY_PHASE1":6480,"PHASE1":6482,"PHASE2":6484,"PHASE3":6486,"PHASE4":6488,"NA":6490},{"trials":6481,"activeCount":99},[],{"trials":6483,"activeCount":99},[],{"trials":6485,"activeCount":99},[],{"trials":6487,"activeCount":99},[],{"trials":6489,"activeCount":99},[],{"trials":6491,"activeCount":99},[6492],{"nctId":6431,"briefTitle":6432,"status":652,"phases":6493,"primaryCompletion":1893,"completion":4188,"start":6434,"enrollment":337,"conditions":6494,"interventions":6495},[91],[6436],[6416,6438,6439,6440,6441],{"intervention":6441,"totalTrials":136,"cells":6497},{"EARLY_PHASE1":6498,"PHASE1":6500,"PHASE2":6502,"PHASE3":6504,"PHASE4":6506,"NA":6508},{"trials":6499,"activeCount":99},[],{"trials":6501,"activeCount":99},[],{"trials":6503,"activeCount":99},[],{"trials":6505,"activeCount":99},[],{"trials":6507,"activeCount":99},[],{"trials":6509,"activeCount":99},[6510],{"nctId":6431,"briefTitle":6432,"status":652,"phases":6511,"primaryCompletion":1893,"completion":4188,"start":6434,"enrollment":337,"conditions":6512,"interventions":6513},[91],[6436],[6416,6438,6439,6440,6441],{"intervention":6515,"totalTrials":136,"cells":6516},"Lidoderm 5 % Topical Patch",{"EARLY_PHASE1":6517,"PHASE1":6519,"PHASE2":6521,"PHASE3":6523,"PHASE4":6525,"NA":6527},{"trials":6518,"activeCount":99},[],{"trials":6520,"activeCount":99},[],{"trials":6522,"activeCount":99},[],{"trials":6524,"activeCount":99},[],{"trials":6526,"activeCount":99},[],{"trials":6528,"activeCount":99},[6529],{"nctId":6530,"briefTitle":6531,"status":652,"phases":6532,"primaryCompletion":5994,"completion":5994,"start":1800,"enrollment":719,"conditions":6533,"interventions":6535},"NCT03120351","Lidocaine 5% Patch (Lidoderm) for the Prevention of Acute and Chest Pain Following Robotic Valve Surgery",[91],[6534],"Perioperative Chest Pain",[6515],{"intervention":5574,"totalTrials":136,"cells":6537},{"EARLY_PHASE1":6538,"PHASE1":6540,"PHASE2":6542,"PHASE3":6544,"PHASE4":6546,"NA":6548},{"trials":6539,"activeCount":99},[],{"trials":6541,"activeCount":99},[],{"trials":6543,"activeCount":99},[],{"trials":6545,"activeCount":99},[],{"trials":6547,"activeCount":99},[],{"trials":6549,"activeCount":99},[6550],{"nctId":5564,"briefTitle":5565,"status":652,"phases":6551,"primaryCompletion":5567,"completion":5568,"start":5569,"enrollment":5570,"conditions":6552,"interventions":6553},[91],[5572],[5574,5575],{"intervention":6555,"totalTrials":136,"cells":6556},"Nefopam Low dose",{"EARLY_PHASE1":6557,"PHASE1":6559,"PHASE2":6561,"PHASE3":6563,"PHASE4":6565,"NA":6567},{"trials":6558,"activeCount":99},[],{"trials":6560,"activeCount":99},[],{"trials":6562,"activeCount":99},[],{"trials":6564,"activeCount":99},[],{"trials":6566,"activeCount":99},[],{"trials":6568,"activeCount":99},[6569],{"nctId":6570,"briefTitle":6571,"status":652,"phases":6572,"primaryCompletion":3332,"completion":3332,"start":3891,"enrollment":2701,"conditions":6573,"interventions":6574},"NCT03122665","Effectiveness of Nefopam for Thermoregulation During Surgery",[91],[2703],[6555,6575],"Nefopam High dose",{"intervention":6575,"totalTrials":136,"cells":6577},{"EARLY_PHASE1":6578,"PHASE1":6580,"PHASE2":6582,"PHASE3":6584,"PHASE4":6586,"NA":6588},{"trials":6579,"activeCount":99},[],{"trials":6581,"activeCount":99},[],{"trials":6583,"activeCount":99},[],{"trials":6585,"activeCount":99},[],{"trials":6587,"activeCount":99},[],{"trials":6589,"activeCount":99},[6590],{"nctId":6570,"briefTitle":6571,"status":652,"phases":6591,"primaryCompletion":3332,"completion":3332,"start":3891,"enrollment":2701,"conditions":6592,"interventions":6593},[91],[2703],[6555,6575],{"intervention":6595,"totalTrials":136,"cells":6596},"Bactrim",{"EARLY_PHASE1":6597,"PHASE1":6599,"PHASE2":6601,"PHASE3":6603,"PHASE4":6605,"NA":6607},{"trials":6598,"activeCount":99},[],{"trials":6600,"activeCount":99},[],{"trials":6602,"activeCount":99},[],{"trials":6604,"activeCount":99},[],{"trials":6606,"activeCount":99},[],{"trials":6608,"activeCount":99},[6609],{"nctId":6610,"briefTitle":6611,"status":111,"phases":6612,"primaryCompletion":5489,"completion":5489,"start":6198,"enrollment":6613,"conditions":6614,"interventions":6616},"NCT01108757","Prevention of Catheter-Associated Urinary Tract Infection in Incontinence and Reconstructive Pelvic Surgery Patients",[91],52,[6615],"Catheter-Associated Urinary Tract Infection",[6595],{"intervention":6618,"totalTrials":136,"cells":6619},"Botulinum toxin",{"EARLY_PHASE1":6620,"PHASE1":6622,"PHASE2":6624,"PHASE3":6626,"PHASE4":6628,"NA":6630},{"trials":6621,"activeCount":99},[],{"trials":6623,"activeCount":99},[],{"trials":6625,"activeCount":99},[],{"trials":6627,"activeCount":99},[],{"trials":6629,"activeCount":99},[],{"trials":6631,"activeCount":99},[6632],{"nctId":6633,"briefTitle":6634,"status":652,"phases":6635,"primaryCompletion":2965,"completion":6636,"start":2893,"enrollment":2320,"conditions":6637,"interventions":6638},"NCT02909907","Comparison of Botulinum Toxin Injections in Forearm FLexor Plus EXtensor Muscles vs. Flexor Muscles Alone for Treatment of Essential Hand Tremor(FLEX-D ET)",[91],"2018-02-28",[1218],[6618],{"intervention":6640,"totalTrials":136,"cells":6641},"Carvedilol",{"EARLY_PHASE1":6642,"PHASE1":6644,"PHASE2":6646,"PHASE3":6648,"PHASE4":6650,"NA":6652},{"trials":6643,"activeCount":99},[],{"trials":6645,"activeCount":99},[],{"trials":6647,"activeCount":99},[],{"trials":6649,"activeCount":99},[],{"trials":6651,"activeCount":99},[],{"trials":6653,"activeCount":99},[6654],{"nctId":6655,"briefTitle":6656,"status":652,"phases":6657,"primaryCompletion":5377,"completion":5377,"start":6658,"enrollment":337,"conditions":6659,"interventions":6660},"NCT01586156","PAHTCH Pulmonary Arterial Hypertension Treatment With Carvedilol for Heart Failure (Carvedilol)",[91],"2012-12",[6224],[6640],{"intervention":6662,"totalTrials":136,"cells":6663},"SAVR Warfarin",{"EARLY_PHASE1":6664,"PHASE1":6666,"PHASE2":6668,"PHASE3":6670,"PHASE4":6672,"NA":6674},{"trials":6665,"activeCount":99},[],{"trials":6667,"activeCount":99},[],{"trials":6669,"activeCount":99},[],{"trials":6671,"activeCount":99},[],{"trials":6673,"activeCount":99},[],{"trials":6675,"activeCount":99},[6676],{"nctId":6677,"briefTitle":6678,"status":111,"phases":6679,"primaryCompletion":6680,"completion":6680,"start":2319,"enrollment":2902,"conditions":6681,"interventions":6683},"NCT02696226","Frequency of Reduced Leaflet Motion After Surgical Aortic Valve Replacement and Transcatheter Aortic Valve Replacement.",[91],"2017-07-28",[6682],"Aortic Valve Disorder",[6662,6684,6685,6686],"SAVR Aspirin","TAVR Warfarin and clopidogrel","TAVR Aspirin and clopidogrel",{"intervention":6684,"totalTrials":136,"cells":6688},{"EARLY_PHASE1":6689,"PHASE1":6691,"PHASE2":6693,"PHASE3":6695,"PHASE4":6697,"NA":6699},{"trials":6690,"activeCount":99},[],{"trials":6692,"activeCount":99},[],{"trials":6694,"activeCount":99},[],{"trials":6696,"activeCount":99},[],{"trials":6698,"activeCount":99},[],{"trials":6700,"activeCount":99},[6701],{"nctId":6677,"briefTitle":6678,"status":111,"phases":6702,"primaryCompletion":6680,"completion":6680,"start":2319,"enrollment":2902,"conditions":6703,"interventions":6704},[91],[6682],[6662,6684,6685,6686],{"intervention":6685,"totalTrials":136,"cells":6706},{"EARLY_PHASE1":6707,"PHASE1":6709,"PHASE2":6711,"PHASE3":6713,"PHASE4":6715,"NA":6717},{"trials":6708,"activeCount":99},[],{"trials":6710,"activeCount":99},[],{"trials":6712,"activeCount":99},[],{"trials":6714,"activeCount":99},[],{"trials":6716,"activeCount":99},[],{"trials":6718,"activeCount":99},[6719],{"nctId":6677,"briefTitle":6678,"status":111,"phases":6720,"primaryCompletion":6680,"completion":6680,"start":2319,"enrollment":2902,"conditions":6721,"interventions":6722},[91],[6682],[6662,6684,6685,6686],{"intervention":6686,"totalTrials":136,"cells":6724},{"EARLY_PHASE1":6725,"PHASE1":6727,"PHASE2":6729,"PHASE3":6731,"PHASE4":6733,"NA":6735},{"trials":6726,"activeCount":99},[],{"trials":6728,"activeCount":99},[],{"trials":6730,"activeCount":99},[],{"trials":6732,"activeCount":99},[],{"trials":6734,"activeCount":99},[],{"trials":6736,"activeCount":99},[6737],{"nctId":6677,"briefTitle":6678,"status":111,"phases":6738,"primaryCompletion":6680,"completion":6680,"start":2319,"enrollment":2902,"conditions":6739,"interventions":6740},[91],[6682],[6662,6684,6685,6686],{"intervention":6742,"totalTrials":136,"cells":6743},"phenylephrine and clonidine",{"EARLY_PHASE1":6744,"PHASE1":6746,"PHASE2":6748,"PHASE3":6750,"PHASE4":6752,"NA":6754},{"trials":6745,"activeCount":99},[],{"trials":6747,"activeCount":99},[],{"trials":6749,"activeCount":99},[],{"trials":6751,"activeCount":99},[],{"trials":6753,"activeCount":99},[],{"trials":6755,"activeCount":99},[6756],{"nctId":6757,"briefTitle":6758,"status":111,"phases":6759,"primaryCompletion":1462,"completion":2628,"start":2676,"enrollment":6760,"conditions":6761,"interventions":6763},"NCT01813149","Mechanism and Treatment of Sympathetically Maintained Pain",[91],128,[6762],"Complex Regional Pain Syndrome (CRPS)",[6742],{"intervention":6765,"totalTrials":136,"cells":6766},"rTPA Treatment",{"EARLY_PHASE1":6767,"PHASE1":6769,"PHASE2":6771,"PHASE3":6773,"PHASE4":6775,"NA":6777},{"trials":6768,"activeCount":99},[],{"trials":6770,"activeCount":99},[],{"trials":6772,"activeCount":99},[],{"trials":6774,"activeCount":99},[],{"trials":6776,"activeCount":99},[],{"trials":6778,"activeCount":99},[6779],{"nctId":6780,"briefTitle":6781,"status":652,"phases":6782,"primaryCompletion":3716,"completion":6783,"start":6198,"enrollment":3011,"conditions":6784,"interventions":6785},"NCT01197573","Enhancing Donated After Cardiac Death (DCD) Utilization With Thrombolytic Therapy",[91],"2018-05",[6436,5572],[6765],{"intervention":6787,"totalTrials":136,"cells":6788},"Same day 4 L preparation",{"EARLY_PHASE1":6789,"PHASE1":6791,"PHASE2":6793,"PHASE3":6795,"PHASE4":6797,"NA":6799},{"trials":6790,"activeCount":99},[],{"trials":6792,"activeCount":99},[],{"trials":6794,"activeCount":99},[],{"trials":6796,"activeCount":99},[],{"trials":6798,"activeCount":99},[],{"trials":6800,"activeCount":99},[6801],{"nctId":6802,"briefTitle":6803,"status":652,"phases":6804,"primaryCompletion":6805,"completion":6805,"start":4188,"enrollment":607,"conditions":6806,"interventions":6808},"NCT02643316","Morning-Only 4 L PEG vs Split Dose Prep for Afternoon Colonoscopies, Endoscopist-Blinded Prospective Study",[91],"2019-08",[6807],"Colonoscopy",[6787,6809],"Split dose 4 L preparation",{"intervention":6809,"totalTrials":136,"cells":6811},{"EARLY_PHASE1":6812,"PHASE1":6814,"PHASE2":6816,"PHASE3":6818,"PHASE4":6820,"NA":6822},{"trials":6813,"activeCount":99},[],{"trials":6815,"activeCount":99},[],{"trials":6817,"activeCount":99},[],{"trials":6819,"activeCount":99},[],{"trials":6821,"activeCount":99},[],{"trials":6823,"activeCount":99},[6824],{"nctId":6802,"briefTitle":6803,"status":652,"phases":6825,"primaryCompletion":6805,"completion":6805,"start":4188,"enrollment":607,"conditions":6826,"interventions":6827},[91],[6807],[6787,6809],{"intervention":6829,"totalTrials":136,"cells":6830},"Gabapentin enacarbil",{"EARLY_PHASE1":6831,"PHASE1":6833,"PHASE2":6835,"PHASE3":6837,"PHASE4":6839,"NA":6841},{"trials":6832,"activeCount":99},[],{"trials":6834,"activeCount":99},[],{"trials":6836,"activeCount":99},[],{"trials":6838,"activeCount":99},[],{"trials":6840,"activeCount":99},[],{"trials":6842,"activeCount":99},[6843],{"nctId":6844,"briefTitle":6845,"status":652,"phases":6846,"primaryCompletion":6847,"completion":3585,"start":6848,"enrollment":6849,"conditions":6850,"interventions":6851},"NCT02840240","Effect of Gabapentin Enacarbil on Opioid Consumption and Pain Scores",[91],"2018-11-30","2016-01",107,[29],[6829],{"intervention":5532,"totalTrials":136,"cells":6853},{"EARLY_PHASE1":6854,"PHASE1":6856,"PHASE2":6858,"PHASE3":6860,"PHASE4":6862,"NA":6864},{"trials":6855,"activeCount":99},[],{"trials":6857,"activeCount":99},[],{"trials":6859,"activeCount":99},[],{"trials":6861,"activeCount":99},[],{"trials":6863,"activeCount":99},[],{"trials":6865,"activeCount":99},[6866],{"nctId":5525,"briefTitle":5526,"status":111,"phases":6867,"primaryCompletion":5528,"completion":5528,"start":884,"enrollment":22,"conditions":6868,"interventions":6869},[91],[29,5530],[5336,5532],{"intervention":6871,"totalTrials":136,"cells":6872},"Human albumin",{"EARLY_PHASE1":6873,"PHASE1":6875,"PHASE2":6877,"PHASE3":6879,"PHASE4":6881,"NA":6883},{"trials":6874,"activeCount":99},[],{"trials":6876,"activeCount":99},[],{"trials":6878,"activeCount":99},[],{"trials":6880,"activeCount":99},[],{"trials":6882,"activeCount":99},[],{"trials":6884,"activeCount":99},[6885],{"nctId":6886,"briefTitle":6887,"status":652,"phases":6888,"primaryCompletion":6889,"completion":6889,"start":1462,"enrollment":6890,"conditions":6891,"interventions":6892},"NCT02882074","Endothelial Function After Cardiac Surgery",[91],"2020-02-20",85,[5176],[6871,6893],"Hydroxyethyl starch",{"intervention":6893,"totalTrials":136,"cells":6895},{"EARLY_PHASE1":6896,"PHASE1":6898,"PHASE2":6900,"PHASE3":6902,"PHASE4":6904,"NA":6906},{"trials":6897,"activeCount":99},[],{"trials":6899,"activeCount":99},[],{"trials":6901,"activeCount":99},[],{"trials":6903,"activeCount":99},[],{"trials":6905,"activeCount":99},[],{"trials":6907,"activeCount":99},[6908],{"nctId":6886,"briefTitle":6887,"status":652,"phases":6909,"primaryCompletion":6889,"completion":6889,"start":1462,"enrollment":6890,"conditions":6910,"interventions":6911},[91],[5176],[6871,6893],{"intervention":6913,"totalTrials":136,"cells":6914},"IV Acetaminophen",{"EARLY_PHASE1":6915,"PHASE1":6917,"PHASE2":6919,"PHASE3":6921,"PHASE4":6923,"NA":6925},{"trials":6916,"activeCount":99},[],{"trials":6918,"activeCount":99},[],{"trials":6920,"activeCount":99},[],{"trials":6922,"activeCount":99},[],{"trials":6924,"activeCount":99},[],{"trials":6926,"activeCount":99},[6927],{"nctId":6928,"briefTitle":6929,"status":652,"phases":6930,"primaryCompletion":3104,"completion":2967,"start":4515,"enrollment":131,"conditions":6931,"interventions":6932},"NCT01822821","Pain Control After Cardiac Surgery Using Intravenous Acetaminophen",[91],[29],[6913],{"intervention":5387,"totalTrials":136,"cells":6934},{"EARLY_PHASE1":6935,"PHASE1":6937,"PHASE2":6939,"PHASE3":6941,"PHASE4":6943,"NA":6945},{"trials":6936,"activeCount":99},[],{"trials":6938,"activeCount":99},[],{"trials":6940,"activeCount":99},[],{"trials":6942,"activeCount":99},[],{"trials":6944,"activeCount":99},[],{"trials":6946,"activeCount":99},[6947],{"nctId":5381,"briefTitle":5382,"status":111,"phases":6948,"primaryCompletion":5384,"completion":5384,"start":3890,"enrollment":5330,"conditions":6949,"interventions":6950},[91],[29],[3015,5387,5337,2010],{"intervention":5445,"totalTrials":136,"cells":6952},{"EARLY_PHASE1":6953,"PHASE1":6955,"PHASE2":6957,"PHASE3":6959,"PHASE4":6961,"NA":6963},{"trials":6954,"activeCount":99},[],{"trials":6956,"activeCount":99},[],{"trials":6958,"activeCount":99},[],{"trials":6960,"activeCount":99},[],{"trials":6962,"activeCount":99},[],{"trials":6964,"activeCount":99},[6965],{"nctId":5440,"briefTitle":5441,"status":111,"phases":6966,"primaryCompletion":5197,"completion":5197,"start":895,"enrollment":1801,"conditions":6967,"interventions":6968},[91],[15],[5445,2010],{"intervention":6970,"totalTrials":136,"cells":6971},"Prolonged RBC storage",{"EARLY_PHASE1":6972,"PHASE1":6974,"PHASE2":6976,"PHASE3":6978,"PHASE4":6980,"NA":6982},{"trials":6973,"activeCount":99},[],{"trials":6975,"activeCount":99},[],{"trials":6977,"activeCount":99},[],{"trials":6979,"activeCount":99},[],{"trials":6981,"activeCount":99},[],{"trials":6983,"activeCount":99},[6984],{"nctId":6985,"briefTitle":6986,"status":652,"phases":6987,"primaryCompletion":1665,"completion":6988,"start":3648,"enrollment":6989,"conditions":6990,"interventions":6993},"NCT00458783","Red Cell Storage Duration and Outcomes in Cardiac Surgery",[91],"2019-01-16",3942,[6991,6992],"Blood Transfusion","Cardiac Surgery",[6970,6994],"Short RBC storage",{"intervention":6994,"totalTrials":136,"cells":6996},{"EARLY_PHASE1":6997,"PHASE1":6999,"PHASE2":7001,"PHASE3":7003,"PHASE4":7005,"NA":7007},{"trials":6998,"activeCount":99},[],{"trials":7000,"activeCount":99},[],{"trials":7002,"activeCount":99},[],{"trials":7004,"activeCount":99},[],{"trials":7006,"activeCount":99},[],{"trials":7008,"activeCount":99},[7009],{"nctId":6985,"briefTitle":6986,"status":652,"phases":7010,"primaryCompletion":1665,"completion":6988,"start":3648,"enrollment":6989,"conditions":7011,"interventions":7012},[91],[6991,6992],[6970,6994],{"intervention":7014,"totalTrials":136,"cells":7015},"Crystalloid",{"EARLY_PHASE1":7016,"PHASE1":7018,"PHASE2":7020,"PHASE3":7022,"PHASE4":7024,"NA":7026},{"trials":7017,"activeCount":99},[],{"trials":7019,"activeCount":99},[],{"trials":7021,"activeCount":99},[],{"trials":7023,"activeCount":99},[],{"trials":7025,"activeCount":99},[],{"trials":7027,"activeCount":99},[7028],{"nctId":7029,"briefTitle":7030,"status":652,"phases":7031,"primaryCompletion":2005,"completion":7032,"start":3807,"enrollment":7033,"conditions":7034,"interventions":7036},"NCT01195883","Effect of Goal-directed Crystalloid Versus Colloid Administration on Major Postoperative Morbidity",[91],"2017-10-20",1102,[7035],"Postoperative Complications",[7014,7037],"Colloid",{"intervention":7037,"totalTrials":136,"cells":7039},{"EARLY_PHASE1":7040,"PHASE1":7042,"PHASE2":7044,"PHASE3":7046,"PHASE4":7048,"NA":7050},{"trials":7041,"activeCount":99},[],{"trials":7043,"activeCount":99},[],{"trials":7045,"activeCount":99},[],{"trials":7047,"activeCount":99},[],{"trials":7049,"activeCount":99},[],{"trials":7051,"activeCount":99},[7052],{"nctId":7029,"briefTitle":7030,"status":652,"phases":7053,"primaryCompletion":2005,"completion":7032,"start":3807,"enrollment":7033,"conditions":7054,"interventions":7055},[91],[7035],[7014,7037],{"intervention":7057,"totalTrials":136,"cells":7058},"epoetin alfa",{"EARLY_PHASE1":7059,"PHASE1":7061,"PHASE2":7063,"PHASE3":7065,"PHASE4":7067,"NA":7069},{"trials":7060,"activeCount":99},[],{"trials":7062,"activeCount":99},[],{"trials":7064,"activeCount":99},[],{"trials":7066,"activeCount":99},[],{"trials":7068,"activeCount":99},[],{"trials":7070,"activeCount":99},[7071],{"nctId":7072,"briefTitle":7073,"status":652,"phases":7074,"primaryCompletion":7075,"completion":5489,"start":2790,"enrollment":9,"conditions":7076,"interventions":7079},"NCT00400686","Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma",[91],"2009-01",[7077,4879,7078],"Anemia","Plasma Cell Neoplasm",[7057],{"intervention":7081,"totalTrials":136,"cells":7082},"intranasal ketorolac",{"EARLY_PHASE1":7083,"PHASE1":7085,"PHASE2":7087,"PHASE3":7089,"PHASE4":7091,"NA":7093},{"trials":7084,"activeCount":99},[],{"trials":7086,"activeCount":99},[],{"trials":7088,"activeCount":99},[],{"trials":7090,"activeCount":99},[],{"trials":7092,"activeCount":99},[],{"trials":7094,"activeCount":99},[7095],{"nctId":7096,"briefTitle":7097,"status":652,"phases":7098,"primaryCompletion":4514,"completion":4514,"start":1576,"enrollment":7099,"conditions":7100,"interventions":7102},"NCT01471639","An Efficacy and Safety Trial of Intranasal Ketorolac in Emergency Department Patients for the Treatment of Acute Pain",[91],37,[7101],"Other Acute Pain",[7081],{"intervention":7104,"totalTrials":136,"cells":7105},"Fluocinolone Acetonide",{"EARLY_PHASE1":7106,"PHASE1":7108,"PHASE2":7110,"PHASE3":7112,"PHASE4":7114,"NA":7116},{"trials":7107,"activeCount":99},[],{"trials":7109,"activeCount":99},[],{"trials":7111,"activeCount":99},[],{"trials":7113,"activeCount":99},[],{"trials":7115,"activeCount":99},[],{"trials":7117,"activeCount":99},[7118],{"nctId":7119,"briefTitle":7120,"status":652,"phases":7121,"primaryCompletion":1171,"completion":1171,"start":7122,"enrollment":337,"conditions":7123,"interventions":7125},"NCT04340505","Imaging of Uveitis Patients Receiving Injectable Fluocinolone Acetonide Implant",[],"2019-08-08",[7124],"Uveitis",[7104],{"intervention":5956,"totalTrials":136,"cells":7127},{"EARLY_PHASE1":7128,"PHASE1":7130,"PHASE2":7132,"PHASE3":7134,"PHASE4":7136,"NA":7138},{"trials":7129,"activeCount":99},[],{"trials":7131,"activeCount":99},[],{"trials":7133,"activeCount":99},[],{"trials":7135,"activeCount":99},[],{"trials":7137,"activeCount":99},[],{"trials":7139,"activeCount":99},[7140],{"nctId":5945,"briefTitle":5946,"status":154,"phases":7141,"primaryCompletion":5948,"completion":5948,"start":883,"enrollment":99,"conditions":7142,"interventions":7143},[91],[611,5950,614,5951,5952,5953,5954],[2897,5956],{"intervention":956,"totalTrials":136,"cells":7145},{"EARLY_PHASE1":7146,"PHASE1":7148,"PHASE2":7150,"PHASE3":7152,"PHASE4":7154,"NA":7156},{"trials":7147,"activeCount":99},[],{"trials":7149,"activeCount":99},[],{"trials":7151,"activeCount":99},[],{"trials":7153,"activeCount":99},[],{"trials":7155,"activeCount":99},[],{"trials":7157,"activeCount":99},[7158],{"nctId":945,"briefTitle":946,"status":652,"phases":7159,"primaryCompletion":948,"completion":948,"start":949,"enrollment":950,"conditions":7160,"interventions":7161},[91],[952,953,954],[841,956],{"intervention":7163,"totalTrials":136,"cells":7164},"Fenoldopam",{"EARLY_PHASE1":7165,"PHASE1":7167,"PHASE2":7169,"PHASE3":7171,"PHASE4":7173,"NA":7175},{"trials":7166,"activeCount":99},[],{"trials":7168,"activeCount":99},[],{"trials":7170,"activeCount":99},[],{"trials":7172,"activeCount":99},[],{"trials":7174,"activeCount":99},[],{"trials":7176,"activeCount":99},[7177],{"nctId":7178,"briefTitle":7179,"status":111,"phases":7180,"primaryCompletion":5528,"completion":5528,"start":7181,"enrollment":1667,"conditions":7182,"interventions":7184},"NCT00743106","The Effect of Fenoldopam in Solitary Partial Nephrectomy Surgery",[91],"2002-09",[7183],"Partial Nephrectomy",[7163],{"intervention":7186,"totalTrials":136,"cells":7187},"Propofol + Remifentanil",{"EARLY_PHASE1":7188,"PHASE1":7190,"PHASE2":7192,"PHASE3":7194,"PHASE4":7196,"NA":7198},{"trials":7189,"activeCount":99},[],{"trials":7191,"activeCount":99},[],{"trials":7193,"activeCount":99},[],{"trials":7195,"activeCount":99},[],{"trials":7197,"activeCount":99},[],{"trials":7199,"activeCount":99},[7200],{"nctId":7201,"briefTitle":7202,"status":154,"phases":7203,"primaryCompletion":7204,"completion":7204,"start":2789,"enrollment":99,"conditions":7205,"interventions":7207},"NCT00555984","Intravenous Anesthesia Versus Anesthesia With Volatile Agents in Elective Craniotomy for Tumors",[91],"2010-03",[7206],"Brain Neoplasms",[7186,7208],"Sevoflurane + Remifentanil",{"intervention":7208,"totalTrials":136,"cells":7210},{"EARLY_PHASE1":7211,"PHASE1":7213,"PHASE2":7215,"PHASE3":7217,"PHASE4":7219,"NA":7221},{"trials":7212,"activeCount":99},[],{"trials":7214,"activeCount":99},[],{"trials":7216,"activeCount":99},[],{"trials":7218,"activeCount":99},[],{"trials":7220,"activeCount":99},[],{"trials":7222,"activeCount":99},[7223],{"nctId":7201,"briefTitle":7202,"status":154,"phases":7224,"primaryCompletion":7204,"completion":7204,"start":2789,"enrollment":99,"conditions":7225,"interventions":7226},[91],[7206],[7186,7208]]